Quarterlytics / Financial Services / ClearView

ClearView

cvw · ASX Financial Services
Claim this profile
Ticker cvw
Exchange ASX
Sector Financial Services
Industry
Employees 201-500
← All annual reports
FY2015 Annual Report · ClearView
Sign in to download
Loading PDF…
Annual Report 2015
Purpose built for our time

Contents

2 

3 

4 

6 

9 

Financial Highlights

Our Values

Chairman’s Letter

Managing Director’s Report

Directors’ Report 

17  Operating and Financial Review

42 

Remuneration Report

Financial Calendar

Annual General Meeting 
11 November 2015

Half Year End 
31 December 2015

Half Year Result Announcement 
February 2016

Year End 
30 June 2016

Annual Report 
August 2016

58  Auditor’s Independence Declaration

Dates are subject to change.

59 

Financial Report

143  Directors’ Declaration

144  Independent Auditor’s Report

146  Shareholders’ Information

150  Directory

1     ClearView Annual Report 2015

ClearView Wealth Limited2015 Financial Highlights

After Tax Profit by Segment, $m

Life Insurance

Wealth Management

Financial Advice

Business Unit Operating Earnings (after tax)

Listed Entity and Other

Total Operating Earnings (after tax)1

Interest expense on corporate debt (after tax)

Underlying NPAT2

Other Adjustments

NPATA3

Amortisation

Reported NPAT

Underlying diluted EPS (cps)

Reported diluted EPS (cps)

Dividend per share (dps)

FY15

15.3 

1.8 

4.4 

21.5 

(0.6)

20.9 

(0.4)

20.5 

1.0

21.5

(9.0)

12.5 

3.85 

2.36 

2.10

FY14

% Change

10.8 

5.9 

3.5 

20.2 

(0.5)

19.7 

0.0 

19.7 

1.6

21.3

(7.4)

13.9 

4.41 

3.10 

2.00

 41% 

(70%)

 27% 

 6% 

(34%)

 6% 

Large

 4% 

(35%) 

1%

 21%

(10%)

(13%)

(24%)

5%

1 

2 

3 

 Total Operating Earnings NPAT represents the Underlying NPAT2 of each of the operating business units before taking into account the interest costs associated 
with corporate debt. 
 Underlying net profit after tax is the Board’s key measure of group profitability and the basis on which dividend payments are determined. It consists of con-
solidated profit after tax adjusted for amortisation (not including capitalised software), the effect of changing discount rates on insurance policy liabilities and 
costs considered unusual to the Group’s ordinary activities.
 NPATA is reported net profit after tax adjusted to exclude the non-cash amortisation of acquired intangibles (not including capitalised software).

Life Insurance

Wealth Management

Financial Advice

In-force Premium

Funds Under Management

Financial Advisers

115.7

87.5

62.1

41.0

41.0

44.1

2010

2011

2012

2013

2014

2015

2.0

1.5

$B

1.0

0.5

0.0

1.90

1.57

1.52

1.38

1.66

1.53

2010

2011

2012

2013

2014

2015

250

200

150

100

50

0

221

82

127

117

98

19

2014

12
2015

55

27

28

70

42

28

102

81

21

2011

2012

2013

Old Book

Non-Advice

LifeSolutions

WealthFoundations

WealthSolutions

Master Trust

Self Employed (Matrix)

Self Employed (CVW)

Employed (CVW)

2.0

1.5

1.0

0.5

0.0

250

200

ClearView Annual Report 2015     2

150

100

50

0

55

27

28

70

42

28

221

82

127

117

98

102

81

21

19

2014

12

2015

Old Book

Non-Advice

LifeSolutions

WealthFoundations

WealthSolutions

Master Trust

Self Employed (Matrix)

Self Employed (CVW)

Employed (CVW)

2010

2011

2012

2013

2014

2015

2011

2012

2013

120

100

80

$M

60

40

20

0

120

100

80

60

40

20

0

ClearView Wealth LimitedOur Values

At ClearView we respond quicker, we care more and we try harder. Why?  
Because we focus only on building and protecting the financial futures of our 
customers and their families, which means we won’t be distracted from this 
mission. So every time our exceptional people decide on something,  
it gets done really, really well.

We’re never satisfied when it comes to doing better 
and we never give up on our people, our customers, our 
partners and the moments that matter. Nothing really 
good has ever come about because someone gave up.  
So if there’s a better way to do it, we’ll find it. 

‘ Ambition is the path to success, PERSISTENCE is the 
vehicle you arrive in.’

We believe that working together benefits the customer 
and that two heads are better than one, and a lot more 
fun. Three are better still. We want more perspectives not 
less. We are a group of like-minded passionate people 
who turn up every day to share, help and be better than 
yesterday... together.

‘ As you navigate through the rest of your life, be open to 
COLLABORATION. Find a group of people who challenge 
and inspire you, spend a lot of time with them, and it will 
change your life.’

A handshake... giving your word... committing... 
promising... and then actually delivering! If these things 
come in shades of grey to you we’re not going to get  
along very well. Only 3 colours matter here -  
right, wrong and the vibrant pink on our logo.

‘ If you have INTEGRITY, nothing else matters. If you 
don’t have INTEGRITY, nothing else matters.’

We’re also proud to never compromise when selecting 
our people and there’s nothing we hate more than fake. 
Only positive, genuine people need apply. Honest people. 
Open. Able to say sorry and admit they were wrong. Tell it 
like it is. Argue their case but accept a decision. What you 
see is what you get.

‘The AUTHENTIC self is the soul made visible.’

3     ClearView Annual Report 2015

ClearView Wealth LimitedChairman’s Letter

Dear Shareholders 

We are pleased to report that the investments made over the past three years are starting to flow 
through from operational results with material earnings growth expected to emerge in FY16. 

This is the third Chairman’s letter that I have drafted for 
ClearView and represents a point of inflection for the 
business. Over the past two Chairman’s letters, I have focused 
on the strategy that the Board has put in place for your 
business, setting out that ClearView was on a three year 
process of investing first in building out its life advice offering 
in FY13, then investing in direct life in FY14 and in the past 
year investing in wealth management. As I noted in previous 
letters, each of these investments involved a substantial 
investment which preceded revenue and profit growth (often 
called a "J Curve" investment), with the expenses associated 
in building out the businesses acting as a drag on earnings.

In this third letter, I can now report that the initial phases 
of the platform that ClearView has been building are 
substantially complete. ClearView now has competitive 
offerings in both the life insurance and the wealth 
management markets. This included the launch of a new 
LifeSolutions product upgrade and the WealthFoundations 
mid market product offering over the past 12 months. This 
is not to say that significant work is not still required, but 
the initial platforms have now been established and going 
forward, the Board believes that the business is through the 
bottom of the "J Curves" of each of its underlying business 
units. In addition, we are aiming to build a high quality advice 
capability which has been enhanced with the merger with 
Matrix.

The early investments that ClearView made in FY13 and FY14 
are now translating into strong earnings momentum with 
life insurance underlying profit increasing by 41% in FY15. 
The overall Underlying Net Profit after Tax (UNPAT) growth in 
FY15 remains modest at 4%, however, this was driven by the 
decision, which was clearly communicated to the market, 
that FY15 remained an investment year, in particular in our 
wealth management business. Overall, ClearView met our 
expectations.

The challenge for ClearView is to now translate the past three 
years of investment into substantial earnings momentum 
going forward. Early indications are positive, and given the 
compounding nature of both life insurance and wealth 
management this should start to flow through into material 
profit growth in FY16.

Operating and Financial Results 

ClearView again achieved strong positive momentum in its 
key operating metrics in FY15:

• 

• 

• 

 Life Insurance: in-force premium is up 32% to $115.7 
million with new business written up 26% to $34.5 million;

 Wealth Management: Funds Under Management (FUM) is 
up 15% to $1.9 billion; net inflows achieved in FY15 were 
a positive $112 million which reflects the launch of our 
new product, WealthFoundations (net flows were broadly 
neutral in FY14); and

 Financial Advice: The Matrix merger provides a stepped 
change with adviser numbers up 89% to 221; Premiums 
Under Advice is up 99% to $187 million and Funds Under 
Management and Advice (FUMA) is up 92% to $7.9 billion.

These operational metrics generally lead to solid growth in 
financial metrics over time given the compound nature of the 
underlying businesses in which we operate:

• 

• 

• 

• 

 UNPAT is up 4% to $20.5 million and consistent with  
expectations;

 UNPAT from life insurance is up 41% to $15.3 million 
which is reflective of the business starting to gain 
additional scale and the emergence of profits from the 
growing in-force portfolios;

 Embedded value is up 9% to $389 million (at a 4% 
discount rate margin) and the Value of New Business 
up 66% to $15.8 million. The growth in Embedded 
Value and the Value of New Business was constrained 
by expense overruns which are reflective of ClearView 
having built an operating structure suitable for the 
scale it aspires to. These expense overruns will likely be 
absorbed in the medium term and will be reflected in an 
increasing Embedded Value and profit realisation as they 
progressively reduce; 

 These results were achieved while maintaining a  capital 
position that requires capital to be set aside for future 
growth (and is effectively a drag on earnings). The net 
cash in the business was $135.6 million, a working capital 
reserve to fund future growth of $48 million is held with a 
net capital position of $32.7 million after amounts drawn 
down under the $50 million debt facility that was put in 
place in December 2014. The debt facility has been drawn 

ClearView Annual Report 2015     4

ClearView Wealth LimitedChairman’s Letter
Continued

to $45.5 million. The Board intends to replace this debt 
facility with one or more longer term capital solutions (for 
example, Tier 2 debt) as the need for, and quantum of, 
longer term capital funding emerges.

The Directors have declared a FY15 fully franked dividend of 
$12.3 million, equating to 2.1 cents per share (up 5% on the 
prior year final dividend). This represents approximately 60% 
of the 2015 UNPAT, which itself was suppressed in FY15 given 
the material investments made in wealth management. 
The FY15 Final Dividend will operate in accordance with our 
dividend reinvestment plan. 

The Board of ClearView continues to operate a share buy 
back in circumstances where the share price is below the 
Company’s view of intrinsic value. No shares have been 
bought back in the past 12 months.

Strategy and Outlook 

ClearView’s strategy continues to be refined but remains 
focused on being:

• 

• 

 a highly focused challenger brand operating in profitable 
segments of life insurance, wealth management and 
financial advice; and

 a differentiated integrated life insurance and wealth 
management provider; well positioned for structural 
growth with the dual convergence of superannuation and 
life insurance products, and the advice and non-advice 
markets.

ClearView continues to focus on the profitable market 
segments and not being “all things to all people”.  FY15 
concludes a successful three year strategy focused on 
building ClearView’s market position in the life insurance, 
wealth management and financial advice markets.

Implementing a high growth strategy has to date required 
an investment in a cost structure prior to the realisation 
of revenue benefits with the initial phases of “J Curve” 
investment now complete.   Expense overruns depress initial 
reported profits but should eliminate as scale is achieved, 
thereby increasing underlying profits realised on the growing 
in-force portfolio.  We remain focused on this with expense 
overruns expected to unwind over the medium term.

ClearView has now established a strong platform to drive 
momentum and convert its strategic positioning into material 
earnings growth.  Material earnings growth is expected to 
emerge in FY16 given the growth profile of the underlying 
businesses and the compound nature of life insurance and 
wealth management businesses.  ClearView is well positioned 
to gain from market disruption around life insurance reforms 
with a potential stepped change in distribution profile if the 
proposed reforms are implemented.

Over the past three years ClearView’s management has 
developed a reputation for delivering on operational metrics 
and driving growth. They have built a solid platform from 
which ClearView can target 5% of the long term life insurance 
profit pool , build a material wealth management business 
and a high quality financial advice business providing 
strategic advice to its clients.

I thank our customers, partners and shareholders for their 
continued support for ClearView.  I would also, of course, like 
to thank all the employees and management at ClearView on 
whom we depend on for our success. 

The Board and management look forward to continuing to 
deliver results on your behalf. 

Dr Gary Weiss

Chairman 

25 August 2015

5     ClearView Annual Report 2015

ClearView Wealth Limited

ClearView Wealth Limited

ClearView Annual Report 2015     6

Managing Director's Report

In 2012 ClearView outlined that it was focused on a phased 
build out of its underlying businesses over a three year period. 
At that  time I explained that the focus was on building 
ClearView into a strong challenger in the life insurance and 
wealth management industries with a strategy focused on:

• 

• 

• 

• 

• 

• 

 Targeting  profitable niches. In particular, I highlighted 
that ClearView was not focused on Group Life but focused 
on quality adviser-led advice;

 Winning clients and advisers through the quality of our 
offering, not through ownership of practices. Our strategy 
was based on “being a home for independent advisers” 
and not trying to replicate the bancassurance model, 
which I believe is fundamentally flawed due to the 
inherent conflicts of interests;

 Building intuitive simple platforms that suit both the 
advisers and their clients; and

 Working towards the convergence of superannuation and 
life insurance solutions along with the convergence of 
personal and general advice, otherwise known as scaled 
advice.

The strategy that ClearView presented to the investment 
community and our shareholders focused on how we 
would execute the building out of ClearView’s advice-led life 
insurance offering in FY13, ClearView’s direct life insurance 
offering in FY14 and ClearView’s wealth management 
offering in FY15. I highlighted that there would be significant 
investment required with this building process and that it was 
necessary to have patient shareholders who understood the 
compounding nature of the businesses that we are building.

Now that ClearView is three years into the execution of this 
strategy process, it is worth reflecting on the current position 
of ClearView against its strategy and the next steps that we 
will take.

Life Advice 

Over the past three years, ClearView has grown from having 
effectively no new business (in FY12, ClearView wrote $3.6 
million of new business) to writing $34.5 million of new 
life advice business in the past 12 months. ClearView has 
grown its share of new business from circa 0.5% to 3.1%1 
in the year ending 31 March 2015. ClearView has achieved 
this impressive position in a short period of time through a 
number of significant initiatives. These include:

• 

 Our LifeSolutions product suite has delivered innovation 
and simplicity of design;

1 

Source: Plan for Life (March 2015); ClearView Management Information

 The product suite is supported by market-leading 
underwriting and claims management support; and

 ClearView has established strong relationship 
management as indicated by the fact that we are equal 
first amongst life insurers in 2014/15 NMG IFA Channel Life 
Risk ‘Top 250 Advisers and AFSLs Programme’ for business 
capability.

This process is never complete – and for a successful 
challenger brand such as ClearView it is necessary to 
continually adapt and change. In the past 12 months, 
ClearView has continued this process through:

• 

• 

• 

 Introduction of parent cover, life cover conversion 
benefits, protected commission and innovative buyback 
cover features;

 Continue to expand our distribution footprint inasmuch as 
ClearView is on the approved product lists (APLs) of over 
200 dealer groups - a clear endorsement of our strategy; 
and

 We continue to develop our platform to make ClearView 
easy to do business with.

As I set out three years ago, there is a compounding impact 
of the investments that ClearView has made over the past 
three years. Shareholders are now starting to see the benefits 
of this, with life insurance profit increasing by 41% over the 
past 12 months. In addition, the Value of New Business 
increased by 66%. This strong earnings growth reflects a 
continued focus on the profitable segments of the market.

The new business sales result from Life Advice at 16% was 
a step down in growth rates from prior years. However, 
this growth needs to be viewed in the context of a very 
difficult year for the industry – where advice-based new 
sales decreased for the first time in a very long time. In 
effect, ClearView maintained its significant outperformance 
of growth to the market, and as the regulatory uncertainty 
decreases and growth returns to the industry, ClearView 
expects that absolute growth will again step up.

Our focus in the near term is to continue incremental 
investment in our products and services to ensure we keep 
our market leading position and growth momentum.

Direct Life

In the last year we have continued to make good progress in 
our Direct life business with new business up 84% over the 
last year.  The business successfully launched a partnership 
with Your Insure in August 2014 which is already starting 

5     ClearView Annual Report 2015

ClearView Wealth Limited

ClearView Wealth Limited

ClearView Annual Report 2015     6
ClearView Annual Report 2015     6

ClearView Wealth LimitedManaging Director's Report
Continued

to bear fruit. ClearView has successfully augmented our 
relationship with Bupa Australia, which continues to deliver a 
steady stream of good quality business.

We have also entered into a number of lead generation 
arrangements which are assisting our new business growth.  

In the future we will continue to evolve our Direct business 
towards a scaled advice model where we can expand the 
segments where we compete.

Wealth Management

In October 2014 we successfully launched our own 
investment management platform.  This was a huge 
achievement inasmuch as it was launched for $5.4 million 
(capitalised costs) in nine months.  To be net flow positive 
$112 million across our wealth business is indicative of its 
success.

The platform is comprehensive and our WealthFoundations 
product suite has a number of industry leading innovations 
including the Foundation Assurance Benefit and model 
portfolios using the fund of fund structure.

The model portfolios assist financial advisers by ensuring 
the changes in both asset allocation and asset manager 
are simultaneously managed from a client perspective.  
The advantage of this approach is the client is not “out 
of the market” or holding inappropriate asset allocation. 
Furthermore, there is a distinct advantage for the financial 
adviser as the “efficiency” of any changes to asset allocations 
and/or asset managers provide substantial administrative 
savings for the financial adviser when compared to traditional 
methods of managing these issues. The profit of the wealth 
management business fell from $5.9 million to $1.8 million 
due primarily to $3.2million (after tax) investment made in 
our new wealth platform and related costs.

The new wealth platform provides a very sound base for 
further innovations in the segments of superannuation, 
investment and retirement incomes. The next upgrade is 
expected to be delivered by the end of this calendar year.

Our investment performance, both short term and long term, 
on behalf of our clients, continues to be in the first or second 
quartile and provides our clients, be they superannuation 
members, life investment policyholders or direct investors, 
security and confidence that their long term investment 
needs will be met.

Regulation

As I set out above, FY15 was a difficult year for life insurance. 
This was driven by a year of regulatory uncertainty. In 
October 2014 ASIC released their Report 413 Review of Retail 
Life Insurance Advice.  This report pointed out the correlation 
between high up front commissions (being greater than 100% 
of the first year premiums) and poor advice as well as poor 
documentation of advice. In response to this, the Financial 
Services Council (FSC) and the Association of Financial 
Advisers (AFA) jointly appointed a former member for APRA, 
John Trowbridge, to provide an independent report on the 
potential restructure of the industry.  

Unfortunately this led to an environment of negative publicity 
for the life insurance industry, where most of the discussion 
has been on adviser remuneration and other conflicted 
remuneration to both advisers and dealer groups. Advisers 
as a general rule are not overpaid, as their commissions 
reflect the costs of providing complex and detailed advice. 
Regulating remuneration for advice risks decreasing the time 
taken to provide advice and has the potential to affect the 
quality of this advice.

ClearView’s general approach is that no amount of regulation 
will alone drive good quality strategic advice. First and 
foremost, providing good quality strategic advice starts with 
the adviser mind-set, where both the dealer groups’ and 
advisers’ attitude is about the welfare of the customer, and 
in particular having a well articulated financial plan for the 
customer. ClearView has focused on selecting advisers that 
genuinely care about the best interests of their clients and are 
known for their integrity. We believe that this cultural focus  
is key.

A significant number of the issues in life insurance advice 
that led to this regulation review have occurred within 
tied distribution networks. In effect, where a bank owns 
an adviser network and insists that that adviser network 
only sells bank manufactured product there is inherently 
conflicts of interest. It is not surprising there have been a 
number of probity issues. ClearView believes that requiring 
open APLs, with a requirement that advisers consider clients’ 
best interests would lead to a higher quality of advice and 
is more important than directly regulating the pricing of 
advice. Unfortunately, this has not yet been one of the 
recommendations coming from the reforms.

7     ClearView Annual Report 2015

ClearView Wealth LimitedManaging Director's Report
Continued

Overall, ClearView believes that the discussions around 
regulatory change are generally positive but focus too much 
on adviser remuneration and not enough on client choice and 
client best interest. However, ClearView is supportive of:

• 

• 

• 

• 

 Changes as recommended by the PJC Inquiry, headed 
by Senator David Fawcett, on adviser education, 
development and standards (subject to appropriate 
grandfathering);

 Sound commission bases need to be available to support 
financial advisers’ businesses. Australian consumers 
are not (yet) ready for a pure fee–for-service model for 
insurance;  

 Except for adviser commission, the FoFA reforms should 
otherwise be implemented for life insurance, for example, 
the payment of volume bonuses and self space fees 
should be prohibited. This would address a number of the 
actual conflicted remuneration issues;

 That vertically integrated companies are required to 
ensure that their dealer groups have fully open APLs. 
There are only 11 life insurers offering life insurance 
advice-based products which is easy for a dealer group 
to manage. We note that there can be more than 
200 investment managers on a typical APL or on an 
investment platform. So 11 life insurers should be easy!

•  We support a sensible industry Code of Conduct; and

• 

 We broadly support the reduction in upfront commissions 
as proposed by the industry and wish to also see a level 
commission system that is set by the market. However, 
our view is that a three year clawback of commission 
liability  is a step too far; a two year clawback is sufficient 
and would achieve the key objectives, and is more 
appropriate in our view. When all is considered, the almost 
halving of upfront commissions and the doubling of the 
responsibility period to two years seems a measured and 
appropriate response.

The Coming Year 

We are very excited by the prospects of 2016.

After a number of years of significant investment, both 
financially and intellectually, ClearView is now focused on 
leveraging that investment and aiming to become Australia's 
best life insurance, wealth management and financial advice 
business. This will, of course, require incremental investment 
but we will do so from solid foundations with both a culture 
and a team focused on great outcomes for our customers 
and partners. For shareholders, their patience will be 
rewarded with what we expect to be a material increase in 
earnings in FY16.

It is an exciting time!....it is a time ClearView is purpose  
built for!

ClearView continues to execute our strategy by:

• 

• 

• 

 Leveraging our position as a integrated life insurance and 
wealth management company to take advantage of the 
obvious convergence opportunities available from both life 
insurance and superannuation;

 Continuing to develop our processes and systems for 
delivering high quality strategic advice to our customers 
through our financial advice network;

 Continuing to improve the service that we deliver to both 
advisers and customers; and

•  Continuing to invest in, and develop, our people.

Achievement of our objectives will be supported by the 
ClearView culture and values which guide and influence 
everything we do. I am proud of the ClearView team and 
what we have been able to accomplish in such a short 
space of time. We are well positioned for the future and I 
am encouraged and excited by the opportunities to increase 
shareholder value.

Simon Swanson 

Managing Director

25 August 2015

ClearView Annual Report 2015     8

ClearView Wealth LimitedDirectors’ Report

The Directors of ClearView Wealth Limited (ClearView or the 
Company) submit their report, together with the financial 
report of the consolidated entity (the Group) for the year 
ended 30 June 2015 (the financial year): 

Gary is a member of the Audit Committee, Risk and 
Compliance Committee and the Nomination and 
Remuneration Committee. He was appointed to the Board on 
22 October 2012 and appointed Chairman on 1 July 2013. 

Directors 
The following persons were Directors of ClearView during the 
whole financial year and since the end of the financial year 
unless otherwise noted: 

•  Dr Gary Weiss (Chairman) 

•  Andrew Sneddon 

•  Bruce Edwards

•  David Brown

•  Gary Burg

• 

Jennifer Newmarch 

•  Michael Alscher

•  Michael Lukin (Alternate to Mrs Newmarch) 

•  Nathanial Thomson

•  Simon Swanson (Managing Director) 

The biographies for the Directors of ClearView are detailed 
below: 

Current Directors 

Andrew Sneddon BEC, CA 

Independent Non-executive Director 

Andrew was a Partner with PricewaterhouseCoopers for 18 
years before retiring in 2008. He has worked across a broad 
range of industries and has extensive experience in mergers 
and acquisitions, business and strategic planning, audit, 
valuation and capital raising, with particular focus on fast 
growth and emerging technology companies. Andrew is the 
Chairman of Fusion Payments Limited, ServiceRocket Inc, 
ServiceRocket International Pty Limited, TGR BioSciences Pty 
Limited, Elastagen Pty Limited and Traditional Therapy Clinics 
Limited. Andrew is also a Non-Executive Director of Innate 
Immunotherapeutics Limited and a member of the Audit and 
Compliance Committees of the Crescent Capital Private Equity 
Funds. 

Andrew is a member of the Audit Committee, Risk 
and Compliance Committee and the Nomination and 
Remuneration Committee. Andrew was appointed an 
Alternate Director on 26 March 2013. His appointment as 
Alternate was revoked and he was appointed as a Director on 
3 December 2013. 

Dr Gary Weiss LLB (Hons), LLM and JSD 

Bruce Edwards BSc, MA, FIAA 

Independent Non-executive Chairman 

Independent Non-executive Director 

Gary has extensive international business experience and 
has been involved in numerous cross-border mergers and 
acquisitions. This includes an established track record in 
life insurance and wealth management businesses. He is 
Chairman of Ridley Corporation Limited, Executive Director 
of Ariadne Australia Limited, a Director of The Straits 
Trading Company Limited, Premier Investments Limited, 
Pro-Pac Packaging Limited, Tag Pacific Limited and Thorney 
Opportunities Limited, and an Alternate Director of  Mercantile 
Investment Company Limited.  Gary’s previous directorships 
include Guinness Peat Group plc, Westfield Group, Coats 
plc (Chairman), Tower Australia Limited, Australian Wealth 
Management Limited, Tyndall Australia Limited (Deputy 
Chairman), Joe White Maltings Limited (Chairman), CIC 
Limited, Whitlam Turnbull & Co Limited and Industrial Equity 
Limited. 

Bruce is a qualified actuary with over 25 years in actuarial 
consulting, including five years as Managing Director of 
KPMG Actuaries. In recent years, he has held directorships 
with a number of life and general insurance companies, life 
insurance distribution companies and superannuation fund 
trustees, as well as lecturing in actuarial science at Macquarie 
University. He is a director of Munich Re in Australia (life and 
general reinsurance business and a direct general insurance 
company). He is a Past President and active member of the 
Rotary Club of Sydney. 

Bruce is the Chairman of the Audit Committee, Risk 
and Compliance Committee and the Nomination and 
Remuneration Committee. He was appointed to the Board on 

22 October 2012. 

9     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

David Brown BCom, MSc, Dip Inv, Dip Mktg, ASIP, MAICD, 
F Fin  

Jenny also worked for Watson Wyatt Worldwide in Madrid 
and Manchester. 

Independent Non-executive Director 

David has significant experience in investment management 
and asset allocation of superannuation and insurance funds. 
He is the Chief Investment Officer of PacWealth Capital Pty 
Ltd, the former Head of Private Markets for Victorian Funds 
Management Corporation and former Senior Funds Manager 
for Queensland Investment Corporation. David is a former 
director of LifeHealthcare Pty Limited and a former Council 
Member of the Australian Private Equity and Venture Capital 
Association Pty Limited. 

David is a member of the Audit Committee and the Risk and 
Compliance Committee. He was appointed to the Board on 22 
October 2012. 

Gary Burg BACC (Wits), MBA (Wits) 

Independent Non-executive Director 

Gary has significant experience in building life insurance 
businesses in South Africa and in Australia. Gary is a director 
of Your Insure Pty Limited and Global Capital Holdings 
(Australia) Pty Limited, a company which manages Principal 
Investments on behalf of various investors. He is a former 
director of (and investor in) 3Q Holdings Limited and South 
African listed Capital Alliance Holdings Limited (which 
owned Capital Alliance Life Limited and Capital Alliance 
Bank Limited). Gary is also a former director and investor in 
a number of Australian based financial services businesses, 
including Prefsure Life Limited and Insurance Line Holdings 
Pty Limited. 

Gary was appointed to the Board on 22 October 2012. 

Jennifer Newmarch BSc (Maths) (Hons), FIA 

Non-executive Director 

Jenny is an Investment Director with ROC Partners Pty 
Limited. Previously, Jenny was a Senior Vice President based 
in Macquarie Funds Group’s Private Markets team, responsible 
for managing Australian private equity programs on behalf 
of institutional investors. Prior to this, she spent two years 
as an Investment Analyst at Mercer Consulting in the UK 
where she completed her actuarial qualification and focussed 
on providing advice in asset liability modelling, investment 
strategy and manager selection to UK pension funds. 

Jenny received a Bachelor of Science majoring in 
mathematics with Honours from Imperial College London and 
is a Fellow of the UK Institute of Actuaries. 

Jenny was appointed to the Board on 1 July 2013. 

Michael Alscher BCom 

Non-executive Director 

Michael is the Managing Partner and founder of Crescent 
Capital Partners Management Pty Ltd (Crescent).  
Prior to founding Crescent, Michael was a consultant at 
Bain International and the LEK Partnership where he spent 
considerable time working across banking and insurance 
clients. After leaving consulting, Michael was the Chief 
Operating Officer and a Director of Gowings Bros Limited. 
Michael is a Director of Metro Performance Glass Limited, 
National Dental Care Pty Limited, Crumpler Pty Limited 
and GroundProbe HoldCo. Pty Limited. He is also a former 
Chairman and Director of Cover-More Group Limited, and a 
former Director of LifeHealthCare Group Limited.  

Michael was appointed Alternate Director to Nathanial 
Thomson on 22 October 2012. His appointment as  
Alternate was revoked and he was appointed as a Director  
on 1 July 2013. 

Michael Lukin BSc (AppMaths) (Hons), CFA, AIAA 

Alternate Non-executive Director 

Michael is a Partner and Director of ROC Partners Pty 
Limited. Prior to this Michael was the Managing Director 
of the Macquarie Investment Management Private Market 
business in Sydney. Michael has 18 years of private equities 
investment experience and serves on the advisory boards 
of five Australian private equity fund managers, and is a 
current AVCAL Council member. He is a Chartered Financial 
Analyst (CFA) and an Associate of the Institute of Actuaries 
of Australia. Before joining Macquarie, Michael was an asset 
consultant with Towers Perrin, providing advice on investment 
matters and manager selection to superannuation funds 
and master trust clients. Michael is also a Director of Baycorp 
Holdings Pty Limited, National Dental Care Pty Limited and 
Space-Time Research Pty Limited. 

Michael was appointed Alternate Director to Jennifer 
Newmarch on 1 July 2013.

ClearView Annual Report 2015     10

ClearView Wealth LimitedDirectors’ Report
Continued

Nathanial Thomson BCom (Hons), LLB (Hons) 

Non-executive Director 

Nathanial is a Partner of Crescent Capital Partners 
Management Pty Limited. Nathanial has significant consulting 
experience for financial institutions at McKinsey & Co. 
He is the former deputy Chairman of Cover-More Group 
Limited prior to its listing on the ASX, a leading broker of 
travel insurance in Australia and former director of Metro 
Performance Glass Limited prior to its listing on the ASX. 

Nathanial is a member of the Nomination and Remuneration 
Committee and was a member of the Audit, Risk and 
Compliance Committee up until 30 June 2014. He was 
appointed to the Board on 22 October 2012. 

Simon Swanson BEC, BBus, ANZIIF (Fellow), CIP, CPA 

Managing Director 

Simon is an internationally experienced financial services 
executive having worked for over 35 years across life 
insurance, funds management, general insurance and health 
insurance. He has successfully led the largest life insurer 
(CommInsure, Sovereign and Colonial) in three countries and 
spent half of his career in the Asia Pacific region. 

Simon is a former Chairman of ANZIIF’s Life, Health and 
Retirement Income Faculty Advisory Board and former 
director of the Australian Literacy and Numeracy Foundation. 

Simon was effectively the founder of ClearView in its current 
form and was appointed as Managing Director on 26 March 
2010. 

11     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

Directorships of other Listed Companies 
Directorships of other listed companies held by Directors in the three years preceding the end of the financial year are as 
follows: 

Name

Company

Period of Directorship

Dr Gary Weiss

Ariadne Australia Limited 
Mercantile Investment Company Limited

Premier Investments Limited
Pro-Pac Packaging Limited
Ridley Corporation Limited
Tag Pacific Limited
Thorney Opportunities Limited
The Straits Trading Company (Listed on the Singapore 
Exchange)

28 November 1989 – ongoing
Non-executive Director 6 March 2012 - 25 
February 2015 
Alternate Director 25 February 2015 - ongoing
11 March 1994 – ongoing
28 May 2012 – ongoing
21 June 2010 – ongoing
1 October 1988 – ongoing
21 November 2013 – ongoing
1 June 2014 – ongoing

Andrew Sneddon

Innate Immunotherapeutics Limited

19 September 2013 - Ongoing

Gary Burg

3Q Holdings Limited (delisted 12/2/2013)

29 March 2012 – 11 September 2013

Michael Alscher

Cover-More Group Limited
LifeHealthCare Group Limited
Metro Performance Glass Limited

14 November 2013 - 30 April 2015
8 November 2013 - 25 February 2015 
31 March 2015 - Ongoing

Company Secretaries 
Chris Robson BA, LLB (Hons), LLM was appointed Company 
Secretary on 4 April 2011. He is also General Counsel at 
ClearView. Chris has over 20 years’ experience in the financial 
services industry. Prior to joining ClearView, Chris was General 
Counsel and Group Company Secretary for Challenger Limited. 
Chris previously held legal roles in the financial services 
industry, as well as in the public sector and private practice. 
He is a member of the Law Society of NSW and the Society of 
Notaries of NSW. 

Athol Chiert, BCOM, BACC, CA was appointed Company 
Secretary on 4 November 2008. He is also the Chief Financial 
Officer at ClearView. Athol has a life insurance and private 
equity background. He was previously the CFO of PrefSure 
Holdings Limited and PrefSure Life Limited and also served 
as a director and executive of the Global Capital Group 
both in Australia and South Africa. Athol has over 15 
years’ experience in the finance industry including holding 
directorships on investee and subsidiary entities. Athol 
commenced his professional career as an accountant with 
Arthur Andersen. 

Appointed Actuary of ClearView Life 
Assurance Limited 
Ashutosh Bhalerao B.Ec, FIAA is the Appointed Actuary of 
ClearView Life Assurance Limited (ClearView Life). Ash joined 
ClearView as Deputy Appointed Actuary in January 2014 
and was appointed to his current role on 5 June 2014. Ash 
has 20 years’ experience in the financial services industry, 
specialising in life insurance. In the five years prior to joining 
ClearView, Ash was the Appointed Actuary for Swiss Re 
Life & Health Australia Limited. Ash has also held other 
senior actuarial roles with TAL Limited, Challenger Limited 
and AMP Limited and has a wide range of experience in, 
financial management and reporting, product pricing, capital 
management, asset-liability management, risk management 
and reinsurance. 

Chief Risk Officer
Greg Martin B.A, FIAA, FFIN, FAICD, CERA Greg is the Chief 
Actuary and Chief Risk Officer of ClearView. He was the 
Appointed Actuary of ClearView Life from 1 March 2011 until 
his resignation from the role on 5 June 2014.  Greg has over 
25 years’ experience specialising in life insurance and funds 
management and has held a number of other Appointed 
Actuary roles during his career. Greg has fellowships with 
the Institute of Actuaries of Australia, FINSIA and the AICD, 

ClearView Annual Report 2015     12

ClearView Wealth LimitedDirectors’ Report
Continued

and is a Chartered Enterprise Risk Actuary. He was a member of the Life Insurance Actuarial Standards Board, a member of 
two advisory panels to the Australian Accounting Standards Board and a member of multiple committees of the Institute of 
Actuaries of Australia. Greg has a wealth of experience in the areas of risk and capital management, financial management 
and reporting, and product pricing and management 

Meetings of Directors 
The numbers of meetings of the Company’s Board of Directors and of each Board Committee held during the year ended 30 
June 2015, and the numbers of meetings attended by each Director were as follows:

Board

Audit, Risk and 
Compliance 
Committee1 Audit Committee2

Risk and 
Compliance 
Committee3

Nomination and 
Remuneration 
Committee

Eligible  

Eligible  

Eligible  

Eligible  

Eligible  

to Attend

Attended

to Attend

Attended

to Attend

Attended

to Attend

Attended

to Attend

Attended

Dr Gary Weiss

Andrew Sneddon

Bruce Edwards

David Brown

Gary Burg

Jennifer Newmarch4 

Michael Alscher

Nathanial Thomson

Simon Swanson

10

10

10

10

10

10

10

10

10

9

9

9

9

10

10

6

9

10

3

3

3

3

-

-

-

-

-

3

3

3

3

-

-

-

-

-

3

3

3

3

-

-

-

-

-

3

2

3

3

-

-

-

-

-

3

3

3

3

-

-

-

-

-

3

2

3

3

-

-

-

-

-

5

5

5

-

-

-

-

5

-

5

4

5

-

-

-

-

5

-

1 
2 
3 
4  

From 1 July 2014 to 31 December 2014.
From 1 January 2015 to 30 June 2015.
From 1 January 2015 to 30 June 2015.
 Mrs Newmarch appointed Mr Michael Lukin as her alternate director on 1 July 2013. Mr Lukin attended 3 Board meetings on behalf of Mrs Newmarch and his 
attendance is included in the table above. 

13     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

Directors’ Shareholdings 
The following table sets out each Director’s relevant interest in shares and rights or options in shares of the Company or a 
related body corporate as at the date of this report. 

Director

Dr Gary Weiss2

Andrew Sneddon

Bruce Edwards

David Brown

Gary Burg

Jennifer Newmarch3

Michael Alscher1

Michael Lukin3

Nathanial Thomson1

Simon Swanson

Fully paid ordinary shares

Executive share plan shares

-

111,041

524,151

-

9,943,259

-

-

-

-

-

-

-

-

-

-

-

-

-

3,186,043

10,000,000

1  Mr Alscher and Mr Thomson represent the interests of CCP Bidco Pty Limited and its Associates that non-beneficially hold 310,076,859 shares.
2  Dr Weiss is an Executive Director of Ariadne Australia Limited which holds 25,450,635 shares.
3  Mrs Newmarch (alternate Mr Lukin) represents the interests of Macquarie Investment Management Limited that non-beneficially holds 62,447,883 shares. 

Shares Issued Under the Executive Share Plan (ESP) 
As at the date of this report, ClearView has a total of 61,158,120 ESP shares on issue of which 32,854,246 have been issued 
to select financial advisers. As outlined in the Operating and Financial Review, recruitment of financial advisers represents a 
significant growth opportunity for ClearView in both the life insurance and wealth management segments. In addition to being 
one of the few non-bank aligned participants in the market, the Group has to date been able to offer such financial advisers the 
opportunity to participate in the overall performance of ClearView through share ownership in the Company. 

In November 2011, the ESP Rules were extended to allow financial advisers to participate in the Plan (as Contractor 
Participants). From February 2013, the Board removed the previously stated cap on the issue of shares under the ESP. While 
there is now not a set limit on the number of shares that may be issued under the ESP, the Board or Board Authorised 
Delegates approve the issue of new ESP shares and monitors the overall quantum of ESP shares on issue, relative to the 
interests of existing shareholders and the overall objectives of the business. 

In accordance with the provisions of the ESP, during the financial year 9,493,682 shares were granted to senior management 
and financial advisers with the grant dates set out below. Allowing for the exercise and reallocation of forfeited ESP shares, the 
net increase in ESP shares issued were 8,989,682.  

ClearView Annual Report 2015     14

ClearView Wealth LimitedDirectors’ Report
Continued

Series 

Opening Balance (1 July 2014) 

Series 43

Series 44 

Series 45

Series 46

Series 47

Series 48

Participant

Grant Date

No. of Shares 
Issued

No. of Shares 
Reallocated

No. of Shares 
Total

Senior Management

26-Nov-14 

Senior Management

26-Nov-14 

Senior Management

26-Nov-14 

Senior Management

30-Mar-15 

Senior Management

30-Mar-15 

Senior Management

30-Mar-15 

 81,518 

 81,518 

 81,518 

107,001

107,000

107,000

100,000

100,000

100,000

34,666

34,667 

34,667 

49,381,666

181,518

181,518

181,518

141,667

141,667

141,667

Total (Senior Management)

 565,555

404,000

969,555

Series 42

Series 44

Series 47

Contractor Participant

9-Jul-14 

4,560,760 

Contractor Participant

26-Nov-14

2,413,367

Contractor Participant

30-Mar-15

1,550,000 

Total (Contractor Participant)

8,524,127

-

-

- 

-

4,560,760 

2,413,367

1,550,000 

8,524,127

Forfeited

Reallocated

Exercised

-

-

-

(104,000)

(104,000)

(300,000)

(300,000)

(100,000)

(100,000)

Closing Balance (30 June 2015)

9,089,682

-

58,371,348

Series 49

Series 50

Reallocated

Contractor Participant

30-Jul-15 

2,709,452

300,000

3,009,452

Senior Management

30-Jul-15 

77,320

-

77,320

-

(300,000)

(300,000)

11,876,454

-

61,158,120

Closing Balance (25 August 2015)

For details of the Plan see Note 29 of the notes to the financial statements.

Indemnification of Directors and Officers 
During the period, the Company purchased Directors and Officers Liability Insurance to provide cover in respect of claims made 
against the Directors’ and Officers’ in office during the financial period and as at the date of this report, as far as is allowable by 
the Corporations Act 2001. 

The total amount of insurance premium paid and the nature of the liability cover provided are not disclosed due to a 
confidentiality clause within the contract. 

As at the date of this report, no amounts have been claimed or paid in respect of this indemnity and insurance, other than 
the premium referred to above. Directors’ and Officers’ Liability Insurance contributed a proportion of the total professional 
indemnity insurance premium. 

The Company has not, during or since the financial period, indemnified or agreed to indemnify the auditor of the Company 
against a liability incurred as an auditor. 

Rounding of amounts 
The Company is of a kind referred to in ASIC Class Order 98/0100 dated 10 July 1998 and in accordance with that Class Order 
amounts in this report, and the financial report, have been rounded off to the nearest thousand dollars. 

Auditor independence and non-audit services 
The Directors have received an independence declaration from the auditors, a copy of which is on page 58. 

15     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

Non-audit services 
Details of amounts paid or payable to the auditor for non-audit services provided during the year by the auditor are outlined in 
Note 10 to the financial statements. 

The Directors are satisfied that the provision of non-audit services, during the year, by the auditor (or by another person or firm 
on the auditor’s behalf) is compatible with the general standard of independence for auditors imposed by the Corporations Act 
2001. 

The Directors are of the opinion that the services as disclosed in Note 10 to the financial statements do not compromise the 
external auditor’s independence, based on advice received from the Audit Committee, for the following reasons: 

• 

• 

 All non-audit services comply with the ClearView audit independence policy and have been reviewed and approved to 
ensure that they do not impact the integrity and objectivity of the auditor; and 

 None of the services undermine the general principles relating to auditor independence as set out in Code of Conduct 
APES 110 “Code of Ethics for Professional Accountants” issued by the Accounting Professional & Ethical Standards Board, 
including reviewing or auditing the auditor’s own work, acting in a management or decision-making capacity for the 
Company, acting as advocate for the Company or jointly sharing economic risks and reward.

Annual Corporate Governance Statement 
ClearView is committed to achieving high corporate governance standards. As provided for in the ASX Corporate Governance 
Council’s Principles and Recommendations, ClearView will now publish its Board approved Corporate Governance Statement on 
its website rather than in its Annual Report. The ClearView 2015 Corporate Governance Statement may be viewed at  
www.clearview.com.au/page/shareholders/corporate-governance.

ClearView Annual Report 2015     16

ClearView Wealth LimitedDirectors’ Report
Continued

Operating and Financial Review 
Principal activities 
ClearView is an Australian financial services company 
with businesses that specialise in life insurance, wealth 
management and financial advice solutions. 

Operating and Financial Review 
This operating and financial review report, which forms part of 
the Directors’ Report, sets out information about the Group for 
the financial year ended 30 June 2015. 

ClearView Business 

ClearView in its current form was created in June 2010 and 
has subsequent to its formation, launched new modern, 
customer focused and market leading products into the 
advised life insurance and wealth management markets since 
late 2011. These new products have experienced substantial 
growth in sales both through the ClearView dealer group 
but also, and significantly, via the third party independent 
financial adviser market. 

FY15 concludes a successful three year strategy focused on 
building ClearView's positioning in the life insurance, wealth 
management and financial advice markets.

ClearView continues to position itself as a highly focused 
challenger brand operating in specific profitable segments.  
ClearView is implementing a high growth strategy with the 
goal of attaining 3%-5% of the long term life insurance profit 
pool, building a material wealth management business and a 
high quality financial advice business.

ClearView generates its revenue through the provision and 
distribution of life insurance, superannuation and investment 
products, and through the provisions of financial advice and 
support services to financial advisers. The markets in which 
ClearView competes are highly regulated. ClearView holds, via 
its operating subsidiaries, an APRA life insurance licence, an 
APRA registrable superannuation entity licence, an ASIC funds 
manager responsible entity licence and two ASIC financial 
adviser licences. In addition, the Company is regulated by 
APRA as a Non Operating Holding Company (NOHC) under the 
Life Insurance Act 1995. 

The Group operates three business segments: Life Insurance, 
Wealth Management and Financial Advice. 

1 

Source: Plan for Life (March 2015); ClearView Management Information

17     ClearView Annual Report 2015

Life Insurance 

ClearView creates products that compete in both the Advised 
and Non-Advice (Direct) segments of the $14.3 billion 
Australian life (risk) insurance market1. ClearView competes 
in a subset of this broader market and in particular in the 
individual risk market (excluding group life) that is $8.6 billion1 
or approximately 60%1 of the total market. 

The Australian life (risk) insurance market is arguably 
“over-consolidated” with significant positions from larger 
institutions (particularly bank owned). The top five insurers 
control approximately 67% of the individual life insurance 
market1. These larger institutions often have legacy issues 
including multiple administration platforms and older, higher 
margin in-force portfolios (partly driven by acquisitions). This 
creates opportunities for a challenger such as ClearView 
which is positioning itself as a disruptor in the retail life 
insurance market. 

While life insurance risk in-force premiums have grown at 
around 10% for a sustained period of time, growth in the 
individual market has slowed in more recent times, with the 
March 2015 industry statistics1 reflecting reduced growth 
rates, below the 10 year industry average. These growth 
fundamentals across the broader market appear to be 
challenging the industry as structural changes to adviser 
remuneration and the related life insurance reforms are 
gradually embraced.  The more recent premium growth in the 
group life market is reflective of the corrective price action 
taken by industry participants. In the individual market, there 
have also been some increased pricing on income protection 
products to better align back book and front book prices at 
the potential expense of lower growth for some players. This 
will be positive for the long term sustainability of the industry. 

Price increases are having an impact on in-force retail 
premiums. However, the underlying industry profitability 
growth has remained subdued, in particular with losses being 
reported in the income protection market and from recent 
lapse experience. ClearView, as a focused challenger, with no 
back book, has outperformed the market and avoided these 
issues to date. 

As at 30 June 2015, ClearView has total in-force life insurance 
premium of $115.7 million (+32%) and during the FY15 
financial year generated new business premium of $34.5 
million (+26%). These represent significant increases over the 
prior year. ClearView currently has a circa 1.3%1 market share 
of in-force premium but a 3.1%1 share of new business in 
the individual life insurance market and is therefore growing 
substantially faster than system.  

ClearView Wealth LimitedDirectors’ Report
Continued

The following graphs reflect the step change in the growth 
profile of ClearView’s life insurance business:  

The following graph reflects the movement in in-force 
premium from $87.5 million to $115.7 million over the 
financial year: 

New Business Written

YTD In-force Movement

$m

40

35

30

25

20

15

10

5

0

Reinvestment in Direct Life

34.5

27.5

8 8 %  pa
3 yr C A G R

19.4

Launch of 
LifeSolutions

5.2

2.0

1.7

2010 2011 2012 2013 2014 2015

$m

140

120

100

80

60

40

20

0

34.5

115.7

15.1

8.8

87.5

Opening

CPI/Age

New Business

Lapses

Closing

115.7

The growth of in-force premium has been driven by the strong 
new business growth (as noted earlier), with lapses partially 
offset by age based premium increases and inflation (“CPI”) 
increases on insurance benefits. 

87.5

(a) Advised Life Insurance 

In-force Premium

%

p a 
G R
3 8
3 yr C A

62.1

41.0

41.0 44.1

$m

120

100

80

60

40

20

0

2010 2011 2012 2013 2014 2015

The Advised Life market has been challenged in more recent 
times given the proposed structural changes to commission 
models and the related implications on adviser remuneration.  
The Australian Securities and Investments Commission 
(ASIC) issued Report 413 Review of Retail Life Insurance 
Advice (2014) that identified unacceptable levels of poor 
quality advice, and a strong correlation between high upfront 
commissions and poor consumer outcomes.  This solicited an 
industry response that led to announcement by the Assistant 
Treasurer in June 2015, supporting the industry proposals.  

As outlined in the announcement these proposals are 
intended to improve the quality of advice as a result of a 
better alignment of interests, more product choice and 
enhanced competition. The proposals have the potential to be 
the most significant reforms to the retail life insurance sector 
since the Wallis Inquiry recommendations were implemented 
in 2001.

ClearView Annual Report 2015     18

ClearView Wealth LimitedDirectors’ Report
Continued

The following table outlines the proposed reforms, observations and potential impacts if these are implemented as proposed:

Retail Life Industry Proposal

Observations

Adviser remuneration arrangements
• 

 Limits on upfront remuneration arrangements 
from 1 January 2016 with transitional 
arrangements;

• 

• 

• 

 Maximum upfront commission of 80% from 
1 January 2016, reducing to 60% by 1 July 
2018;

 Maximum ongoing commission of 20% in all 
subsequent years from 1 January 2016;

 Three year clawback of commissions; 100% in 
Yr 1, 60% in Yr 2 and 30% in Yr 3;

• 

 Reviewed by government by end of 2018.

Quality of advice and insurer practices

• 

• 

• 

 ‘Open architecture’ approach to APLs; shelf 
space payments to AFSLs to get products on 
APL also needs consideration/ removal;

 Government to consider measures to widen 
APLs by 1 July 2016;

 Life Insurance Code of Conduct to be 
developed by 1 July 2016; best practice 
standards for insurers.

• 

• 

• 

• 

• 

• 

• 

• 

 Impacts on funding of adviser 
businesses and potentially practice 
values in near term;

 Need to support advisers that have an 
unaffordable capital strain;

 Improves upfront capital strain to life 
insurer, increased return on equity 
(albeit potentially lower profit margins);

 Unlikely to result in reduced premiums 
to consumer;

 Impacts on direct life insurance 
unclear.

 APLs can be limited to a small number 
of products;

 Opening of APLs and removal of shelf 
space fees maximises choice available 
to clients; best interest duty;

 Vertically integrated providers should 
be required to have 100% open APLs to 
remove potential conflicts of interests.

ClearView 
Impact

Industry 
Impact

✔ 

✔

BUT 
considering 
how best 
to support 
advisers with 
unaffordable 
capital strain

✔ ✔ ✔

+/_

Licensee (AFSLs) remuneration arrangements

• 

• 

• 

 Volume based payments/ rebates (also linked 
to lapse/ persistency bonuses) to be banned 
from 1 July 2016;

 Appropriate grandfathering to be consistent 
with FOFA laws.

Enforcement, Monitoring and Efficiency

• 

• 

• 

 Ongoing reporting of policy replacement data 
to ASIC from 1 January 2016;

 ASIC review of SOAs to make disclosure 
simpler and more effective;

 Rationalisation of legacy products consistent 
with FSI recommendation.

 Removal of these payments coupled 
with the adverse impacts on dealer 
splits from reduction in upfront 
commissions impacts on the financial 
viability of dealer groups and ability to 
provide support service

• 

• 

 Complexity in simplifying SOAs given 
increased compliance obligations (best 
interests duty etc);

 Legacy products can include complex 
guarantees; historical product designs 
did not allow flexibility in products.

✔

+/_

✔

✔

Industry has proposed to work with the Government to 
implement these reforms. The Government has stated that 
it will consider the industry’s proposals in the context of 
its response to the Financial System Inquiry. Should these 
reforms proceed, the Government will ensure that there is 
appropriate monitoring of consumer outcomes – including 
the impact of the reforms on the cost of premiums.  Whilst 
the regulatory uncertainty is creating short term challenges, 

ClearView with its unique positioning has continued to grow 
and remains well placed to benefit longer term.

The Advised Life market segment comprises life insurance 
products placed by financial advisers.  The ClearView product 
suite, branded LifeSolutions, was launched in December 2011 
and is a high quality advice based product suite, providing 
top quartile benefits and terms at market competitive prices. 
LifeSolutions includes term life, permanent disability, trauma 

19     ClearView Annual Report 2015

ClearView Wealth Limited 
 
Directors’ Report
Continued

and critical illness benefits, child cover, parent cover, income 
protection and business expense cover. Policies can be issued 
directly from ClearView Life or via the ClearView Retirement 
Plan (the ClearView superannuation fund).  

In the first half of FY15, ClearView implemented a 
LifeSolutions product upgrade to further improve the product 
features and offering. The near term strategy is to build on 
this success by continuing to invest in technology to support 
the portfolio’s growth and drive back office efficiencies, 
upgrade adviser interaction and to introduce further product 
improvements and innovations over time.

The following graphs reflect the step change in the growth 
profile of LifeSolutions since launch in December 2011: 

New Business Written

$m

30

25

20

15

10

5

0

27.5

23.6

16.9

3.7

-

-

2010 2011 2012 2013 2014 2015

In-force Premium

$m

100

80

60

40

20

0

71.0

45.2

21.0

3.8

2010 2011 2012 2013 2014 2015

LifeSolutions has continued to strongly outperform the 
market with new business increasing to $27.5 million for 
the year ended 30 June 2015 (+16% over the prior year).  
LifeSolutions in-force premium is $71 million as at 30 June 
2015 (+57% over the prior year), and now represents 61% of 
ClearView’s total life insurance in-force book.  

ClearView has 221 financial advisers (including 82 Matrix 
advisers) many of whom provide life insurance products 
to their clients (including LifeSolutions). ClearView’s life 
insurance products are also placed across Australia through 
third party dealer groups (providing ClearView access to a 
broad base of financial advisers), with LifeSolutions products 
being included on 206 Approved Product Lists as at 30 June 
2015.  ClearView’s appeal to the independent adviser market 
is summarised as follows:

• 

• 

• 

 Compelling product offer (top quartile rated by research 
houses);

 Non-institutionally owned, leading advocate for the 
independent financial adviser;

 Stability of pricing, single pricing series (lack of legacy 
issues);

•  Protected income on commissions;    

•  Agile - ability to respond quickly to change; and

•  Accessible Senior Management Team and Board.

ClearView's opportunities for further growth in the Advised 
Life market include the following:

• 

• 

 Potential open architecture of Life APL’s for all licensees 
(potential life insurance industry reforms). Regulatory 
changes can create a stepped change in distribution 
profile if certain changes are implemented – the final 
position on some of these are yet to be resolved; and

 Opportunity to become a preferred retail life manufacturer 
by focusing on innovation and adaptation in light of the 
potential industry changes. 

(b) Non-Advice (Direct) Life Insurance 

The Non-Advice (Direct) Life market segment encompasses 
products that are purchased directly by consumers. This can 
include life insurance products sold through direct marketing, 
telemarketing, call centre referrals or online. 

ClearView has an exclusive distribution agreement with Bupa 
Australia, Australia’s second largest private health insurer. 
This allows ClearView to distribute Non-Advice (Direct) Life 
products to the Bupa Australia customer base and remains 
a core component of the Non-Advice strategy. ClearView 

ClearView Annual Report 2015     20

ClearView Wealth LimitedDirectors’ Report
Continued

also has distribution agreements with a number of credit 
unions, as well as third party distribution partners under an 
outsourced model (lead generation sources).  

noting that it takes time to run off given age based and CPI 
premium increases.  The following graphs reflect the change 
in the growth profile of the Non-Advice product suite:

ClearView intends focusing more, in the medium term,  
on the mid market segment of the Non-Advice (Direct) 
Life market given the potential dual convergence of 
superannuation and life insurance products coupled with 
the potential convergence of the advised and non advised 
markets over time. This is being driven by:

• 

• 

 tax efficiency, regulatory reforms and more common 
capital/governance requirements; and

 consumer driven forces that are re-shaping the industry, 
for example, digitisation and the rise of self-directed 
consumers. 

ClearView has the ability to use its market positioning, 
challenger brand and the regulatory licences to take 
advantage of the dual convergence.

ClearView commenced investing in revitalising its Non-Advice 
insurance business in FY14 with a longer term view aligned 
to the strategic outcomes outlined above. This investment 
included recruiting a new direct team and a refocused direct 
distribution approach. A new call centre was established in 
Parramatta, and capacity has been expanded in line with the 
growth in volumes. This has resulted in some short term cost 
base impacts, which are being incurred with the objective of 
creating shareholder value in the medium term. 

Non-Advice life insurance new business increased to $7 
million (+84% yoy) for the year ended 30 June 2015, albeit 
with an intentional slow down in growth in 2H FY15 given 
certain retention initiatives that are underway.  In-force 
premium in the new Non-Advice book increased to $9.6 
million as at 30 June 2015, reflecting year on year growth  
of 73%.  

ClearView acquired a profitable in-force Non-Advice portfolio 
(circa $41 million) in June 2010 with strong cash flow 
generation (from its predecessors of NRMA Life and MBF 
Life). The in-force portfolio had no intermediated business 
or exposure to group life or pre global financial crisis income 
protection policies. ClearView refers to this block of business 
as the “Old Book". The Old Book is largely closed to new 
business (minor sales and policy increases only) and its 
strong cash flow generation (including the recovery of prior 
acquisition costs incurred to acquire the in-force book) is 
being invested in growth by partly funding the strong growth 
in the new products’ life insurance new business premium 
being written. As at 30 June 2015, the Old Book’s in-force 
premium was $35.1 million.  This is a 4% decline year on year; 

21     ClearView Annual Report 2015

New Business Written

8

7

6

5

4

3

2

1

0

7.0

3.8

2.5

1.6

0.4

-

2010 2011 2012 2013 2014 2015

In-force Premium

41.0

41.0

41.3
2.2

41.0
2.9

42.3

5.6

44.8

9.6

41.0

41.0

39.1

38.2

36.8

35.1

50

40

30

20

10

0

$m

2010

2011

2012

2013

2014

2015

Old Book

Non-Advice

The near term strategy is to consolidate the Non-Advice 
business (and the investment made to date) with a focus 
on retention coupled with servicing and accessing its key 
strategic partners to increase customer penetration.  
The strong growth in new business volumes in FY15 was 
offset by lapse losses incurred on new direct business written 

ClearView Wealth LimitedDirectors’ Report
Continued

via the warm lead referral channel resulting in adverse 
lapse experience in these channels. Therefore, there was 
an intentional slow down in new business volume growth 
in 2H FY15 to align with retention strategies and system 
enhancements.  These initiatives are expected to be fully 
implemented in 1H FY16.  

ClearView entered into a new partnership and funding 
arrangement with Your Insure Pty Limited (Your Insure) 
with a total funding commitment of $3.3 million by way of 
a Convertible Note (CN) on a draw down basis (based on 
the achievement of predetermined KPIs) to fund the Your 
Insure business that is start up in nature. ClearView has an 
option to convert the CN into 50% equity (by 30 June 2019) 
once the Your Insure business has become self funding. Your 
Insure commenced operations in August 2014, with $1.7 
million being drawn down as at 30 June 2015.  In the year to 
30 June 2015, Your Insure achieved new business volumes 
of $1.7 million.  ClearView continues to closely monitor 
its progress including retention given the current lower 
socio demographics of its customer base.  From a strategic 
perspective, Your Insure expands ClearView’s market reach by 
its participation in the lower market demographic segment of 
the Non-Advice market. 

Key priorities for FY16 include the following:

• 

• 

• 

• 

 Focus on retention in the warm lead referral channels 
with the further build out of the retention team and 
implementation of system enhancements;

 Gain further traction with strategic partners to increase 
customer penetration; 

 Product enhancements and development with related 
investment in systems; and

 Increased focus on scaled advice opportunities 
including the convergence of life insurance and wealth 
management products.

Wealth Management 

Total industry retail funds under management (FUM) 
increased to circa $736 billion1 as at 31 March 2015, up 14% 
over the prior year, driven primarily by improved market 
conditions. Retail FUM has grown at an average rate of circa 
10%1 per annum over the past six years since the March 
2009 trough (global financial crisis).  Following a period of 
consolidation, there is market concentration in that a small 
number of key participants control the majority of retail FUM, 
with the top five players (the four major banks and AMP) 
controlling around 73%1 of the retail market.

1 

Source: Plan for Life (March 2015); ClearView Management Information

There has also been a shift in the market dynamics over time 
with the bundled fee product arrangements changing to open 
architecture fee structures offered by wrap platforms and 
the like. The unbundling of fee structures has predominantly 
related to the choice of investment manager, outsourcing 
of administrative functions (including white labelling) and 
distribution. This, together with the cost spotlight on the 
industry (including significant regulatory reforms), has 
resulted in margin pressure across the wealth value chain.

Fee and margin pressure is likely to continue across the 
industry given the following: 

• 

• 

• 

• 

• 

• 

 Heightened consumer awareness of the costs inherent in 
historic fee structures; 

 Price competition across the whole wealth management 
sector; 

 Regulatory changes including the introduction of MySuper 
products for all default balances and potential responses 
to the Financial Services Inquiry; 

 Potential emergence of lower cost providers going direct 
to market; 

 Lower margins associated with the search for yield and 
capital preservation by investors (cash and fixed interest 
securities); and 

 Super account consolidation that will lead to the 
elimination of per account fees on multiple accounts and 
lower fee rates on the primary account. 

ClearView provides wealth management products via four 
primary avenues:

• 

• 

 Master Trust - Life investment contracts issued by 
ClearView Life. Products include ordinary savings, 
superannuation and allocated pension products, with the 
latter two provided via the ClearView Retirement Plan. 
These continue to operate under a bundled fee structure;

 WealthSolutions - A superannuation and retirement 
income wrap (issued via the ClearView Retirement Plan) 
and an Investor Directed Portfolio Service (IDPS). This 
is offered via the WealthSolutions platform which was 
launched in December 2011. WealthSolutions includes a 
menu of approximately 250 investment funds, ASX listed 
shares, term deposits and seven ClearView managed 
funds. It also provides a number of model portfolios 
managed by ClearView for superannuation investors;

• 

 WealthFoundations - Life investment contracts issued 
by ClearView Life. Products include superannuation and 
allocated pension products, issued via the ClearView 

ClearView Annual Report 2015     22

ClearView Wealth LimitedDirectors’ Report
Continued

Retirement Plan. This is offered via the WealthFoundations 
platform which was launched in October 2014. 
WealthFoundations includes a menu of 16 investment 
options with transparency provided to the customer who 
can see through to the underlying fund managers; and

• 

 Managed Investment Schemes (MIS) - Products are 
issued via ClearView Financial Management Limited 
(CFML) as the ASIC licensed Responsible Entity and include 
MIS products available on ClearView’s WealthSolutions 
platform.

ClearView’s products have historically competed in the 
master trust and wrap segments of the retail market. A 
master trust is an administrative service that typically enables 
customers to hold a portfolio of different investments that 
the customer selects from the master trust menu. A wrap is 
similar to a master trust, but it typically allows the customer 
to hold a broader variety of investments, such as listed shares 
and term deposits, and operates through a “cash hub”. 

Given the potential margin compression and bundled 
fee structure, the ClearView Master Trust product fee 
arrangements are not considered sustainable on new flows in 
the future. These accounts are gradually rolling off given that 
the product is not actively marketed to new members and 
that there is a large component of the book in the pension 
phase. The WealthSolutions product is aimed at higher 
end wrap clients (>$250K investable funds) and therefore 
addresses the higher end, wrap segment of the retail market.  
The recently launched WealthFoundations product is aimed 
at smaller account balances integrated with a life insurance 
cross sell opportunity.   Key principles of the product design 
and launch of WealthFoundations have been the following: 

• 

• 

 Manager branded, but non-complex, investment option 
building blocks; 

 Some innovation and differentiation: positioning, pricing 
and adviser supporting features; 

•  Straightforward, easy to understand in-built fee structure; 

•  Competitive pricing; 

• 

 Leverage the LifeSolutions product (life insurance cross 
sell) and ClearView and Matrix dealer group distribution; 
and 

•  Speed to market. 

It is important to note that WealthFoundations leverages 
off both the life insurance cross sell opportunity as well 
as the regulatory structure within ClearView. This allows 
the new wealth product to include some innovation and 
differentiation. WealthSolutions will undergo a product 

23     ClearView Annual Report 2015

upgrade and enhancement in FY16 to further support the 
adviser base. The following diagram reflects the market 
positioning of WealthSolutions and WealthFoundations:

Wealth Products:  
WealthSolutions and WealthFoundations

WealthSolutions
Extensive investment options 
including direct shares
Tax parcelling 
Wholesale funds

l

e
c
n
a
a
b
t
n
u
o
c
c
A

WealthFoundations
Easy Choice investments
Actively managed by Trustee 
Bundled Fees

Investor sophistication/adviser active management

Implementing a new compliant and functional wealth 
platform (to host both WealthFoundations and once 
migrated, the Master Trust and MIS products) has been a 
key strategic priority and required material investment in the 
wealth management business in FY15. There has historically 
been significant investment made in life insurance with the 
related growth that has followed, but given the potential 
convergence of life insurance and wealth management, and 
in line with its integrated strategy, ClearView has launched 
its new platform and WealthFoundations in FY15.  Capitalised 
costs associated with the launch of both the new platform 
and WealthFoundations are $5.4 million as at 30 June 2015, 
with the write off of the amortised software over four years 
having commenced in October 2014.  

The new platform will also administer the Master Trust 
and MIS products after their migration (over time) that 
is anticipated to create operational efficiencies once 
implemented.  The project to migrate the administration 
of the Master Trust and MIS products was deferred in 
FY15 in order to both reprioritise and bring forward some 
other development projects, as well as to reduce the 
overall expected costs and impacts of the migration when 
implemented. 

The nature of a wealth management business is such that 
any upfront investments is made ahead of earnings and given 
that these costs are “non-deferrable” under the accounting 
standards this had a material adverse impact of $3.2 million 
on UNPAT in FY15.  This effectively reflects the third phase 
of “J Curve” investment and includes the build out of a new 

ClearView Wealth Limited 
Directors’ Report
Continued

contemporary platform (including software amortisation 
costs), the incremental growth and development costs 
related to the launch of the WealthFoundations and the  
costs incurred/provisioned for the subsequent migration  
of the Master Trust and MIS products onto the new platform 
over time.

ClearView has in-force FUM of $1.9bn as at 30 June 2015 
(+15%), with $0.72bn on new products launched. ClearView 
is $112 million net flow positive in FY15; representing a 
significant improvement in net flows over prior periods (was 
in net outflow of circa $150 million in FY11 and FY12 post the 
acquisition of the businesses).  Overall this reflects:

The overall FUM and net flows are reflected in the 
graphs below, including the performance of the new 
WealthFoundations product since its launch in October 2014:

Net Flows

2011

2012

2013

2014

2015

200

150

100

50

0

-50

$m

-100

-150

-200

FUM

2.0

1.8

1.6

1.4

1.2

1.0

0.8

0.6

0.4

0.2

0.0

$b

112

-16

-8

-147

-152

1.90

1.66

1.57

1.52

1.53

2.2
1.38

2010

2011

2012

2013

2014

2015

• 

• 

• 

 WealthSolutions net inflows of $163 million (+7%);  
in-force FUM of $0.61 billion (+50%);

 WealthFoundations net inflows of $112 million (launched 
October 2014); in-force FUM of $0.11 billion; and

 Master Trust net outflows of $164 million (-2%); in-force 
FUM, including closed MISs, of $1.18 billion (-6%); net 
outflows are partially offset by the positive performance 
of investment markets in FY15. The performance of 
investment markets plays a key part in “holding up” 
the Master Trust FUM, given that this is effectively a 
closed book with a portion of the FUM in the pension 
phase.  The Master Trust FUM is being replaced by lower 
margin new business written in the WealthSolutions and 
WealthFoundations products due to the more competitive 
pricing of the new contemporary products. 

ClearView’s wealth management products are currently 
distributed primarily by ClearView Financial Advice and Matrix 
Planning Solutions. ClearView has further strengthened its 
adviser support through the merger with Matrix that has 
the ability to deliver significant revenue synergies given 
ClearView’s market proven products.  ClearView and Matrix 
dealer groups have 221 financial advisers most of whom 
recommend wealth management products and services to 
their clients. Following the launch of WealthFoundations, 
ClearView is expected to expand its distribution reach by 
achieving recognition of the newly launched product on third 
party APLs (that is, expand the wealth distribution outside of 
the ClearView and Matrix dealer groups). ClearView’s appeal 
to the independent adviser market includes the following:

• 

• 

In-house competitively priced product;

 Experienced in house research team providing unbiased 
implemented models and research;

•  Non-institutionally owned;

• 

In-house business implementation, support and training;

•  Agile - ability to respond quickly to change; and

Master Trust

WealthSolutions

•  Accessible Senior Management Team and Board.

WealthFoundations

ClearView Annual Report 2015     24

ClearView Wealth LimitedDirectors’ Report
Continued

Opportunities for growth in the independent adviser market 
include the following:

• 

• 

• 

 Convergence of life insurance and superannuation 
has opened new distribution opportunities with 
WealthFoundations;

 Leverage off current LifeSolutions distribution agreements/
relationships; and

 Wealth product design that provides efficiency and 
profitability for the adviser.

Key priorities for FY16 include the following:

• 

• 

 Broadening the distribution of the recently launched 
WealthFoundations product to further improve net flows; 
leverage off existing LifeSolutions distribution agreements; 
and

 Implement WealthSolutions product upgrades and 
enhancements to further support adviser base. 

Financial Advice 

Overall the financial advice industry has faced significant 
challenges over the past year, particularly in light of the 
regulatory uncertainty, the proposed life insurance reforms 
(and related impacts on adviser remuneration) coupled with 
a heightened media focus that has had an impact on the 
confidence of advisers, their businesses and consumers.  
Furthermore, the FoFA reforms continue to be implemented 
(with changes still occurring in 2H FY15) with the more 
recent introduction of the best interests duty documentation 
requirements, financial adviser register and implementation 
of the opt in legislation.  

In the vast majority of cases, if the proposed life insurance 
reforms are implemented, the cost of providing policyholder 
advice, in the first year of a policy, is likely to exceed the 
remuneration (commission) received by the adviser (unless 
an appropriate “fee for service” can be agreed between the 
adviser and the customer). Effectively, this potentially puts 
a significant upfront capital strain on the financial adviser, 
especially for those businesses that do not have large in-force 
books.  Furthermore, the proposed claw back arrangements 
are obviously a significant risk management issue for an 
adviser (which could be compared to a warranty period 
in other industries).  It is therefore inevitable, that some 
financial advisers will elect to withdraw from the industry.  

The impacts of these changes on the financial viability of non 
vertically integrated dealer groups also requires consideration. 
The removal of shelf space fees, volume bonuses and the 

like coupled with the reduction in upfront commissions and 
the consequential impact on dealer group “splits” will have a 
detrimental impact on the financial viability of many dealer 
groups and the ability of the dealer group to provide quality 
support services to financial advisers and their practices. 

The proposed reforms are underpinned by an assumption that 
there will be an efficiency gain and productivity improvement 
in the adviser's business.  This includes the proposed review 
of the Statements of Advice (SOAs) by ASIC to make the 
disclosure requirements simpler and more effective. Given the 
regulatory changes and best interest duty requirements, there 
is substantial complexity in simplifying SOAs and it is as yet 
unclear whether these efficiencies through the simplification 
of the SOA process can actually be achieved.  

The focus on quality of advice remains key to the long 
term success (client retention and compliance) of advice 
businesses.  The regulatory framework has to date supported 
vertically integrated players with the tightening regulatory 
environment creating barriers to entry.  ClearView is 
positioning itself as a fast moving disruptor, that given its 
vertically integrated model and market construct (non bank 
aligned), has the ability to reposition itself including how best 
to support its advisers within these regulatory changes.

ClearView provides financial advice services through its wholly 
owned subsidiaries, CFA and Matrix Planning Solutions (MPS or 
Matrix). ClearView completed the acquisition of Matrix on 10 
October 2014. The strategic rationale for the acquisition was 
as follows:

• 

• 

• 

• 

• 

 Matrix has a very strong brand in the independent advice 
market; this provides an enhanced ability to attract and 
recruit financial advisers by leveraging off the non-bank 
aligned model and brand;

 There is a very strong cultural alignment with ClearView 
financial advisers; high quality independently minded 
advisers that are culturally aligned with ClearView’s values 
and processes;

 The merger provided ClearView with enhanced and 
strengthened distribution opportunities;

 Matrix was (at the time of acquisition) 78% owned by 
advisers; post transaction the issue of performance based 
shares means a significant component of the purchase 
price is aligned to ClearView Group outcomes; and

 The merger should assist ClearView in achieving operating 
leverage by scaling faster through an expanded supportive 
adviser base.

25     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

The integration of Matrix has achieved the following 
operational highlights to date:

• 

• 

• 

• 

• 

• 

 Strong cultural alignment and integration between 
ClearView and Matrix advisers;

 Relocation of the Matrix business and staff to the  
Sydney head office location of ClearView;

 Completion of hosted desktop integration with  
ClearView systems;

 Integration of general ledger platforms and payroll onto 
the ClearView systems;

 Integration of the Matrix business into the ClearView 
corporate governance frameworks; and

 Commencement of the migration of Matrix adviser 
practices onto the ClearView adviser software system 
(CWT system).

The focus in FY16 will be on the continued development and 
roll out of best of breed quality advice processes, completion 
of the migration of adviser practices onto the CWT system, 
commencement of branding initiatives and the achievement 
of performance based targets over time.

3.1

8

6

4

$b

4.8

The number of financial advisers in CFA has increased to 139 
as at 30 June 2015 representing an increase of 19% over the 
prior year. In addition, Matrix has a total of 82 advisers as at 
30 June 2015, raising the total for the Group to 221.  CFA and 
Matrix have approved product lists (APLs) that include third 
party product providers, LifeSolutions, WealthSolutions and 
WealthFoundations. CFA’s APL also includes the Master Trust 
product. 

ClearView

Matrix

0

2

As at 30 June 2015, the financial advice segment (CFA and 
Matrix) has funds under management and advice (FUMA) 
of $7.9 billion and life insurance in-force premiums under 
advice (PUA) of $187 million.  The growth in FUMA and PUA is 
driven by the merger with Matrix and the further recruitment 
of self employed advisers in CFA. This is reflected in the key 
performance metrics outlined in the following graphs,  
as at 30 June 2015.

7.9

3.1

200

240

82

160

4.8

139

8

6

$b

4

2

0

120

80

40

0

ClearView

Matrix

Total

ClearView

Matrix

Total

Funds Under Management and Advice (FUMA)

8

6

$b

4

2

0

3.1

7.9

4.8

ClearView

Matrix

Total

Financial Advisers

7.9

Total

240

200

160

120

80

40

0

82

221

139

ClearView

Matrix

Total

Premiums Under Advice (PUA)

240

200

160

120

80

40

0

200

180

160

140

120

$m

100

80

60

40

20

0

82

221

51

187

139

ClearView

Matrix

Total

ClearView

Matrix

Total

136

$m

100

200

180

160

140

120

80

60

40

20

0

51

187

136

ClearView

Matrix

Total

221

200

180

160

140

120

$m

100

80

60

40

20

0

51

187

136

ClearView

Matrix

Total

ClearView Annual Report 2015     26

ClearView Wealth LimitedDirectors’ Report
Continued

Of the $7.9 billion FUMA in-force as at 30 June 2015, $0.6 
billion is in WealthSolutions, $0.1 billion in WealthFoundations 
and $1.2 billion is in the Master Trust and old MIS products. Of 
the $187 million PUA in-force as at 30 June 2015, $44 million 
is in LifeSolutions.

Key priorities for FY16 include the following:

• 

• 

• 

 The continued integration of the Matrix advisers, in 
particular with a focus on the development and roll 
out of best of breed quality advice processes, the 
continued migration of adviser practices onto the CWT 
system, commencement of branding initiatives and the 
achievement of performance based targets over time; 

 Continue to expand the adviser base through recruitment 
of self employed advisers. This includes focusing on the 
recruitment of high quality advisers who have the right 
cultural fit for ClearView and Matrix; and

 Compliant culture and focus with implementation of best 
of breed advice processes.

Risks 

The Group’s activities expose it to a variety of risks, both 
financial and non-financial. Risk management is an integral 
part of the Group’s management process. For details on Risk 
Management please refer to Note 5 of the Annual Financial 
Statements on page 89. 

Strategy 

ClearView’s strategy continues to be focused on being:

• 

• 

 a highly focused challenger brand operating in specific 
profitable segments; and

 an integrated life and wealth provider; well positioned 
for structural growth with the dual convergence of 
superannuation and life insurance products and the 
advice and non-advice markets.

ClearView has developed and launched new modern, 
customer focused and market leading products into the 
Advised Life insurance and wealth management markets 
since late 2011.  ClearView’s key competitive strengths 
remains the integrated nature of its businesses coupled 
with no material legacy (pricing, back books and systems).  
The market is arguably “over-consolidated” and with 
significant positions from larger institutions (particularly bank 
owned) that often have legacy issues including multiple 
administration platforms and older, higher margin in-
force portfolios (partly driven by acquisitions).  This creates 
opportunities for a challenger such as ClearView which is a 
differentiated business with limited legacy issues.  

ClearView is implementing a high growth strategy with the 
goal of achieving 3%-5% of the long term life insurance 
profit pool, building a material wealth management business 
and a high quality financial advice business.  Underlying 
and supporting these objectives, and to build profitability, 
ClearView’s key execution focuses are:

1. 

 To expand its distribution presence across the 
independent financial adviser and direct channels:

• 

• 

• 

 Support a high quality support network with real 
responsiveness;

 Produce flexible products that meet consumer and 
adviser needs; and

 To provide a “home” for genuinely independent 
financial advisers.

2. 

 Target profitable markets with new innovative product 
offerings:

• 

• 

 Operate as a nimble player enabling speed to market; 
and

 Operate an engaged and proactive culture focused on 
meeting customer and adviser needs.

3. 

 Improve the efficiency and reach of our operations to 
expand margins over time:

• 

 Investment in automation and efficiency continues. 
Ongoing investment in technology should allow 
ClearView to become more efficient in the near term; 
and

•  An intense focus on key service elements.

Implementing a high growth strategy has to date required 
an investment in a cost structure prior to the realisation 
of revenue benefits with the initial phases of “J Curve” 
investment now complete.  Expense overruns depress initial 
reported profits but should eliminate as scale is achieved, 
thereby increasing underlying profits realised on the growing 
in-force portfolio. 

FY15 concluded a successful three year strategy focused on 
building ClearView's market position in the life insurance, 
wealth management and financial advice markets. ClearView 
remains in a strong position to continue growth through 
structural market trends, continuing to aim to provide best 
of breed advice and customer service, and innovation in the 
medium term, with a particular focus on: 

• 

 Gaining from market disruption around life insurance 
reforms with a potential stepped change in distribution 
profile, especially if certain parts of the proposed reforms 
are implemented;

27     ClearView Annual Report 2015

ClearView Wealth Limited 
 
 
 
 
 
 
Directors’ Report
Continued

• 

• 

 Benefiting from the increasing convergence of the advice 
and non-advice markets, and life insurance and wealth 
management products, by providing differentiation given 
its ability to use the market positioning, challenger brand 
and the regulatory licences of ClearView; and

 Increase scale over time thereby progressively reducing 
the expenses overruns. These will be absorbed as the 
business grows to scale over the medium term.

ClearView has now established a strong platform to drive 
momentum and convert its strategic positioning into material 
earnings growth.  Material earnings growth is expected to 
emerge in FY16 given the growth profile of the underlying 
businesses and the compound nature of life insurance and 
wealth management businesses.

ClearView is well positioned to gain from market disruption 
around life insurance reforms with a potential stepped 
change in distribution profile if the proposed reforms are 
implemented.

While ClearView remains a high growth company (relative to 
the in-force portfolio) it will likely require net capital funding; 
the $50 million Debt Funding Facility will be replaced with one 
or more longer term capital solutions as the need for, and 
quantum of, longer term capital funding emerges.

ClearView's overall strategy is supported by an experienced 
management team in the life insurance and wealth 
management markets. Furthermore, members of the 
ClearView Board have significant experience in investing and 
directing growing life insurance, wealth management and 
other financial services businesses. 

Financial Results 

Overview of Result 

The Group has achieved the following results for the year ended 30 June 2015: 

After Tax Profit by Segment, $m

Life Insurance

Wealth Management

Financial Advice

Business Unit Operating Earnings (after tax)

Listed Entity and Other

Total Operating Earnings (after tax)1

Interest expense on corporate debt (after tax)

Underlying NPAT2

Other Adjustments

NPATA3

Amortisation

Reported NPAT

Underlying diluted EPS (cps)

Reported diluted EPS (cps)

Dividend per share (dps)

FY15

15.3 

1.8 

4.4 

21.5 

(0.6)

20.9 

(0.4)

20.5 

1.0

21.5

(9.0)

12.5 

3.85 

2.36 

2.10

FY14

% Change

10.8 

5.9 

3.5 

20.2 

(0.5)

19.7 

0.0 

19.7 

1.6

21.3

(7.4)

13.9 

4.41 

3.10 

2.00

 41% 

(70%)

 27% 

 6% 

(34%)

 6% 

Large

 4% 

(35%) 

1%

 21%

(10%)

(13%)

(24%)

5%

1 

2 

 Total Operating Earnings NPAT represents the Underlying NPAT2 of each of the operating business units before taking into account the interest costs associated 
with corporate debt. 
 Underlying net profit after tax is the Board’s key measure of group profitability and the basis on which dividend payments are determined. It consists of con-
solidated profit after tax adjusted for amortisation (not including capitalised software), the effect of changing discount rates on insurance policy liabilities and 
costs considered unusual to the Group’s ordinary activities.

3  NPATA is reported net profit after tax adjusted to exclude the non-cash amortisation of acquired intangibles (not including capitalised software).

ClearView Annual Report 2015     28

ClearView Wealth Limited 
Directors’ Report
Continued

UNPAT is the Board’s key measure of profitability and the basis 
on which dividends are determined. This measure consists 
of reported net profit after tax, adjusted for the amortisation 
of intangibles (not including capitalised software), the effect 
of changing discount rates on the insurance policy liabilities 
and any costs considered unusual to the Group’s ordinary 
activities (for example, the Matrix deal and integration costs 
incurred in FY15).  

Total Operating Earnings after Tax (Operating NPAT) 
represents the UNPAT of each of the operating business units 
before taking into account the interest costs associated with 
corporate debt.  The Debt Funding Facility was implemented 
in December 2014, with $45.5 million drawn down as at 
30 June 2015.  The UNPAT in FY15 therefore includes the 
after tax interest expense of $0.4 million, being the costs 
associated with the capital funding structure of ClearView 
and have been separated out within underlying earnings.

Operating NPAT has increased by $1.2 million (+6%) 
compared with that for the year ended 30 June 2014.  UNPAT 
has increased by $0.8 million (+4%) compared with that for 
the year ended 30 June 2014.  When the reported UNPAT is 
adjusted for the investment in Wealth Management in FY15 
and the Matrix acquisition, UNPAT increases to $22.9 million, 
up 17% on FY14.  This is analysed by operating segment in 
further detail below:

• 

• 

• 

 Life Insurance Operating NPAT of $15.3 million, is up 41%; 
reflective of the emergence of profit from the growth 
in the underlying in-force portfolios given initial “deep” 
investment in the business in FY12-FY14 financial years;

 Wealth Management Operating NPAT of $1.8 million, 
down 70%; reflective of the third phase of the “J Curve” 
investment in FY15 with the build out of a new wealth 
platform and the development of the WealthFoundations 
product that had an adverse $3.2 million NPAT impact in 
FY15;

 Financial Advice Operating NPAT of $4.4 million, up 27%; 
reflective of the consolidation of the Matrix dealer group 
for the first time that had a positive impact of $0.8 million 
in FY15.  The improvement in operating expenses is driven 
by the transition of the employed planners into the self 
employed model and some back office scale efficiencies 
achieved post the integration of Matrix but partially offset 
by the further investment in adviser support services 
(across the broader group) to support a larger adviser base 
in the merged businesses; and

• 

 Listed Operating NPAT of -$0.6 million , down 34% or 
$0.1 million and reflects the interest income on the cash 
equivalents held in the listed and central services entities 
and in the shareholders fund of ClearView Life Assurance 
Limited, the Group’s life insurance subsidiary, less the 
costs associated with maintaining a listed entity.

Reported diluted earnings per share for the year reduced from 
3.10 cents per share to 2.36 cents per share (-24%) and fully 
diluted underlying earnings per share for the year reduced 
from 4.41 cents per share to 3.85 cents per share (-13%).  
The underlying EPS calculations when compared period 
to period have been adversely impacted by the 70 million 
shares issued in the $45 million capital raising in 2H FY14 
(this represents capital that is set aside for growth in future 
periods) and the impacts of the 15.4 million shares issued for 
the Matrix acquisition (the vesting of these shares is subject 
to performance conditions that is aligned to ClearView 
outcomes).

Overall the result reflects: 

• 

 Strong growth in life insurance - the growth of 
LifeSolutions has continued in FY15, with new 
business premium growing at 16% over the prior year.  
LifeSolutions in-force premium is $71.0 million as at 30 
June 2015 (+57%), representing 61% of the total life 
insurance in-force book.  The Non-Advice life insurance 
business has shown strong volume growth with life 
sales increasing by 84% over the past 12 months, albeit 
there was an intentional slow down in volume growth 
in 2H FY15 to align with retention strategies and system 
enhancements.  The new Non-Advice in-force book is $9.7 
million (+73%); with the old book in-force premium of 
$35.1 million (-4%) as at 30 June 2015;

• 

 Key experience items on the life insurance result are as 
follows: 

• 

• 

 An adverse impact of a claims experience loss of $0.1 
million (after tax) relative to the expected claims cost. 
This adverse claims experience variation follows the 
positive claims experience in FY14 of $1.1 million;

 The positive impact of life insurance lapses being 
lower than the rate assumed in the life insurance 
policy liability (determined as at 30 June 2014) with 
an experience profit of $0.1million (after tax) (lapse 
experience loss of $0.9 million in FY14); and

29     ClearView Annual Report 2015

ClearView Wealth Limited 
 
 
Directors’ Report
Continued

• 

 The negative impact of non-deferred expense 
experience being the investment ahead of earnings 
(expense overruns) with an experience loss of $4.5 
million (after tax) (compared to expense experience 
loss of $4.5 million in FY14).

 Overall claims and lapse experience offset each other. 
Further details on these experience items (including 
expenses) are provided in the analysis below. 

• 

 FUM has been positively impacted by favourable 
investment markets and positive net flows of $112 million 
(FUM is up 15%). Funds management fees, however, 
increased by 3% which reflects the run off of the higher 
margin Master Trust product. WealthSolutions continues 
to build to scale coupled the successful launch of 
WealthFoundations in FY15;

• 

 FUMA of $7.9 billion across the Group has been positively 
impacted by the Matrix merger and favourable investment 

markets (FUMA is up 92%). Premiums Under Advice 
($187 million as at 30 June 2015) similarly has been 
positively impacted by the Matrix merger.  Net financial 
planning fees are up 21% driven by the Matrix merger. The 
recruitment of self employed advisers into ClearView has 
had limited impact on margin to date due to the adviser 
split arrangements (number of advisers excluding Matrix is 
up 19%).

• 

 Increases in the operating cost base over the year (+27%). 
This was driven by the consolidation of Matrix for the 
first time (+$1.9 million) and the material investment 
in Wealth Management in FY15 (+$4.5 million).  This 
impacted on both the cost to income ratio and the non-
deferred expense overruns in particular in the Wealth 
Management segment. The drivers of the operating 
expense base increase from FY14 to FY15 is illustrated in 
the graphs below: 

FY14 vs FY15 Cost Base Waterfall

1.9

61.5

2.2

4.5

55.1

2.1

1.3

1.6

1.4

70.1

80

70

60

$m

50

40

30

20

FY Cost Base
Invest m ent in  W ealth

M atrix D ealer Group
A djusted FY14 Cost Base

Key explanations of the movements follow: 

• 

80

 Investment in Wealth Management (+$4.5 million) – 
This relates to the investment in a new contemporary 
platform, the incremental growth and development costs 
2.2
related to the launch of the WealthFoundations and the 
costs incurred/provisioned for the subsequent migration of 
the Master Trust product onto the new platform over time;

55.1

61.4

4.5

1.9

60

70

Direct Life

Distribution/M arketing

A dviser Support Cost

Fu nctional Cost
Shared Services/Listed

FY15 Cost Base

• 

• 

 Matrix Dealer Group (+$1.9 million) – These reflect 
the costs related to the Matrix dealer group post the 
acquisition on 10 October 2014;

1.6

1.3

70.1

1.4
 Direct Life (+$2.2 million) – This relates to the continued 
2.1
investment in the Non-Advice business including the 
build out of the team and call centre capability to support 
the increased volumes between periods. Life sales in 
the direct business have increased by 84% over the prior 

$M

50

40

30

20

FY Cost Base

Investment in Wealth

Matrix Dealer Group

Adjusted FY14 Cost Base

Direct Life

Distribution/Marketing

Adviser Support Cost

Funtional Cost

Shared Services/Listed

FY15 Cost Base

ClearView Annual Report 2015     30

ClearView Wealth Limited 
 
 
Directors’ Report
Continued

• 

• 

• 

comparable period.  The build out of the retention team 
and development of system enhancements remains  
a key focus. 

 Distribution/Marketing (+$2.1 million) – The distribution/
front end costs include the option cost associated with 
ESP shares issued to financial advisers and the continued 
build out of the business development team (BDMs) and 
national presence. The initial focus of the BDMs through 
the growth phase is on broadening out the distribution 
of the product, which will change the mix of adviser 
support over time as further critical mass in new business 
is achieved. Distribution also includes the increased 
investment in the Wealth Management “front end” and 
marketing to further support the growth of the business;

 Adviser Support Costs (+$1.3 million) – The Group 
continues to make further investment in financial advice 
to support a broader base of advisers across the dealer 
group partially offset by the employed planner transitions 
to the self employed model (reduced costs with offsetting 
reduced net fees);  

 Functional Areas (+$1.6 million) – These relate to 
increases in the functional areas to support the growth in 
the business, including administration, call centre, claims 
and underwriting costs. These reflect the growth in the 
underlying volumes period to period; and  

Non-Deferred Expenses Overruns

• 

 Shared Services/Listed (+$1.4 million) - Shared services 
cost increases and business support costs should reduce 
“per customer” as the scale of the business increases. 
This includes the “spreading” of the costs of the shared 
services functions as the business grows.  

The current level of costs being incurred during the business’s 
current growth phase exceeds the long term expense 
assumptions adopted. The business is investing in operating 
costs ahead of revenue to generate this growth. This includes 
an investment in incremental costs above what is required 
for the current scale of ClearView (expense overruns) to build 
capability for the future. Market competitive premium and 
fee rates implicitly support market average participant (scale) 
expense rates. Expense margins available are therefore 
proportional to new business written and in-force revenues. 
As ClearView grows, these expense overruns are likely to be 
absorbed and ClearView should achieve operating leverage. 

Expense overruns depress initial reported profits; these should 
unwind as scale is achieved, thereby increasing underlying 
profit realised through the in-force portfolios. In the year to 
30 June 2015, the non-deferred expense overruns across 
the business had a negative impact on UNPAT of $8.1 million 
(FY14: $7.7 million).  The movements between segments are 
reflected in the graph below:

10

8

6

$m

4

2

0

-2

7.7

8.1

4.5

4.5

4.6

2.1

1.1

Life Insurance

Wealth Management

Financial Advice

Total

1.0

FY14

FY15  

31     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

Overall, the increase in non-deferred expense overruns to 
$8.1 million (+5%) is driven by the material investment of 
$3.2 million in Wealth Management in FY15. Excluding this 
investment (third phase of “J Curve”) and the related impact 
on the increase to $4.6 million in Wealth Management, the 
non-deferred expense overruns would have reduced. This 
reflects efficiencies gained through increased scale benefits 
(period to period), albeit with some movement between 
segments given certain allocation of expenses. Given the 
current size of the in-force business, these overruns are 
predominantly driven by: 

• 

 Life Insurance - the investment in LifeSolutions and the 
Direct Life business. FY15 also includes some absorption 
of the further investment in support services to support a 
larger adviser base (see Financial Advice below). Shared 
services cost increases and business support costs should 
reduce “per customer” as the scale of the business 
increases. This includes the “spreading” of the costs of the 
shared services functions as the business grows;

• 

• 

 Wealth Management - the material investment in 
WealthFoundations and the new wealth platform/
migration costs in FY15 as noted above; and

 Financial Advice underruns are driven by the transition 
of the employed planners into the self employed model 
and some back office scale efficiencies achieved post the 
integration of Matrix but partially offset by the further 
investment in adviser support services (across the broader 
group) to support a larger adviser base in the merged 
businesses.

The elimination of expense overruns, coupled with the 
growth ambitions of the business, remains a key focus of 
management and the Board. 

The following table reconciles the operating expenses 
analysed above to the Reported Operating Expenses line in 
the Annual Financial Statements: 

Reconciliation of Operating Expenses to Reported Operating Expenses Per Annual  
Financial Statements

Operating expenses per waterfall (Page 30)

Custody and investment managment expenses

Interest expense

Reinsurance technology costs

Stamp duty

Medicals

Matrix deal and integration costs

Amortisation of software

Operating expenses per annual financial statements

The following additional items impact the statutory net profit 
after tax, and comprise the reconciling items in the table on 
page 28: 

• 

• 

 The amortisation of the intangibles is associated with the 
acquisition of wealth and life insurance businesses from 
Bupa, the ComCorp financial advice business and Matrix. 
These are separately reported to remove the non-cash 
effect of the write-off of these acquired intangibles. 
However, amortisation associated with capitalised 
software is reported as part of Operating NPAT; 

 The policy liability discount rates effect is the result of the 
changes in long term discount rates used to determine 
the insurance policy liabilities. The life insurance policy 
liability (based on Australian International Financial 
Reporting Standards (AIFRS)) is discounted using market 
discount rates that typically vary at each reporting 

FY15  
$m

70.1

 7.3 

 0.5 

 0.5 

 3.4 

 1.0 

 2.3 

(3.8)

81.3

FY14 
$m

55.1

 6.1 

-

-

 2.1 

 0.7 

-

(3.3)

 60.7 

date and create volatility in the policy liabilities and 
consequently earnings. The change in discount rate 
impact reflects the change in interest rates between 
periods. ClearView separately reports this volatility which 
represents a timing difference in the release of profit and 
has no impact on underlying earnings. This movement in 
policy liability does, however, create a cash flow tax effect; 
and

• 

 Certain costs were recognised in the current period in 
relation to the deal and integration costs associated with 
the merger of Matrix. The costs incurred include onerous 
lease costs, legal fees, due diligence costs, employee 
termination expenses and other restructure related 
costs. The costs associated with the aforementioned are 
considered unusual to the ordinary activities of the Group 
and are therefore not reflected as part of Operating NPAT. 

ClearView Annual Report 2015     32

ClearView Wealth LimitedDirectors’ Report
Continued

Analysis of Result by Segment 

The following waterfall reflects the result by operating segment below:

UNPAT Waterfall

4.4

19.7

0.9

20.9

0.1

0.4

20.5

0.2

4.1

3.2

22.9

20.4

0.8

30

25

20

$m

15

10

5

0

FY14 U N PAT

Life Insurance 
B U O perating N PAT
W ealth M anage m ent 
B U O perating N PAT

Financial A dvice 
FY15 B U O perating U N PAT
B U O perating N PAT

Interest expense 
Listed B U O perating N PAT
on corporate debt

Invest m ent in  W ealth
FY15 U N PAT

M atrix

A djusted FY15 U N PAT

Life Insurance 

Life Insurance BU Operating NPAT has increased by $4.4 
million (+41%) compared with that for the year ended 30 
June 2014.  The experience items for FY15 are detailed in the 
table below:

$m, Year Ended 20 June 2015

Actuarial planned Operating NPAT

Claims experience

Lapse experience

Expense experience

Other

Actual Operating NPAT

This result reflects: 

2014

15.1

1.1

(0.9)

(4.5)

0.1

10.8

2015

19.2

(0.1)

0.1

(4.5)

0.6

15.3

• 

• 

 Actuarial planned Operating NPAT reflects the expected 
profit margins on the in-force book based on actuarial 
assumptions ($19.2 million in FY15; +27%).  This is 
reflective of the strong growth in the business partially 
offset by the run off of the higher margin old direct book

 Adverse claims experience loss (after tax) of $0.1 million 
compared to an experience profit in FY14 of $1.1 million 
(relative to planned margins). Given the current size of 
the life insurance portfolio and reinsurance arrangements 
in place (arrangements vary by product) some statistical 
claims volatility can be expected. Claims experience is 
anticipated to average out over time at the actuarial best 
estimate assumptions. As the in-force of LifeSolutions 

33     ClearView Annual Report 2015

• 

• 

• 

grows, with higher reinsurance arrangements in place, the 
relative claims volatility is expected to reduce from period 
to period; 

 Favourable lapse experience relative to the rates assumed 
in the life insurance policy liability (determined at 30 June 
2014) with an experience profit of $0.1 million (after tax) 
in FY15 (relative to planned margins) ($0.9 million loss 
in FY14). The favourable lapse experience predominantly 
offset the adverse claims experience. 

 The LifeSolutions business continues to display positive 
lapse experience relative to assumptions while the 
business written pre 2011 is now broadly in line with 
expectation, given the assumption changes made in 
June 2014. This positive experience was partially offset 
by lapse losses incurred on new direct business written 
via certain channels.  In particular, the distribution and 
product profile of this has been highly geared to the warm 
lead referral channel resulting in some adverse lapse 
experience to date. Therefore, there was an intentional 
slow down in new business volume growth in 2H FY15 to 
align with retention strategies/system enhancements;

 The growth in life insurance initial commission in the 
financial year is driven by the upfront variable commission 
cost related to the increased new business volumes. These 
acquisition costs are deferred and amortised within the 
policy liability, over the expected life of the policies, in 
accordance with the accounting standards; 

ClearView Wealth LimitedDirectors’ Report
Continued

• 

 An increase in acquisition expenses in life insurance 
(front end costs). These are in addition to the upfront 
commissions and are driven by:

• 

• 

• 

• 

  Variable stamp duty and medical policy acquisition 
costs related to increased new business volumes;

  Increased distribution costs related to the option cost 
associated with ESP shares issued to advisers and the 
continued build out of the business development team 
(BDMs) and national presence as noted earlier in the 
report;

 The increase in the functional areas to support 
the growth in the business including system and 
administration related costs; and 

 The continued investment in the Non-Advice business 
including the build out of the team and call centre 
capability to support the growth and run rates 
achieved, as noted earlier in the report.

All these acquisition costs are deferred within the policy 
liabilities in accordance with the accounting standards; 

• 

• 

• 

 Maintenance expenses relate to the increased call  
centre and administration costs (including claims 
administration) as the in-force portfolios grow across 
business lines. Furthermore, there is some absorption  
of the further investment in support services to support  
a larger adviser base; 

 Increased reinsurance expense is aligned to the growth 
in the in-force portfolios given the upfront reinsurance 
support is provided in the first year of a policy;

 Market competitive premium rates implicitly support 
market average participant (scale) expense rates. 
Expense margins available are therefore proportional to 
new business premium written and in-force premium 
revenues. As the business gets to scale, these costs 
are progressively supported by business volumes that 
create operating leverage. Expense overruns depress 
initial reported profits; these should eliminate as scale is 
achieved, thereby increasing underlying profit realised on 
the growing in-force portfolio. Given the investment phase 
of the business, this resulted in a maintenance expense 
experience loss of $4.5 million for the year ($4.5 million  
in FY14); and 

• 

 Increase in investment earnings given the reallocation 
of shareholder cash to the life insurance segment 
(given the growth in the business and its related capital 
requirements). 

Wealth Management 

Wealth Management Operating NPAT has decreased by  
$4.1 million (-70%) compared with that for the year ended  
30 June 2014.  This result reflects the following:

• 

• 

• 

• 

• 

• 

 The profitability of Wealth Management is driven by the 
fees earned off FUM in ClearView product less expenses 
incurred. Overall FUM increased by 15%, with positive net 
flows of $112 million in FY15, compared to net outflows of 
$8 million in the prior period. This predominantly reflects 
the successful introduction of the WealthFoundations  
(a competitive mid-market wealth product) in October 
2014 and the continued growth of WealthSolutions;

 Given that new business is written into WealthSolutions 
and WealthFoundations at lower margins than the 
existing in-force Master Trust products, fee income 
increased by 3% over the prior year. The margin 
compression and the run off of the Master Trust business 
is assumed in the Embedded Value calculations;

 WealthSolutions and WealthFoundations products have 
primarily been sold to date via the ClearView dealer group. 
The distribution of these products is expected to be rolled 
out further given the increased Matrix adviser distribution 
footprint and the ability to expand the distribution to 
third party APLs. The focus on servicing the ClearView and 
Matrix dealer groups to distribute the WealthSolutions and 
the newly launched WealthFoundations product more 
broadly commenced in FY15.  This resulted in an increased 
front end cost base;

 Increased cost base (+52%) given the investment in 
both the build out of a new platform (including the costs 
incurred/provisioned for the subsequent migration of the 
Master Trust product onto the new platform over time) 
and the incremental development and growth costs 
associated with WealthFoundations ($4.5 million of costs 
incurred) . The increase also includes further investment in 
distribution as noted above. WealthSolutions continues to 
build to scale.  This impacted on both the cost to income 
ratio (up to 51%) and the expense overruns (up to $4.6 
million from $2.1 million in FY14);

 The internal advice fee represents inter segment advice 
fee (50bps) paid to financial advice on Master Trust FUM; 
the reduction is in line with average FUM;

 Funds management expenses increased given 
the expanded wealth product range (launch of 
WealthFoundations) and increased FUM levels  
between periods;

ClearView Annual Report 2015     34

ClearView Wealth Limited 
 
 
 
Directors’ Report
Continued

• 

• 

 Given the growth in WealthSolutions FUM and the 
outsourced variable cost structure to the platform 
provider, platform fees increased in line with the  
average WealthSolutions FUM levels and average  
account balances; 

 A tax benefit of $0.2 million is included in the Wealth 
Management result (exempt fees in the Master Trust 
product range), but is offset in the Listed segment (given 
no deductibility of expenses); overall the Group has a 30% 
effective tax rate which is consistent between periods; and

• 

 A reduction in investment earnings given the reallocation 
of shareholder cash between segments. 

Financial Advice 

Financial Advice Operating NPAT has increased by $0.9 million 
(+27%) compared with that for the year ended 30 June 2014.  
This result reflects the following:

• 

• 

• 

• 

• 

 There has been growth in the number of self employed 
advisers in the ClearView advice business driven by 
recruitment of advisers into the ClearView dealer group as 
well as the merger with Matrix. The expanded distribution 
footprint has the ability to deliver significant revenue 
synergies given ClearView’s market proven products.

 Funds Under Management and Advice (FUMA) levels 
increased over the period driven by the positive 
performance of investment markets and the further 
recruitment of self employed advisers. The merger with 
Matrix materially expands the distribution footprint of 
ClearView.

 Net financial planning fees are up 21% driven by the 
Matrix merger. The recruitment of self employed advisers 
into ClearView has had limited impact on margin to date 
due to the adviser split arrangements (number of advisers 
excluding Matrix is up 19%).  Matrix contributed a net 
retained margin of $2.8 million in FY15;

 The financial advice fees expense includes the transition 
of employed planners to the self employed model (this 
causes a reduction in operating expenses but an increase 
in the financial advice fees expense given the split 
arrangements now in place);

 The consolidation of the Matrix dealer group for the first 
time in the result.  This had a positive Operating NPAT 
impact of $0.8 million for the period from 10 October 
2014, but this result included some one-off tax and other 
benefits of $0.2 million; and 

• 

 Cost base increase of 20%, predominantly relates to the 
consolidation of Matrix for the first time; the operating 

35     ClearView Annual Report 2015

expenses benefited from the transition of employed 
planners into the self employed model and some back 
office scale efficiencies achieved post the integration of 
Matrix but was partially offset by the further investment 
in adviser support services (across the broader group) to 
support a larger adviser base in the merged businesses.

Listed Entity/Other 

Listed Operating NPAT has decreased by $0.1 million (-34%) 
compared with that for the year ended 30 June 2014.  This 
result reflects the following:

• 

• 

• 

• 

 The investment earnings on the cash and investments 
held in the listed and central services entities and in 
the shareholders fund of ClearView Life, less the costs 
associated with maintaining a listed entity.  The Company 
manages capital at the listed entity level in accordance 
with its Internal Capital Adequacy Assessment Process 
(ICAAP) policy;

 An increase in investment earnings (+24%) given the 
timing of the $45 million capital raising in 2H of FY14 and 
draw downs under the Debt Funding Facility, partially 
offset by the purchase consideration paid for the Matrix 
acquisition ($7.75 million) and the reallocation of 
shareholder cash between segments;

 Cost base increase of 45% driven by the allocation of 
a component of shared services overhead to the listed 
entity in FY15 (+$0.5 million); and

 Tax expense of $0.1 million (FY14: $0.3 million) related 
to timing differences, partially offsetting tax benefits 
in the Wealth Management segment.  The Group has 
an effective tax rate of 30% (consistent with the prior 
comparable period).

Statement of Financial Position 

The Statement of Financial Position of the Group as set out on 
page 61 reflects the following key metrics as at 30 June 2015: 

• 

• 

• 

 Net assets of $336.8 million (June 2014: $310.2 million) 
representing a 9% increase over the prior comparable 
period; 

 Net tangible assets of $280.8 million (June 2014: $268.4 
million) ($317.3 million including ESP loans) representing a 
7% increase over the prior comparable period; 

 Net asset value per share (including ESP loans) of 64.0 
cents per share (June 2014: 62.3 cents per share) 
representing an increase of 3% over the prior comparable 
period; and 

ClearView Wealth LimitedDirectors’ Report
Continued

• 

 Net tangible asset value per share (including ESP loans) 
of 54.4 cents per share (June 2014: 54.6 cents per share) 
representing a decrease over the prior comparable period. 
The decrease was driven by the acquired intangibles 
and goodwill from the Matrix transaction and related 
accounting treatment.

• 

• 

Net assets were impacted during the year by (+$26.6 million): 

 Movements in the Executive Share Plan Reserve due to 
the treatment of the ESP expense in accordance with the 
accounting standards (+$0.9 million); and

 Subscription for shares by O&B Limited for cash 
consideration in accordance with the subscription deed 
entered into as part of the Matrix acquisition (+$0.3 
million).

•  A reported profit of $12.5 million outlined above; 

• 

• 

• 

 Net impacts of the FY14 final dividend and the fully 
underwritten dividend reinvestment plan (DRP) (+$0.4 
million).  A further 13.7 million shares was issued under 
the DRP.  The net positive impact of the dividend declared 
relates to the repayment of ESP loans in accordance with 
the plan rules;

 15.4 million shares issued (+$14.6 million) as contingent 
consideration for the purchase of Matrix (subject to 
performance conditions);

 Recognition of a General Reserve in relation to the 
valuation of the contingent consideration for the purchase 
of Matrix (-$2.1 million); 

The net asset value per share and net tangible asset value 
per share are reflected above on a fully diluted basis, as 
ClearView ESP shares have been issued to employees and 
contractor participants as at 30 June 2015 (in accordance 
with the ClearView ESP Rules). The ClearView ESP shares on 
issue have a corresponding non-recourse loan from ClearView 
to facilitate the purchase of ClearView ESP shares by the 
participants. The shares and loans are not reflected in the 
statutory accounts as they are accounted for as an “option” 
in accordance with Australian Accounting Standards. If the 
loan is not repaid, the relevant ClearView ESP shares are 
cancelled or reallocated in accordance with the ClearView  
ESP Rules. 

Embedded Value 

Life Insurance and Wealth Management are long term businesses that involve long term contracts with customers and 
complex accounting treatments. Embedded Value (EV) represents the discounted value of the future net cash flows anticipated 
to arise from the in-force life policies and investment client balances as at the valuation date. 

EV calculations at a range of risk discount margins is shown below: 

Risk margin over risk free:

Life Insurance

Wealth Management

Financial Advice

Value of In-Force (VIF)

Net Worth

Total EV

ESP Loans

Total EV Incl. ESP Loans

Imputation Credits:

Life Insurance

Wealth Management

Financial Advice

3% dm
$m

 261.5 

 43.1 

 30.8 

 335.4 

 71.9 

 407.3 

 36.5 

 443.8 

 41.3 

 11.1 

 8.5 

4% dm
$m

 246.9 

 41.2 

 29.0 

 317.1 

 71.9 

 389.0 

 36.5 

 425.5 

 38.8 

 10.6 

 8.2 

5% dm
$m

 234.0 

 33.3 

 28.5 

 295.8 

 71.9 

 367.7 

 36.5 

 404.2 

 36.5 

 8.4 

 8.2 

Total EV Incl. Imputation Credits and ESP Loans

EV per Share Incl. ESP Loans (cents)

EV per Share Incl. Imputation Credits and ESP Loans (cents)

 504.7 

 483.1 

 457.3 

 76.1 

 86.6 

 73.0 

 82.9 

 69.3 

 78.4 

ClearView Annual Report 2015     36

ClearView Wealth LimitedDirectors’ Report
Continued

The EV movement analysis is as follows:

Embedded Value (EV) Movement Analysis @ 4%DM

15.8

(0.1)

(0.2)

1.4

1.3

389.0

23.8

(7.2)

(1.2)

400

390

380

$m

370

360

350

340

330

320

310

359.0

4.7

355.4

(8.3)

300

@ 4 %  d m  (As Published)
I m pact M atrix Acqusition
N et Capital A pplied
EV after N et capital an d 
Expected G ain
Value of N e w Business A d ded
I m pact of M aint. Expense
I m pact of Claim s
I m pact of Discontin uance
I m pact of M atrix Acqusition
EV - Ju ne 2014 

FU M A m ark to m arket & 
EV - 30 Ju ne 2015 @ 4 % d m
Other I m pacts
Listing Costs
Change in business m ix

• 

 Net Capital Applied (-$8.3 million): The net impact of the 
following: 

• 

• 

• 

• 

 The cash consideration of the Matrix merger and 
deal and integration costs (net of tax), the Dividend 
Reinvestment Plan (DRP) and related repayment of 
ESP loans by participants given their ineligibility to 
participate in the DRP under the Plan Rules

 Matrix Merger (+$4.7 million): The impact of the Financial 
Advice Client Book acquired as part of the Matrix merger 
that partially offsets the cash component paid as noted 
above;

 Expected gain (+$23.8 million): Expected gain represents 
the unwind of the discount rate within the value of in-
force and investments earnings on net worth;

 Value of New Business (VNB) (+$15.8 million): The 
value added by new business written over the period. 
The current value of new business is suppressed by the 
start up and growth costs incurred. The acquisition cost 
overruns should decrease as the business grows, providing 
it with operating leverage;

• 

• 

 The claims experience (relative to actuarial assumptions) 
(-$0.1 million): The claims experience of LifeSolutions 
was favourable in FY15. There was some adverse claims 
experience on the old book and new non-advice book. 
Given the current small size of the insurance portfolio, 
some claims volatility from period to period is to be 
expected;

 The impact of lapses on the life insurance book and 
FUMA discontinuance (-$0.2 million): The life insurance 
lapses impact (+$0.5 million) was driven by better than 
expected lapses for the LifeSolutions product and the old 
book partially offset by lapse rates for the new non-advice 
business being higher than expected. The balance of the 
impact was due to higher discontinuance rates for the 
Wealth and Financial Advice business (-$0.7 million) – 
some of this loss is reflected in the value of new business 
in respect of some business that has been upgraded from 
the old book to new products;

37     ClearView Annual Report 2015

ClearView Wealth Limited 
Directors’ Report
Continued

• 

 The adverse maintenance expense experience: (-$7.2 
million): This relates to the maintenance expense 
overruns versus the long term unit costs assumed in the 
EV. Emerging life insurers and wealth managers invest 
and incur overhead costs ahead of “getting to scale”. 
The expense rates assumed in the EV are based on 
longer term unit costs, as opposed to current “expense 
overrun” levels. As business gets to scale, these costs are 
progressively supported by business volumes that creates 
operating leverage. Expense overruns depress the growth 
in EV initially; these are eliminated as scale is achieved, 
thereby increasing underlying profit margins on the in-
force portfolio and removing the drag on the growth of EV. 
The Financial Advice business had a positive maintenance 
expense variance (+$2.1 million) that reduced the 
overruns in Life Insurance (-$4.1 million) and Wealth 
management (-$4.8 million). The increase in Wealth 

• 

• 

• 

management overruns was driven by the investment in 
a new platform and WealthFoundations. The acquisition 
costs overruns are reflected within, and reduce, the value 
of new business added;

 Expenses were impacted by the Group’s listed overhead 
costs which are not allowed for in the Embedded Value 
(-$1.2 million); 

 FUMA Mark-to-Market (+$1.4 million): The net investment 
performance on the funds under management resulted in 
higher fee income relative to expectations over the period 
and a higher present value of future fees at the end of the 
period; and

 Basis and Assumption Changes ($+1.3 million): This 
includes the net effect of capital reallocations by 
segment, model enhancements, timing effects, actuarial 
assumption changes, capital base changes and the non-
cash ESP expenses. 

While the EV measures are determined in the context of the Group’s business as a going concern, they do not include 
any additional value in respect of future new business that may be written after the valuation date. The EV measure uses 
assumptions related to future experience. A sensitivity analysis on the key assumptions in the EV is outlined below: 

Embedded Value (EV) Sensitivity Analysis @ 4%DM

Inflation +0.5%;-0.5%

-3.2

3.3

Risk-free rate +1%;-1% 

-13.8

15.5

FUMA -10%;+10% 

-6.2

6.4

Expenses +10%; -10% 

-13.4

Discontinuance/ 
Lapse Rate

 +1%; -1% 

-14.6

Claims +10%;-10% 

-12.8

13.4

12.7

16.6

-15.0

-10.0

-5.0

0.0

5.0

10.0

15.0

20.0

ClearView Annual Report 2015     38

ClearView Wealth LimitedCapital Management 

Debt Funding Facility

On 18 December 2014, the Company entered into  
a three year, $50 million revolving facility (Debt Funding 
Facility) with the Commonwealth Bank of Australia (CBA). 

The Board has determined that entering into the Debt 
Funding Facility is both the most cost effective and efficient 
way to support the current funding needs of ClearView over 
the short to medium term.

It is intended that the funding provided under the Debt 
Funding Facility will be replaced in due course with one or 
more longer term capital solutions as the need for, and 
quantum of, longer term capital funding emerges.  As such 
the net capital position of the Group after amounts drawn 
down under the Debt Funding Facility is $32.7 million at 30 
June 2015.  

As at 30 June 2015, the Company has drawn down $45.5 
million of the Debt Funding Facility. Refer to note 28 for 

further details of the Debt Funding Facility.

Directors’ Report
Continued

Dividends 

The Directors have declared a fully franked dividend in 2015 
of $12.30 million (2014: $10.98 million). This equates to 2.1 
cents per share (2014: 2.0 cents per share) and represents 
approximately 60% of the 2015 UNPAT and is in line with the 
Company’s dividend policy (+5% increase in the dividend per 
share over the prior year). No interim dividend was paid during 
the year (2014: nil). For further details on the Company’s 
dividend policy (and related Dividend Reinvestment Plan 
(DRP)) refer to Capital Management section below. 

The Board seeks to pay dividends at sustainable levels and 
has a target payout ratio of between 40% and 60% of UNPAT. 
Furthermore, it is the intention to maximise the use of its 
franking account by paying fully franked dividends (refer to 
commentary on interim dividends that follows). 

ClearView’s ability to pay a franked dividend depends upon 
factors including its profitability, the availability of franking 
credits and its funding requirements which in turn may 
be affected by trading and general economic conditions, 
business growth and regulation. Accordingly, no assurance 
can be given as to the timing, extent and payment of 
dividends. 

No interim dividend was paid during the year. The ability to 
pay fully franked interim dividends has to date been limited 
by the availability of franking credits and the effect on tax 
paid of the changes in long term discount rates used to 
determine the insurance policy liabilities between the half 
year period and year end. As a sufficient franking account 
balance is progressively established, the payment of interim 
dividends will continue to be considered.

The FY15 Final Dividend will continue to operate in 
accordance with the DRP that: 

• 

• 

 Provides shareholders the opportunity to reinvest into the 
Group’s fast growing life insurance business, while at the 
same time retaining capital within the Group; and

 Given the illiquidity of the shares, it was not considered 
appropriate to minimise the dilutive impact of the DRP 
through the on market purchase of the number of shares 
required to satisfy the DRP participation. 

The major shareholders, Crescent Capital and its associates, 
have committed to participate in the DRP at the fixed price of 
95 cents per share.

39     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

Capital Position 

An analysis of reconciliation of the net assets in the Statement of Financial Position to the Group capital position after amounts 
drawn down under the Debt Funding Facility as at 30 June 2015 is outlined in the table below: 

e
c
n
a
r
u
s
n
I
e
f
i
L

t
n
e
m
e
g
a
n
a
M

h
t
l
a
e
W

d
e
t
a
l
u
g
e
R
A
R
P
A

s
e
i
t
i
t
n
E

r
e
h
t
O

$m

$m

$m

$m

247.6 

13.9 

3.3 

264.8 

t
n
e
m
e
g
a
n
a
M

h
t
l
a
e
W

$m

8.1 

e
c
i
v
d
A

i

l
a
n
a
n
i
F

d
e
t
a
l
u
g
e
R
C
I
S
A

s
e
i
t
i
t
n
E

d
e
t
a
l
u
g
e
R

l
l

A

s
e
i
t
i
t
n
E

r
e
h
t
O
/
C
H
O
N

p
u
o
r
G

$m

$m

$m

$m

$m

16.5 

24.5 

289.4 

47.5 

336.8 

Net Assets

Goodwill & Intangibles

(5.3)

(4.7)

-

(10.0)

-

(7.7)

(7.7)

(17.7)

(38.3)

(56.0)

Net Tangible Assets

Capital Base Adjustment:

242.4 

9.2 

3.3 

254.9 

8.1 

8.7 

16.8 

271.7 

9.2 

280.9 

Deferred Acquisition Costs (DAC)

(186.0)

(0.2)

(0.4)

(0.1)

-

-

(186.2)

-

(0.4)

(0.1)

-

-

-

(186.2)

-

(186.2)

(0.1)

(0.5)

(4.3)

(4.8)

Other Adjustments to Capital 
Base

Regulatory Capital Base

Prescribed Capital Amount

Available Enterprise Capital

Internal Benchmarks 

Working Capital

Risk Capital

Excess/(Deficit) over Internal 
Benchmarks

56.0 

(5.8)

50.2 

9.0 

3.3 

68.3 

8.0 

8.7 

16.7 

85.0 

4.9 

89.8 

(3.5)

(0.7)

(10.0)

(5.0)

(0.7)

(5.7)

(15.7)

(2.3)

(18.0)

5.5 

2.6 

58.3 

3.0 

8.0 

11.0 

69.2 

2.6 

71.8 

(21.6)

(22.8)

(1.9)

(3.4)

(2.5)

(26.0)

-

-

-

(26.0)

(22.0)

(48.0)

0.0 

(26.1)

(2.1)

(4.7)

(6.8)

(33.0)

(3.7)

(36.7)

5.9 

0.2 

0.1 

6.1 

0.9 

3.3 

4.2 

10.3 

(23.1)

(12.8)

Debt Funding Facility

-

-

-

-

-

-

-

-

Excess after Debt Funding Facility

5.9 

0.2 

0.1 

6.1 

0.9 

3.3 

4.2 

10.3 

45.5 

22.4 

45.5 

32.7 

Under the APRA capital standards, adjustments are made 
to the Capital Base for various asset amounts which are 
deducted, for example intangibles, goodwill and deferred tax 
assets (net of deferred tax liabilities). ClearView’s capital is 
currently rated Common Equity Tier 1 capital in accordance 
with the APRA capital standards.

The regulated entities have $10.3 million of net assets 
in excess of its internal benchmarks as at 30 June 2015. 
Internal benchmarks exceed regulatory capital requirements 
and include capital held for the protection of ClearView’s 
regulatory capital position in respect of risk outcomes where 
the regulatory capital cannot be readily accessed and to 
protect the various regulated entities’ regulatory licences. 
Furthermore, a working capital reserve is the capital held to 
support the capital needs of the business beyond the risk 
reserving basis. This includes the net capital anticipated to 
be needed to support the medium term new business plans 

(in accordance with the Internal Capital Adequacy Process).  
Internal benchmarks include a working capital reserve in the 
regulated entities of $26 million as at 30 June 2015 to fund 
anticipated new business growth over the medium term. 

Internal benchmarks in the non-regulated entities include a 
further working capital reserve of $22 million as at 30 June 
2015, therefore totalling $48 million that is set aside across 
the Group, to fund anticipated new business growth over 
the medium term.  Life insurance currently has high upfront 
costs – but from year two generates positive cash flows. 
While ClearView remains a high growth company (relative 
to the in-force portfolio) it will likely remain a negative 
cash flow business and require net capital funding. This is 
reserved for under the Group’s ICAAP basis and is reviewed 
over a three year forward period on a continuous basis.  The 
ClearView ICAAP has to date been conservatively reserved for 
on the basis that there is no changes to the variable upfront 

ClearView Annual Report 2015     40

ClearView Wealth Limited 
 
 
 
 
 
 
 
 
 
Share Buy-back 

As has previously been stated, the Board of ClearView 
considers that buying back shares in circumstances where the 
share price is materially below the Company’s view of intrinsic 
value is in the best interests of ClearView shareholders. 

The Board has determined to extend, for an additional 12 
months, its share buy-back that has been in place since 19 
December 2013. The buy-back arrangements currently in 
place will continue to apply.  No further shares have been 
bought back since 30 June 2014.

Events subsequent to balance date

Dividends

On 25 August 2015, the Group proposed a final dividend of 
$12.30 million representing 2.1 cents per share fully franked. 
The record date for determining entitlement to the dividend 
is 3 September 2015 and the dividend will be paid on 17 
September 2015. Since the dividend has not been declared 
at year end it has not been recognised as payable in these 
accounts. 

Changes in state of affairs 

Other than discussed above, there were no other significant 
changes in the state of affairs of the Group during the year 
ended 30 June 2015. 

Directors’ Report
Continued

commission model (part of the proposed life insurance 
industry reforms as noted earlier in the report). Currently, 
there is still significant uncertainty of the final form of the 
proposed changes and continues to be closely monitored, 
including the impacts on the capital requirements of  
the Group.

The net position of the Group after amounts drawn down 
under the Debt Funding Facility as at 30 June 2015 represents 
an increase of $7.1 million since 30 June 2014. This increase 
since 30 June 2014 reflects the following key items: 

•  The Underlying NPAT for the year (+$20.5 million);

• 

• 

• 

• 

• 

• 

• 

• 

• 

 The net capital absorbed by the growth of the business 
over the period (-$35.2 million); 

 The increase in the working capital reserve (-$2.0m) 
reflecting capital set aside to fund the anticipated new 
business growth over the medium term; 

 Increase in risk capital reserved due to increasing new 
business volumes, the Matrix merger and the net impacts 
of capitalised software (-$11.9 million);

 Net impact of the underwritten DRP and the increase in 
the ESP reserve (+$1.3 million); 

 Net impact of the shares issued as part of the Matrix 
acquisition (+$12.8 million); 

 Goodwill and intangibles raised on the acquisition of 
Matrix, that are excluded from net tangible assets  
(-$20 million); 

 The draw down of $45.5 million under the CBA Debt 
Funding Facility (+$45.5 million); 

 The after tax deal and integration costs associated with 
the merger of Matrix (-$1.9 million); and

 The net impacts of the tax effect on the change in policy 
liability discount rate and other movements in the capital 
base (-$2.0 million). 

41     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

Remuneration Report
This Remuneration Report, which forms part of the Directors’ 
Report, sets out information about the remuneration of 
ClearView’s Directors and its Key Management Personnel 
(KMP) for the financial year ended 30 June 2015. 

The term “KMP” refers to those persons having authority 
and responsibility for planning, directing and controlling the 
activities of the consolidated entity, directly or indirectly, 
including any Director of the consolidated entity. 

The prescribed details for each person covered by this report 
are detailed below under the following headings: 

•  Details of the Directors and KMP; 

•  Overview of Remuneration Strategy and Objectives; 

• 

• 

 Remuneration Policy including the relationship between 
the Remuneration Policy and Company performance; 

 Remuneration of Directors and KMP including share based 
payments granted as compensation; and 

•  Key terms of employment contracts. 

Details of the Directors and KMP

The Directors of the Group and Company during or since the 
end of the financial year were:

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

 Dr Gary Weiss  
(Chairman, Independent Non-executive Director) 

 Andrew Sneddon  
(Independent Non-executive Director) 

 Bruce Edwards  
(Independent Non-executive Director)

 David Brown  
(Independent Non-executive Director) 

 Gary Burg  
(Independent Non-executive Director) 

 Jennifer Newmarch  
(Non-executive Director) 

 Michael Alscher  
(Non-executive Director) 

 Michael Lukin  
(Alternate Non-executive Director)  
(Alternate Director to Jennifer Newmarch)

 Nathanial Thomson  
(Non-executive Director) 

 Simon Swanson  
(Managing Director)

The KMP of the Group and the Company in addition to the 
Directors during or since the end of the financial year were:

• 

• 

• 

• 

• 

• 

• 

• 

 Athol Chiert  
Chief Financial Officer and Company Secretary

 Chris Robson  
General Counsel and Company Secretary 

 David Charlton  
General Manager, ClearView Direct 

 Greg Martin 
Chief Actuary and Risk Officer 

 Justin McLaughlin  
Chief Investment Officer

 Todd Kardash  
General Manager, Distribution (until 10 October 2014). 
Appointed Chief Executive Officer, Matrix Planning 
Solutions 13 October 2014. 

 Tony Thomas  
General Manager, Operations and Technology 

 Christopher Blaxland-Walker   
General Manager, Distribution (Appointed 13 October 
2014)

Overview of Remuneration Strategy and Objectives

ClearView’s remuneration approach has the following 
objectives: 

•  Attract, retain and motivate skilled employees; 

•  Reward and recognise employees for strong performance; 

• 

• 

• 

 Reward employees in a way that aligns remuneration with 
prudent risk-taking and the long-term financial soundness 
of the business, and with gains to its shareholders; 

 Maintain a competitive, yet financially-viable salary 
structure; and 

 Clarify responsibilities and decision-making authority in 
relation to remuneration at ClearView. 

Remuneration Policy

ClearView’s current Remuneration Policy was updated in 
June 2015 and is compliant with the obligations set out 
by the Australian Prudential Regulatory Authority (APRA) 
under Prudential Standards CPS 510 ‘Governance’ and 
SPS 510 ‘Governance’. It also forms part of ClearView’s 
Risk Management System and overall Risk Management 
Framework (in accordance with the Prudential Standards). 
The Board has approved this policy and retains overall 
responsibility for all remuneration decisions in respect to 
persons relevant to each entity. The Policy is reviewed at least 

ClearView Annual Report 2015     42

ClearView Wealth LimitedDirectors’ Report
Continued

once every three years. Any changes to the Policy must also 
be approved by the Board. 

ClearView has an established Group Nomination and 
Remuneration Committee (Remuneration Committee) 
which, among other things, is responsible for overseeing the 
remuneration and human resource practices for the Group. 
Key responsibilities of the Remuneration Committee are as 
follows: 

• 

• 

• 

• 

• 

• 

• 

• 

 Reviewing and recommending to the Board ClearView’s 
Remuneration Policy, including its effectiveness and 
compliance with legal and regulatory requirements, on a 
regular basis; 

 Identifying any material deviations of remuneration 
outcomes from the intent of the Remuneration Policy, 
including any unreasonable or undesirable outcomes that 
flow from existing remuneration arrangements; 

 Reviewing and making annual recommendations to the 
Board on the remuneration of the Managing Director, 
Senior Management Team (SMT) members (all of whom 
are KMP listed above) and other persons whose activities 
may, in the Remuneration Committee’s opinion, affect the 
financial soundness of ClearView; 

 Reviewing and making annual recommendations to 
the Board on the remuneration structures, including 
risk-adjusted performance targets, for those persons or 
categories of persons which, in the Board’s opinion, could 
individually or collectively affect the financial soundness 
of the institution, ensuring that due regard is given to the 
balance between the achievement of business objectives 
and the associated risk; 

 Reviewing and making annual recommendations to the 
Board on the remuneration structures of external persons 
retained directly by ClearView under contract whose 
activities, individually or collectively, may affect the 
financial soundness of the institution; 

 Reviewing compliance with the relevant regulatory and 
prudential requirements; 

 Ensuring it has the necessary experience and expertise in 
setting remuneration and sufficient industry knowledge 
and/or external advice to allow for effective alignment of 
remuneration with prudent risk-taking, supplementing its 
expertise with appropriate external expert advice; 

 Reviewing and recommending to the Board (and if 
required to shareholders) any short-term and long-term 
incentive payments for the Managing Director and Senior 
Management Team (SMT); and 

• 

 Reviewing and providing recommendations to the 

43     ClearView Annual Report 2015

Board (and if required to shareholders) in relation to 
any termination benefits for Non-executive directors, 
Managing Director, other SMT members and key  persons 
which exceed one year’s average base salary as defined in 
the Corporations Act 2001. 

ClearView’s Remuneration Policy is in place to: 

•  Outline employee obligations and ClearView’s obligations; 

• 

 Set out roles, responsibilities and accountabilities of the 
KMP; 

•  Set out clear reporting and controls; 

• 

• 

 Define various terms to ensure a common understanding; 
and 

 Clarify what happens if this policy or associated 
procedures are breached.

Relationship between Remuneration Policy and 
Company Performance. 

The primary objectives of the Remuneration Policy are to 
ensure that remuneration is competitive, aligned with the 
Company’s business objectives in both the short term and 
the long term, and appropriate for the results delivered 
by the individual. In accordance with this objective, the 
Company has structured remuneration packages to provide 
an appropriate mix of fixed and performance based pay 
components which are based on both the individual’s 
performance and Group performance. By adopting a robust 
approach to remuneration, the Group aims to attract and 
retain top talent. 

The remuneration framework is also designed to reward 
prudent risk-taking, support effective risk management and 
prioritise the long term financial soundness of the business 
and its shareholders. 

Total KMP remuneration is made up of three components: 

• 

Fixed Remuneration; 

•  Short Term Incentive (STI); and 

•  Long Term Incentive (LTI). 

The design of remuneration structures and performance 
conditions will reflect ClearView’s key risks, as relevant to 
particular roles by: 

• 

• 

 Ensuring that the components of remuneration 
appropriately balance risk and business outcomes, having 
regard to the percentage of “at risk” to “not at risk” 
remuneration that is, variable to fixed remuneration; 

 Using appropriate risk-adjusted objectives in ClearView’s 
incentive awards for key persons and categories of 
persons; 

ClearView Wealth LimitedDirectors’ Report
Continued

• 

• 

 Appropriate use of long-term incentives to ensure 
performance can be suitably validated and the 
consequence of the risk to which ClearView has been 
exposed can be fully assessed; and 

 Ensuring any sign-on and termination payments with 
respect to Directors, SMT members and other key 
personnel, comply with legislative requirements, are 
appropriate and prudent and contain suitable hurdles. 

Fixed Remuneration

Fixed Remuneration is made up of base remuneration 
and superannuation. Base salary includes cash salary and 
any salary sacrifice items. The Group provides employer 
superannuation contributions of 10% of each KMP’s 
superannuation salary, capped at the relevant concessional 
contribution limit. 

The Fixed Remuneration is based on each employee’s 
experience, qualifications, capability and responsibility and 
not to specific performance conditions. An employee’s 
responsibility includes accountabilities, delegations, KPIs and 
risk profiles. To ensure an employee’s Fixed Remuneration is 
competitive, it is benchmarked against median salary survey 
results from a group of comparable Australian financial 
service companies. Fixed Remuneration is reviewed annually, 
following the end of the 30 June performance year. 

Independent market remuneration data was purchased from 
two independent sources and reviewed to benchmark the 
Fixed Remuneration for KMP for the 2015 financial year. The 
sources were the Financial Industry Remuneration Group 
(FIRG) and Aon Hewitt reports. Both are primary providers 
of data and the most appropriate for roles in the industry 
in which ClearView operates. ClearView also purchased 
additional data from Mercer for specialist roles. The 
benchmarking reports were used as a guide, and were not a 
substitute for thorough consideration of all the issues by the 
Remuneration Committee.

No formal consulting advice was sought from independent 
external research houses and Remuneration Consultants in 
2015. 

Any increase to individual remuneration for the Managing 
Director, SMT and any other person whose activities may, in 
the Remuneration Committee’s opinion, affect the financial 
soundness of ClearView, must be approved by the Board on 
the recommendation of the Remuneration Committee after 
engaging and taking advice, where appropriate.

Short Term Incentive (STI) plan

The STI plan for KMP aims to provide a common motivation 
to act in the best interests of the Company to reach or 
exceed Company goals for the financial year. They are based 
on rewarding an individual with a bonus calculated as a 
percentage of Fixed Remuneration. Company performance 
targets are set for the KMP by the Remuneration Committee. 

For FY15, the award of the STI component for KMP is based 
on the achievement of two company goals equally weighted, 
namely: 

• 

• 

 Underlying Net Profit after Tax (UNPAT). UNPAT is the 
Board’s key measure of group profitability and the basis 
on which dividend payments are determined. It consists 
of reported net profit after tax adjusted for amortisation 
(not including capitalised software), the effect of changing 
discount rates on insurance policy liabilities and costs 
which are considered unusual to the Group’s ordinary 
activities; and 

 Embedded Value growth. Life insurance and wealth 
management are long term businesses that involve long 
term contracts with customers and complex accounting 
treatments. Embedded Value calculations are used as 
key measures to assess the performance of the business 
from period to period. An Embedded Value represents the 
discounted value of the future cash flows anticipated to 
arise from the in-force life policies and investment client 
balances as at the valuation date. 

Underpinning the achievement of the financial goals is sound 
business strategy, leadership, client focus, an appropriate 
product and superior service and continuing development of 
systems and processes. Furthermore, the EV component is 
longer term in nature. 

STI outcomes fall within a range of 0% to 120% of the Target 
STI with 100% pegged to achieving target performance (as 
set out in the Board approved Business Plan). The resultant 
potential maximum STI awards for KMP range from 0% to 
60% of Fixed Remuneration. In 2015, KMP therefore received 
an STI bonus of 36.1% of their Fixed Remuneration (in line 
with the target STI component) representing 24.0% of their 
total remuneration. This was based on achievement of the 
following:

• 

• 

 UNPAT – Actual UNPAT of $20.5 million; and

 EV – Actual EV growth of 8.6%1; 

1  Growth rate for the bonus calculation was the reported EV excluding assumption and model changes, and the Matrix acquisition.

ClearView Annual Report 2015     44

ClearView Wealth LimitedDirectors’ Report
Continued

105% of the target STI range was achieved based on the 
range of achieved outcomes.

The Managing Director sets specific key individual objectives 
for the KMP which support the achievement of Company 
goals. The individual performance targets are linked to a 
KMP’s position and/or team objectives and reflect the level of 
risk that ClearView is exposed to by the individual’s actions. 

Whilst the quantum of KMP STI is determined by Company 
goals, the Managing Director is responsible for assessing the 
performance of KMP and for recommending the total STI to 
be paid. Therefore, the Managing Director may recommend 
STI payments below or over and above the specified 
company outcomes in the case of below target or exceptional 
performance respectively. The Managing Director’s 
recommendations are presented to the Remuneration 
Committee for consideration and recommendations are 
made to the Board for approval. It is only when Board 
approval has been obtained that STI bonuses are payable.

Given that the target STI component is considered moderate 
in the industry in which the Group operates it has to date not 
been considered appropriate to introduce deferral provisions 
for the STI component.

Background to Long Term Incentive Plan (LTIP)

ClearView in its current form was created by the acquisition 
and successful integration of the life insurance, wealth 
management and financial advice businesses acquired from 
MBF Holdings Pty Limited (Bupa Australia) on 9 June 2010 
(the Acquisition). 

Key attributes of the Acquisition were as follows: 

• 

• 

• 

 Potential to use the platform acquired to create a new 
non-bank owned life insurance and wealth management 
company that could bring innovation to the market and 
challenge the incumbents; 

 No material legacy issues, enabling speed to market; and 

 No material exposure to group life, pre global financial 
crisis income protection or capital guaranteed products. 

ClearView was required to undertake a significant 
transformation to: 

• 

• 

 Build out a new management team with a track record in 
growing life insurance, wealth management and financial 
advice businesses; 

 Develop and launch advise based products providing 
access to new market segments; 

• 

• 

• 

• 

 Utilise the strong cash flow generated by the in-force 
portfolios at the time of the Acquisition to fund the initial 
growth phase in the Advised Life market and stem the 
outflows in the acquired Wealth Management in-force 
portfolios; 

 Expand into the independent financial advice market, 
with products having the quality to be included on the 
Approved Product Lists of third party dealer groups; 

 Reinvest in its Non-Advice (Direct) life insurance business 
with the build out of a call centre capability and focusing 
on establishing long term distribution partnerships; and

 Raise sufficient capital to fund the next phase of growth 
in both the Advised and Non-Advice segments of the life 
insurance market.

ClearView was therefore required to undergo a significant 
transformation, that has been achieved over the last 
four years with the development of systems, launch of 
LifeSolutions (full suite of life insurance advice products), 
WealthSolutions (ClearView Wrap platform) and 
WealthFoundations (wealth mid-market product), the 
recruitment of employees, experienced self employed 
financial advisers and distribution partners. 

ClearView has an ownership-based compensation scheme for 
the Senior Management Team (SMT), key management and 
revenue generators of the Group to assist in the recruitment, 
rewarding, retention and motivation of employees. This 
scheme is designed to recognise leaders and reward those 
decisions and actions which have a direct and positive impact 
on the results that ClearView delivers for shareholders, at the 
time and in the future. 

The Executive Share Plan (ESP) was established to assist in 
the recruitment of the SMT and employees with deep life 
insurance and wealth management experience, to execute on 
a core strategy and thereby to show ClearView’s recognition 
of the employees’ contribution, by providing an opportunity 
to share in the future growth and profitability of ClearView. 
The ESP was set up in the context of the “start up phase” and 
the nature of the ClearView business at the time when the 
scope and the timing of any future success of the business 
was still unknown and uncertain. The ESP aligns the interests 
of participants more closely with the interests of shareholders 
including the extension of the ESP to financial advisers in 
November 2011.

In July 2012, ClearView received a takeover offer from  
CCP Bidco Pty Limited (CCP Bidco), a consortium of investors 
including Crescent Capital Management Pty Limited.  

45     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

The new shareholders brought with them extensive 
experience in the financial services industry, in particular 
life insurance and wealth management and a strong 
commitment to support the management team and 
execution of the agreed strategy for growth. Subsequent  
to the change in shareholder, benchmarking of the LTI for  
the SMT was performed by PwC, an independent 
Remuneration Consultant, in February 2013. 

The Board subsequent to this review decided in February  
2013 to:

• 

• 

• 

 Remove any cap on the issue of shares under the ESP to 
retain the flexibility to use it as a recruitment tool for both 
employees and financial advisers;  

 Remove the interest on the loans that had until this 
date been capitalised and treated as part of the limited 
recourse principal, except that after tax dividends 
on Shares issued under the ESP was applied towards 
reduction of the loan; and

 Issue further grants to participants where considered 
appropriate (aligned to the overall remuneration review of 
the SMT members by PwC).  These further LTI grants were 
issued in a “lump sum” rather than on the basis of an 
annual grant and were aligned to the achievement of an 
increase in the share price of ClearView.

The interest rate on the limited recourse loans had to this 
point effectively acted as an in built performance hurdle. The 
Board decided to remove the interest rate on the loans for all 
participants given that the interest imposed was significantly 
diluting the efficacy of the ESP as an employee recruitment 
and retention tool, in particular for those staff receiving the 
earlier grants of ESP shares and to achieve its purpose given 
the start up phase of the business at the time.  The Board 
believed, nothwithstanding the removal of the interest rate on 
the loans, that the long term interests are aligned given that 
value is only attributed to participants through an increase 
in the share price and that 50% of the STI component is also 
aligned to the longer term, being the Embedded Value (refer 
to STI section above).

The use of derivatives over ClearView Securities could distort 
the proper functioning of performance and vesting conditions 
of the ESP. Accordingly, derivatives over ClearView shares  
are not permitted to be held in relation to any ClearView 
shares that are unvested or the subject of a holding lock 
under the ESP. 

Overview of the Executive Share Plan (ESP or Plan)

In accordance with the provisions of the Plan, as approved 
by shareholders at the 2012 Annual General Meeting, the 

ownership-based compensation scheme allows participation 
in the Plan of: 

• 

• 

 Employee Participants - These participants are key 
managers, members of the Senior Management Team 
and the Managing Director; and 

 Contractor Participants - These participants are financial 
advisers. 

Eligible Employees under the Plan Rules therefore include 
both Employee Participants and Contractor Participants of 
the Company and its related bodies corporate. Non-executive 
Directors are ineligible to participate in the Plan in accordance 
with the Plan Rules. 

Offer and Consideration

Under the ESP, the Board may invite Eligible Employees to 
participate in an offer (Offer) of fully paid ordinary shares in 
ClearView, subject to the terms of conditions of the ESP. Each 
ClearView Share is issued at a price to be determined by the 
Board prior to making an Offer and this price is set out in the 
invitation (Invitation) to Eligible Employees. This price may be 
the market price of a Share (as defined in the ESP Rules) on 
the date of the Invitation. Taking into account the liquidity, 
volatility, and the average trading activities of the ClearView 
Shares, the Board determined in February 2013 that it is 
appropriate and reasonable for ClearView to adopt the 
Volume Weighted Average Price (VWAP) over a 90 day period 
to determine the market value of the ClearView Shares for the 
purposes of ESP issues. This has been implemented for all ESP 
Share issues since that date. Prior to this, no ESP Shares were 
issued at a price below 50 cents per share, being the price at 
which the original capital raising was completed in June 2010.

Restrictions on Offer

Shares may not be offered under the ESP to an Eligible 
Employee if that Eligible Employee would hold, after the 
issue of the Shares, an interest in more than 5% of the issued 
Shares of ClearView or be able to control the voting rights of 
more than 5% of the votes that might be cast at a general 
meeting of ClearView. 

As at the date of this Report, the Board has not set a limit 
on the number of Shares that may be issued under the 
Plan. The Board or Board Authorised Delegates approve the 
issue of new ESP shares and monitors the overall quantum 
of ESP shares on issue, relative to the interests of existing 
shareholders and the overall objectives of the business. 

Financial Assistance

The Company may provide financial assistance to an Eligible 
Employee for the purposes of subscribing for Shares under the 

ClearView Annual Report 2015     46

ClearView Wealth LimitedDirectors’ Report
Continued

ESP. The financial assistance will be a limited recourse loan 
equal to the purchase value of the Shares and is repayable as 
follows: 

conditions (if any) attaching to the Shares issued prior to 14 
February 2013 have been satisfied (or waived) a holding lock 
will cease to have effect if: 

• 

• 

 • 

 For Share issues prior to 14 February 2013 - within 60 
days (or a longer period determined by the Board in its 
discretion) after the 5th anniversary of the grant of the 
financial assistance (unless it is required to be repaid at an 
earlier date owing to the operation of the Rules); or

 For Share issues after 14 February 2013 - within 60 
days (or a longer period determined by the Board in its 
discretion) after all performance and vesting criteria  
have been met; or

 For Shares issues after 1 May 2014, 2 months (or a period 
determined by the Board at it's discretion) immediately 
following the 6th anniversary of the grant of the financial 
assistance.

The financial assistance will become immediately repayable 
in the event of certain “disqualifying circumstances” including 
failure to meet performance or vesting conditions, cessation 
of the Employee Participant’s employment in circumstances 
defined in the ESP Rules or termination of the Contractor 
Participant’s contract with a Group Company for the provision 
of services. For Employee Participants, the financial assistance 
is secured over the shares and rights attached to the shares. 

The Board has delegated authority to Mr Swanson and Mr 
Thomson to approve granting an extension to the loan 
term of all ESP participants who remain employees at the 
expiration of their loan term for a period until a Change in 
Control of the Company (as defined in the ESP Rules). 

Until 14 February 2013, the interest rate on the loans was 
the Reserve Bank of Australia cash rate plus a margin of 25 
basis points per annum, compounded semi annually. Interest 
until this date has been capitalised and treated as part of the 
limited recourse principal, except that after tax dividends on 
shares issued under the ESP is applied towards reduction of 
the loan balance. 

In February 2013 the Board decided to remove the interest 
rate on the loans for all Participants (other than the Managing 
Director that required Shareholder approval). On 6 November 
2013, at the 2013 AGM, Shareholders approved the removal 
of interest on the Managing Directors loan, so as to align with 
the interest rate which applies to equivalent loans made to 
other participants in the Plan. 

Holding Lock

• 

 The Board accepts a disposal request (as defined in the 
ESP Rules) (Disposal Request); or 

•  5 years have passed from the Acquisition Date; or 

 If the Participant: 

• 

• 

 is an Employee Participant, their employment with the 
Group ceases, or 

 is a Contractor Participant, their contractor agreement is 
terminated; or 

•  The ESP is terminated, or 

•  The holding lock period otherwise ceases; 

provided that the Financial Assistance and any interest that 
has been accrued have been repaid. 

For shares issues from 14 February 2013 the Holding Lock 
ceases on vesting or forfeiture of Shares.

The holding lock is imposed through the share registry and in 
accordance with the ASX Listing Rules. Participants will not be 
able to sell their shares on ASX or have an off-market transfer 
registered (and are also otherwise prohibited from dealing in 
the shares) while the holding lock is in place. 

If the participant is a Contractor Participant, following the 
removal of the holding lock over the Shares of the participant, 
the participant may not sell, or otherwise deal with, any such 
Shares without the prior written consent of the Company, 
which consent the Company may give or withhold in its 
absolute discretion and which consent may be given subject 
to conditions. 

Eligible Employees are entitled under the ESP Rules to make 
a Disposal Request provided the performance and vesting 
conditions have been met (or waived). The holding lock 
applicable to their ESP shares will cease to have effect upon 
the Board (in its absolute discretion) accepting the Disposal 
Request. ClearView may dispose of these ESP shares on behalf 
of the participant in one or more of the following ways (at the 
discretion of the Board): 

• 

• 

 Reallocate the Shares to give effect to acquisitions by 
other Eligible Employees under the ESP; 

 Sell to the Company in accordance with buy-back 
provisions of the Corporations Act; or 

•  Offer or sell to buyers on the ASX. 

The shares granted under the ESP to participants are subject 
to a holding lock restricting the holder from dealing with the 
shares. Where all performance conditions and/or vesting 

The amount payable by these Eligible Employees to ClearView 
following such a disposal is the amount outstanding in 
relation to the financial assistance, including accrued interest. 

47     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

The Eligible Employees may retain any surplus proceeds. 
There are no Disposal Requests outstanding as at the date of 
this report.

Change of Control

Under the ESP Rules, all performance and vesting conditions 
in relation to Shares held by an Eligible Employee who is an 
Employee Participant are deemed to have been satisfied 
upon a Change of Control unless stated otherwise in the 
participants invitation offer. A Change of Control is defined 
under the ESP Rules as being: 

(a) Until 14 February 2013:

• 

• 

• 

 A person who did not Control the Company at the date of 
issue of the Plan Shares gains Control of the Company (but 
only if the person is not itself Controlled by another person 
who Controlled the Company at the date of issue); or 

 Other circumstances occur which the Board determines 
in its absolute discretion are analogous to a Control 
transaction and justify removal of Performance Conditions 
and/or Vesting Conditions, 

 “Control” is defined as where a person and its related 
bodies corporate holds more than 50% of the Shares in 
ClearView. 

(b) After 14 February 2013:

•  12 months after a Change of Control; or 

• 

• 

 Circumstances occur which the Board determines in its 
absolute discretion are analogous to a Control transaction 
and justify removal of Performance Conditions and/or 
Vesting Conditions. 

 “Control” is defined as Crescent Capital Partners and its 
Associated Entities no longer holding 20% of the voting 
rights of the Company. 

The above provisions concerning change of control apply 
only to Employee Participants and not Contractor Participants 
under the ESP. 

(c)  After 1 July 2015:

• 

 For ESP Shares issued to employee participants after  
1 July 2015, unless stated otherwise in the participants 
Invitation Offer, all performance and vesting conditions 
in relation to these shares, are not deemed to have been 
met upon a Change of Control.  

ClearView Annual Report 2015     48

ClearView Wealth LimitedDirectors’ Report
Continued

Consequences of ClearView’s performance on shareholder wealth

The following tables set out the summary information about the Group’s earnings and movements in shareholder wealth for 
five years to 30 June 2015: 

Revenue1 ($’000)

Net profit after tax ($’000)

Underlying Net Profit/(loss) after Tax

Total Operating Earnings after Tax

Dividend (Final) (cents)

Dividend (Special) (cents)2

Basic EPS (cents)1

Diluted EPS (cents)

Fully diluted Underlying EPS (cents)

Embedded Value3 ($m)

Embedded Value per share (cents)3

Share Price at the beginning of the year (cents)

Share Price at the end of the year (cents)

30 Jun 15

30 Jun 14

30 Jun 13

30 Jun 12

30 Jun 11

 253,640

190,301

172,278

143,182

136,019

 12,572

 20,533

20,867

13,880

19,738

19,738

1,876

16,014

16,014

22,336

19,241

19,241

8,665

19,317

19,317

 2.10 

 -   

 2.43 

 2.36 

 3.85 

 389   

73.0

80.0

95.0

 2.00 

 -   

 3.13 

 3.10 

 4.41 

359

71.2

59.0

80.0

 1.80 

 2.20 

 0.46 

 0.46 

 3.65 

291

69.4

46.0

59.0

 1.80 

 -   

 5.46 

 5.24 

 4.53 

269

65.0

50.0

46.0

 1.80 

 -   

 2.12 

 2.10 

 4.59 

n/a

n/a

52.0

50.0

3 

1   Revenue from continuing operations excludes net fair value gains/losses in financial assets.
2  

 In accordance with the Implementation Agreement entered into between the Company and CCP Bidco, on 26 September 2012, ClearView declared an un-
franked special dividend of 2.2 cents per share that was paid on 16 October 2012.
 EV calculated at a 4% discount rate margin. Previously reported EV of $279m at 30 June 2013 and $265m at 30 June 2012 adjusted for dividends, net capital 
applied, cash takeover bid related costs and the estimated reduction in the discount rate margin to 4% (for comparative purposes). The 2011 EV has been 
excluded given changes to discount rates, dividends and net capital applied. 
 The EV at each reporting date excludes any value for future growth, potential value of franking credits, costs associated with being listed on the ASX, short 
term prospective growth and development costs and ESP loans outstanding at balance date. EV per share calculations has been adjusted to include ESP loans 
outstanding at balance date.

Remuneration of Directors and KMP

Non-executive Directors’ Remuneration

Non-executive Directors are remunerated by way of one base fee (inclusive of Superannuation Guarantee) that is based on 
market rates for comparable companies for the time, commitment and responsibilities undertaken by Non-executive Directors. 
The level of remuneration for each Non-executive Director is set by the Remuneration Committee, within the total annual 
remuneration limits approved by the Company and the shareholders at a general meeting. Any increase to individual Non-
executive Director remuneration must be approved by the Board on the recommendation of the Remuneration Committee 
after engaging and taking advice, where appropriate. All reasonable out of pocket expenses incurred in connection with 
a Director’s duties on behalf of ClearView Wealth are reimbursed. There is no direct link between Non-executive Directors’ 
remuneration and the annual results of ClearView Wealth or its related entities. The Non-executive Director remuneration 
is based on the role of the individual director, their membership on Board Committees, and directorships of other ClearView 
entities. 

Non-executive Directors are not entitled to participate in equity schemes of the Company, and are not entitled to receive 
performance-based bonuses. Non-executive directors are not entitled to retirement benefits other than in respect of any 
superannuation entitlements.

The present limit on aggregate remuneration for Non-executive directors is $1,000,000 including superannuation (2014: 
$1,000,000). Directors’ fees can be paid as superannuation contributions. The fee pool is the only source of remuneration for 
Non-executive Directors. 

49     ClearView Annual Report 2015

ClearView Wealth Limited  
Directors’ Report
Continued

The compensation of each Non-executive Director for the year ended 30 June 2015 is set out below: 

Short term employee benefits

Post  
employment

Share based 
payments

Total

2015

Salary  
& Fees

$

Non-executive Directors

G Weiss

B Edwards 

D Brown 

G Burg 

J Newmarch1

M Lukin1

N Thomson2

A Sneddon

M Alscher3

Total

182,648

95,000

77,626

73,059

66,667

13,333

85,000

85,000

-

Bonus

Non-  
monetary

Termination 
Payment

Superannu-
ation

$

-

-

-

-

-

-

-

-

-

$

-

-

-

-

-

-

-

-

-

$

-

-

-

-

-

-

-

-

-

$

 17,352 

-

 7,374 

 6,941 

-

-

-

-

-

Executive 
Share Plan of 
total remu-
neration
$

Performance 
based

%

$

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

 200,000 

 95,000 

 85,000 

 80,000 

 66,667 

 13,333 

 85,000 

 85,000 

-

710,000

678,333

 -   

 -   

 -   

31,667

 -   

1 

2 

3 

 Mr Lukin receives fees as an alternate to Mrs Newmarch from 1 May 2015. Mr Lukin and Mrs Newmarch have agreed they will receive no fees as a Director 
although fees are payable to ROC Partners. Mrs Newmarch received fees until 30 April 2015. 
 Mr Thomson has agreed that he will receive no fees as a Director although fees are paid to Crescent Capital Partners Manangement Pty Limited of which he is 
an employee.
 Mr Alscher agreed that he would receive no fees for his services as a Director and Crescent Capital Partners Management Pty Limited agreed to receive  
no directors fees in respect of Mr Alscher’s directorship for the 2015 financial year.

ClearView Annual Report 2015     50

ClearView Wealth Limited 
 
 
Directors’ Report
Continued

The compensation of each Non-executive Director for the year ended 30 June 2014 is set out below: 

Short term employee benefits

Post  
employment

Share based 
payments

Total

2014

Salary  
& Fees

$

Non-executive Directors

G Weiss1

B Edwards 

D Brown 

G Burg 

J Newmarch2

J Fallick4

M Lukin2

N Thomson3

A Sneddon4

M Alscher5

Total

183,066

95,000

77,803

73,227

40,000

-

40,000

121,230

85,000

-

715,326

Bonus

Non-  
monetary

Termination 
Payment

Superannu-
ation

$

-

-

-

-

-

-

-

-

-

-

-

$

-

-

-

-

-

-

-

-

-

-

-

$

-

-

-

-

-

-

-

-

-

-

-

$

16,934

-

7,197

6,773

-

-

-

-

-

-

30,904

Executive 
Share Plan of 
total remu-
neration
$

Performance 
based

%

$

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

200,000

95,000

85,000

80,000

40,000

-

40,000

121,230

85,000

-

746,230

1  Dr Weiss was appointed Chairman on 1 July 2013 and his fees were increased to $200,000 per annum from that date.
2 

 Mr Lukin was paid fees as an alternate to Mrs Newmarch from 1 January 2014. Mr Lukin and Mrs Newmarch have agreed they will receive no fees as a Director 
although fees were paid to Macquarie Investment Management Limited of which they were employees until 6 June 2014 (from which date they are now paid 
to ROC Partners). Mrs Newmarch was paid fees until 31 December 2013.
 Mr Thomson has agreed that he will receive no fees as a Director although fees are paid to Crescent Capital Partners Management Pty Limited of which he is an 
employee. Mr Thomson fees include an additional payment of $36,230 for special duties in the year ended 30 June 2014.
 Mr Sneddon was appointed Alternate Director to Mr Fallick on 26 March 2013. Mr Sneddon was paid fees as an alternate to Mr Fallick from 26 March 2013 
until 3 December 2013. On the resignation of Mr Fallick on 3 December 2013, Mr Sneddon’s appointment as Alternate was revoked and he was appointed as a 
Director on 3 December 2013 at which time he started receiving his own Non-executive Director fees.
 Mr Alscher agreed that he would receive no fees for his services as a Director and Crescent Capital Partners Management Pty Limited agreed to receive  
no directors fees in respect of Mr Alscher’s directorship for the 2014 financial year.

3 

4 

5 

51     ClearView Annual Report 2015

ClearView Wealth Limited 
Directors’ Report
Continued

Managing Director and Senior Management Team Remuneration

The compensation of each member of the KMP of the Group for the year ended 30 June 2015 is set out below: 

Short term  
employee benefits

Post  
employment

Share based 
payments

Salary & Fees

Bonus

Non-monetary

Superannuation

Executive 
Share Plan1

Performance 
based

2015

S Swanson

A Chiert

C Robson

G Martin

J McLaughlin

T Kardash3

T Thomas

D Charlton

E Singfield

$

605,083

356,144

307,161

358,513

309,343

279,064

334,123

268,192

- 

$

317,951 

112,291 

96,843 

117,965 

99,691 

93,388 

105,376 

84,859 

- 

$

12,020 

 6,534 

-

12,020 

-

9,080 

-

-

-

C Blaxland-Walker2 

266,500

84,689 

Total

3,084,123

1,113,053

9,080 

48,734

$

19,467

19,467

19,467

35,092

26,268

35,672

23,408

19,467

6,487

19,467

$

-

48,300

-

48,300

-

18,412

36,780

20,405

-

5,018 

%

33.3%

29.6%

22.9%

29.1%

22.9%

25.7%

28.4%

26.8%

0.0%

23.3%

Total

$

954,521 

542,736 

423,471 

571,890 

435,302 

435,616 

499,687 

392,923

6,487 

384,754

224,262

177,215

27.8% 4,647,387

 Benefit calculated under the Binomial model in respect of the future value of the ESP shares issued. 

1 
2  Appointed General Manager, Distribution 13 October 2014.
3  Appointed Chief Executive Officer, Matrix Planning Solutions 13 October 2014.

The compensation of each member of the KMP of the Group for the year ended 30 June 2014 is set out below: 

Short term  
employee benefits

Post  
employment

Share based 
payments

Salary & Fees

Bonus

Non-  
monetary

Superannuation

Executive 
Share Plan1

Performance 
based

$

591,210

347,500

299,980

364,992

307,493

269,887

301,331

206,343

280,843

$

310,541

109,526

94,590

115,049

96,935

85,255

95,297

68,027

32,312

$

11,575

6,534 

 - 

11,575

- 

8,635

 - 

 - 

 - 

$

17,725

17,725

17,725

25,327

24,526

17,725

17,725

17,661

20,845

$

 5,687 

 48,300 

 - 

 48,300 

 - 

24,150 

 36,181 

 2,230 

 - 

%

33.8%

29.8%

22.9%

28.9%

22.6%

27.0%

29.2%

23.9%

9.7%

Total

$

 936,738 

 529,585 

 412,295 

565,243 

 428,954 

 405,652 

 450,534 

294,261 

 334,000 

2,969,579

1,007,532

 38,319 

176,984

 164,848 

26.9%

4,357,262 

2014

S Swanson

A Chiert

C Robson

G Martin

J McLaughlin

T Kardash

T Thomas

D Charlton3

E Singfield2

Total

1  

 Benefit calculated under the Binomial model in respect of the future value of the ESP shares issued. This includes modification to the inputs due to the removal 
of interest on the ESP loans (in relation to S Swanson ESP shares).
Cessation of employment on 1 May 2014.

2 
3  Appointed 1 May 2014. 

ClearView Annual Report 2015     52

ClearView Wealth Limited 
 
Directors’ Report
Continued

Share Based Payments Granted As Compensation

Limited recourse loans have been granted by the Company to the ESP participants to fund the acquisition of shares under  

the ESP. 

The following tables outlines the ESP loans made to KMP or their related entities as at 30 June 2015 and June 2014: 

2015

S Swanson

A Chiert

G Martin

C Robson

J McLaughlin

T Kardash

T Thomas

D Charlton

C Blaxland-Walker

Total

2014

S Swanson

A Chiert

G Martin

C Robson

J McLaughlin

T Kardash

T Thomas

D Charlton

Total

Loans 
Granted
$

Interest 
charged
$

Repay-
ments
$

Loan  
Cancelled
$

Balance at 
end
$

Highest in 
period $

Balance at 
beginning

6,335,453

1,368,287

1,542,738

491,184

824,197

778,029

915,000

524,239

497,844

Balance at 
beginning

6,431,753

1,392,362

1,571,628

500,814

838,642

792,474

-   

-   

-   

-   

-   

-   

- 

- 

249,999 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

915,000

524,239

11,527,673

1,439,239

13,276,971

249,999

Loans 
Granted
$

Interest 
charged
$

-   

-   

-   

-   

-   

-   

-   

-   

 -

-

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

(102,000) 

(25,500)

(30,600)

(10,200)

(15,300)

(15,300)

(15,300)

(7,089)

(10,200)

-   

-   

-   

-   

-   

-   

-   

-   

- 

6,233,453

6,335,453

1,342,787

1,368,287

1,512,138

1,542,738

480,984

808,897

762,729

899,700

517,150

491,184

824,197

778,029

915,000 

524,239 

737,643 

737,643

(231,489)

-  13,295,481

-

Repay-
ments
$

(96,300)

(24,075)

(28,890)

(9,630)

(14,445)

(14,445)

 - 

 - 

Loan  
Cancelled
$

Balance at 
end
$

Highest in 
period $

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

6,335,453

6,431,753

1,368,287

1,392,362

1,542,738

1,571,628

491,184

824,197

778,029

500,814

838,642

792,474

915,000

 915,000 

524,239

 524,239 

(187,785)

 -  12,779,127

- 

53     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

Shares granted to KMP and equity holdings

During and since the end of the financial year an aggregate of 247,525 shares (2014: 2,195,000) were granted by the Company 
to KMP under the ESP. 

The following table outlines the ESP shares issued to KMP or their related entities as at the date of this report: 

Director, KMP, to 
which the series 
relates

Fair value at 
grant date 
(pre-modifi-
cation1) 

Fair value at 
grant date 
(post-modi-
fication1) 

Exercise 
price per 
share ($)

Aggregate 
value at 
grant date 
($)

Expiry date

Justin McLaughlin

 0.10 

 0.10 

 0.59 

51,500

Change in Control

Share series

Series 61,2,6,9

Series 71,2,6,9

Series 101,3,6,9

Series 111,4,6,9

Series 121,5,6,9

Series 151,5,9

Series 161,5,9

Athol Chiert/Justin 
McLaughlin

Simon Swanson

Simon Swanson

Simon Swanson

Greg Martin/Chris 
Robson

Todd Kardash

Series 161,5,8,9

Chris Blaxland-Walker

Series 267

Series 267

Series 267

Series 31

Series 32

Series 38

Series 39

Series 40

Series 438

Series 448

Series 458

Athol Chiert

Greg Martin

Todd Kardash

Tony Thomas

Tony Thomas

David Charlton

David Charlton

David Charlton

Chris Blaxland-Walker

Chris Blaxland-Walker

Chris Blaxland-Walker

 0.07 

 0.11 

 0.08 

 0.06 

 0.10 

 0.10 

 0.10 

 0.29 

 0.29 

 0.29 

 0.17 

 0.19 

 0.17 

 0.19 

 0.22 

 0.15 

 0.18 

 0.21 

 0.10 

 0.11 

 0.08 

 0.06 

 0.13 

 0.13 

 0.13 

 n/a 

 n/a 

 n/a 

 n/a 

 n/a 

 n/a 

 n/a 

 n/a 

 n/a 

 n/a 

 n/a 

 0.49 

 0.50 

 0.58 

 0.65 

 0.50 

 0.50 

 0.50 

 0.57 

 0.57 

 0.57 

 0.61 

 0.61 

 0.75 

 0.75 

 0.75 

 1.01 

 1.01 

 1.01 

98,057

Change in Control

224,074

Change in Control

323,295

Change in Control

241,927

Change in Control

294,000

127,366

127,366

1/07/2016

1/09/2016

1/09/2016

289,798

Change in Control

289,798

Change in Control

144,899

Change in Control

123,873

Change in control

140,797 1 Year Post change 
in control

38,230

44,307

50,054

12,385

14,775

16,975

30/05/2018

30/05/2019

30/05/2020

26/11/2018

26/11/2019

26/11/2020

1 

2 

3 
4 
5 
6 
7 

8 
9 

 On the 14th February 2013, the Board approved a change to the rules of the ESP which changed the interest rate charged on the financial assistance granted 
to the ESP Participants from the RBA official cash rate plus 25 basis points to zero percent. This resulted in changes to the inputs of the option pricing model 
which had an impact on the fair value of the option at the date of the change.
 Change of control provision was triggered on 23 October 2009 by GPG increasing its shareholding above 50%. As a result, the vesting conditions for employees 
that were issued shares prior to the date of change of control were accelerated. 
Shares vested 1 year from date of commencement of employment on 26 March 2011.
Shares vested 2 years from date of commencement of employment on 26 March 2012.
Change of control provision was triggered on 26 September 2012 by CCP Bidco obtaining a shareholding above 50%.
The Board approved granting an extension of the loan term until such time as there is a change of control in the Company.
 Special condition relating to shares issued to KMP in Series 26: the shares may be sold on change of control with 50% of the funds held for in escrow for a 
period of 12 months.
 Chris Blaxland-Walker became KMP on 13 October 2014. 
Vesting conditions have been met up to the date of this report.

ClearView Annual Report 2015     54

ClearView Wealth LimitedDirectors’ Report
Continued

The following table summaries the performance and vesting conditions for shares issues to Employee Participants under the 
ESP as at the date of this report are:

Vesting Conditions

Performance Conditions

Series

Series 6 – 30 June 2008 Issue

Series 7 – 29 September 2009 Issue

Series 10 – 25 June 2010 Issue

Series 11 – 25 June 2010 Issue

Series 12 – 25 June 2010 Issue

Series 15 – 18 August 2011 Issue

Series 16 – 6 October 2011 Issue

Series 26- 16 April 2013 Issue

Nil1

Nil1

Nil2

Nil2

Nil2,4

Nil4

Nil4

Upon a change in control of the company3

Series 27- 16 April 2013 Issue

First year anniversary upon the change in control

Series 31- 14 October 2013 Issue

Upon a change in control of the company

Series 32- 14 October 2013 Issue

First year anniversary upon the change in control

Series 38- 30 May 2014 Issue

Series 39- 30 May 2014 Issue

Series 40- 30 May 2014 Issue

Series 43- 26 November 2014 Issue

Series 44- 26 November 2014 Issue

Series 45- 26 November 2014 Issue

Remain an employee of the company for 4 years from 
Grant date of shares

Remain an employee of the company for 5 years from 
Grant date of shares

Remain an employee of the company for 6 years from 
Grant date of shares

Remain an employee of the company for 4 years from 
Grant date of shares

Remain an employee of the company for 5 years from 
Grant date of shares

Remain an employee of the company for 6 years from 
Grant date of shares

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

1 
2 

3 

Change of control provision was triggered on 23 October 2009 by GPG increasing its shareholding above 50%.
 In accordance with Mr Swanson’s employment contract, Mr Swanson is entitled to a long term incentive comprising 10 million Shares in accordance with the 
ESP, and vesting progressively over three years from the commencement date of his contract as follows: 
Series 10: 2 million shares at an issue price of 50 cents vesting on 26 March 2011 (vested); 
Series 11: 4 million shares at an issue price of 58 cents vesting on 26 March 2012 (vested); and 
Series 12: 4 million shares at an issue price of 65 cents vesting on 26 September 2012 (vested) on change of control of ClearView. 
The Shares issued to Mr Swanson have vested progressively each year as outlined above.
 Special condition relating to shares issued to KMP in Series 26: 50% of the shares may be sold on change of control, 50% can be sold after employment for 1 
year thereafter and are held in escrow.

4   Change of control provision was triggered on 26 September 2012 by CCP Bidco obtaining a shareholding above 50%.

55     ClearView Annual Report 2015

ClearView Wealth LimitedDirectors’ Report
Continued

All unvested Shares will automatically vest in accordance with the rules of the Plan upon a change of control as outlined above. 

The following table outlines the fully paid ordinary shares of the Company (including those held under the ESP) owned by the 
KMP as at 30 June 2015: 

o
t

t
c
e
j
b
u
s

s
e
r
a
h
S

s
n
o
i
t
i
d
n
o
c
g
n
i
t
s
e
v

.

o
N

 -   

 -   

 -   

g
n
i
t
s
e
v
o
t

t
c
e
j
b
u
s

.

o
N
s
n
o
i
t
i
d
n
o
c

t
o
n
s
e
r
a
h
S

t
a
e
c
n
a
l
a
B

i

f
o
g
n
n
n
g
e
b

i

.

o
N
r
a
e
y
l
a
i
c
n
a
n
fi

.

o
N
n
o
i
t
a
s
n
e
p
m
o
c

s
a
d
e
t
n
a
r
G

.

o
N
r
a
e
y
l
a
i
c
n
a
n
fi

f
o
d
n
e
e
c
n
a
l
a
B

g
n
i
t
s
e
v
o
t

t
c
e
j
b
u
s

d
l
e
h
e
c
n
a
l
a
B

.

o
N
s
e
g
n
a
h
c

r
e
h
t
o
t
e
N

 -   

 511,367 

 -   

 9,700,741 

 -   

 108,333 

 12,784 

 524,151 

 242,518 

 9,943,259 

 2,708 

 111,041 

.

o
N
s
n
o
i
t
i
d
n
o
c

 -   

 -   

 -   

d
e
t
s
e
v
e
c
n
a
l
a
B

.

o
N
d
n
e
r
a
e
y
t
a

 -   

 -   

 -   

t
e
y
t
o
n
t
u
b
d
e
t
s
e
V

.

o
N
e
l
b
a
s
i
c
r
e
x
e

 -   

 -   

 -   

d
n
a
d
e
t
s
e
V

.

o
N
e
l
b
a
s
i
c
r
e
x
e

 -   

 -   

 -   

2015

B Edwards

G Burg

A Sneddon

S Swanson

A Chiert

D Charlton

 -    12,000,000  13,108,334 

 1,000,000 

 1,500,000 

 2,640,384 

695,000

 -   

 695,000 

J McLaughlin

 -   

 1,500,000 

 1,500,000 

T Kardash

G Martin

T Thomas

C Robson

 500,000 

 1,000,000 

 1,500,000 

 1,000,000 

 2,000,000 

 3,333,772 

1,500,000

 -   

 1,688,556 

 -   

 1,000,000 

 1,000,000 

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 77,709  13,186,043 

 -    10,000,000 

 8,000,000  2,000,000

 -   

 2,640,384 

 1,000,000 

 1,500,000 

 -

 1,500,000 

 -   

 695,000 

695,000   

 -   

 -   

 -   

 -   

 1,500,000 

 -   

 1,500,000 

 -   

 1,500,000 

 -   

 1,500,000 

 500,000 

 1,000,000 

 1,000,000 

 2,094 

 3,335,866 

 1,000,000 

 2,000,000 

 2,000,000 

 38,953 

 1,727,509  1,500,000

 -   

 -   

 18,000 

 1,018,000 

 -   

 1,000,000 

 1,000,000 

-

 -   

 -   

 -   

-

C Blaxland-Wakler

- 

 1,000,000  1,000,000 

 247,525 

-

 1,247,525 

 247,525 

 1,000,000  1,000,000

Key terms of employment contracts
The following contractual and other arrangements are in place in respect of the KMP as at the date of this report.

Notice period 
by either the 
employee or the 
Company

Other

Term

Ongoing 6 months notice

KMP

Simon 
Swanson

Athol Chiert

Ongoing 6 months 

notice for the 
first 3 years of 
employment,  
3 months notice 
after 3 years.

Todd Kardash Ongoing 13 weeks

If, in the 6 months following a change of control, 
Mr Swanson’s remuneration or his duties and 
responsibilities are reduced through no fault of 
his own, then Mr Swanson will have a right to 
terminate the contract with immediate effect. In 
this case, and in addition to vesting of Mr Swanson’s 
ESP Shares, the Company will be obliged to pay Mr 
Swanson 6 months base salary plus the maximum 
short term incentive amount for that calendar year.

For all terminations after the first 3 years of 
employment an additional 26 week payment is 
payable.

Target 
Incentive 
% of base 
salary

Maximum 
Incentive 
% of base 
salary

50%

60%

30%

36%

In the case of redundancy, a severance payment 
of 3 months’ base salary (or any greater payment 
required under the National Employment 
Standards).

30%

36%

ClearView Annual Report 2015     56

ClearView Wealth Limited 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Report
Continued

KMP

Term

Notice period 
by either the 
employee or the 
Company

Other

Chris Robson

Ongoing 13 weeks

Greg Martin

Ongoing 13 weeks

Justin 
McLaughlin

Ongoing 12 months 

notice for the 
first 3 years of 
employment, 6
months notice 
after 3 years.

Tony Thomas

Ongoing 13 weeks

David 
Charlton

Ongoing 13 weeks

Christopher 
Blaxland- 
Walker 

Ongoing 13 weeks

In the case of redundancy, a severance payment 
of 3 months’ base salary (or any greater payment 
required under the National Employment 
Standards).

In the case of redundancy, a severance payment 
of 3 months’ base salary (or any greater payment 
required under the National Employment 
Standards).

For all terminations after the first 3 years of 
employment an additional 26 week payment is 
payable.

In the case of redundancy, a severance payment 
of 3 months’ base salary (or any greater payment 
required under the National Employment 
Standards).

In the case of redundancy, a severance payment 
of 3 months’ base salary (or any greater payment 
required under the National Employment 
Standards).

In the case of redundancy, a severance payment 
of 3 months’ base salary (or any greater payment 
required under the National Employment 
Standards). 

Target 
Incentive 
% of base 
salary

Maximum 
Incentive 
% of base 
salary

30%

36%

30%

36%

30%

36%

30%

36%

30%

36%

30%

36%

All current Directors are subject to re-election by shareholders at least every 3 years. All current KMP contracts provide for an 
annual review of Fixed Remuneration.

Signed in accordance with a resolution of the Board of Directors made pursuant to s298(2) of the Corporation Act 2001.

On behalf of the Directors

Dr Gary Weiss  
Chairman

25 August 2015 

57     ClearView Annual Report 2015

ClearView Wealth LimitedAuditor’s Independence Declaration 

Deloitte Touche Tohmatsu 
A.B.N. 74 490 121 060 

550 Bourke Street 
GPO Box 78 
Melbourne 3000 
Australia 

DX 10307SSE 
Tel:  +61 (0) 3 9671 7000 
Fax:  +61 (0) 3 9671 7001 
www.deloitte.com.au 

The Board of Directors 
Clearview Wealth Limited  
Level 12, 20 Bond Street 
Sydney NSW 2000 

25 August 2015 

Dear Directors 

ClearView Wealth Limited 

In  accordance  with  section  307C  of  the  Corporations  Act  2001,  I  am  pleased  to  provide  the  following 
declaration of independence to the directors of ClearView Wealth Limited. 

As lead audit partner for the audit of the financial statements of Clearview Wealth Limited for the financial 
year  ended  30  June  2015,  I  declare  that  to  the  best  of  my  knowledge  and  belief,  there  have  been  no 
contraventions of: 

(i)  the auditor independence requirements of the Corporations Act 2001 in relation to the audit; 

and 

(ii)  any applicable code of professional conduct in relation to the audit.   

Yours sincerely 

DELOITTE TOUCHE TOHMATSU 

Peter A. Caldwell 
Partner  
Chartered Accountant 

Liability limited by a scheme approved under Professional Standards Legislation.
Member of Deloitte Touche Tohmatsu Limited. 

ClearView Annual Report 2015     58

ClearView Wealth Limited 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2015 Financial Report Contents

Statement of Profit or Loss and  
other Comprehensive Income 

Statement of Financial Position  

Statement of Changes in Equity 

Statement of Cash Flows 

Notes to the financial statements
1  General information 

60

61

62

64

65

2  Application of new and revised Accounting Standards  65

22  Payables 

23  Provisions 

24  Deferred tax balances 

25  Convertible note 

26  Policy liabilities 

27  Issued capital 

28  Borrowings 

29  Share-based payments 

3  Significant accounting policies 

4 

 Critical accounting judgments and key sources  
of estimation uncertainty  

5  Risk management 

6  Capital Adequacy 

7  Segment information 

8  Fee and other revenue 

9 

Investment Income 

10  Operating expenses 

11  Income tax 

12  Movements in reserves 

13  Sources of profit 

14  Earnings per share 

15  Cash and cash equivalents 

16  Investments 

17  Receivables 

18  Fixed interest deposits 

19  Goodwill 

20  Intangible assets 

21  Property, plant and equipment 

30  Shares granted under the employee share plans 

31  Dividends 

32   Reconciliation of net profit for the year to net  

cash flows from operating activities 

33  Subsidiaries 

34  Business combinations 

35  Related party transactions  

36  Financial Instruments 

37  Disaggregated information by fund 

38  Investment in controlled unit trusts 

39  Leases 

40  Contingent liabilities and contingent assets 

41  Capital commitments 

42  Guarantees 

43  Subsequent events 

Directors’ Declaration 

Independent Auditor’s Report 

Shareholders’ Information 

Directory 

69

82

89

93

95

97

97

97

98

100

101

102

102

103

103

104

104

105

106

The Financial Report was authorised for issue by the Directors on 25 August 2015.

107

108

109

110

111

112

113

113

120

120

121

122

123

125

127

136

140

140

141

142

142

142

143

144

146

150

59     ClearView Annual Report 2015

ClearView Wealth LimitedConsolidated statement of profit or loss and other 
comprehensive income
For the year ended 30 June 2015

Continuing operations

Revenue from continued operations

Premium revenue from insurance contracts

Outward reinsurance expense

Net life insurance premium revenue

Fee and other revenue

Investment income

Operating revenue before net fair value gains on financial 
assets

Net fair value gains on financial assets

Net operating revenue

Claims expense

Reinsurance recoveries revenue

Commission and other variable expenses

Operating expenses

Depreciation and amortisation expense

Change in life insurance policy liabilities

Change in reinsurers’ share of life insurance liabilities

Change in life investment policy liabilities

Movement in liability of non-controlling interest in controlled 
unit trusts

Profit/(loss) before income tax expense

Income tax expense/(benefit)

Total comprehensive income/(loss) for the year

Attributable to:

Equity holders of the parent

Earnings per share

Basic (cents per share)

Diluted (cents per share)

Underlying earnings per share

Basic (cents per share)

Diluted (cents per share)

To be read in conjunction with the accompanying Notes.

Consolidated

Note

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

8

9

10

10

26

26

26

11

14

105,164

(18,361)

86,803

95,014

71,823

76,785

(10,344)

66,441

59,098

64,762

253,640

190,301

72,818

80,442

326,458

(32,951)

15,010

(87,044)

(81,255)

(12,847)

40,951

(7,367)

270,743

(25,929)

11,680

(45,654)

(60,732)

(10,823)

34,228

(9,994)

(109,198)

(126,385)

(27,968)

(15,651)

 -   

 -   

 -   

 -   

 14,399 

14,399

 -   

14,399

 -   

 -   

 -   

 -   

 -   

 -   

 -   

687

687

 -   

687

 -   

 -   

 -   

(3,023)

(1,145)

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

23,789

11,217

12,572

21,483

7,603

13,880

11,376

(482)

11,858

(458)

(138)

(320)

12,572

13,880

11,858

(320)

2.43

2.36

3.97

3.85

3.13

3.10

4.46

4.41

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

ClearView Annual Report 2015     60

ClearView Wealth LimitedConsolidated statement of financial position
As at 30 June 2015

Assets

Cash and cash equivalents

Investments

Receivables

Fixed interest deposits

Reinsurers’ share of life insurance policy liabilities

Deferred tax asset

Property, plant and equipment

Convertible note

Goodwill

Intangible assets

Total assets

Liabilities

Payables

Current tax liabilities

Provisions

Life insurance policy liabilities

Life investment policy liabilities

Borrowings

Liability to non-controlling interest in controlled unit trusts

Deferred tax liabilities

Total liabilities

Net assets

Equity

Issued capital

Retained losses

Executive Share Plan Reserve

Profit reserve

General reserve

Total equity

To be read in conjunction with the accompanying Notes.

Consolidated

Note

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

15

16

17

18

26

24

21

25

19

20

22

23

26

26

28

24

27

12

12

12

12

 200,769 

 183,299 

 34,447 

 1,111 

 1,450,251 

 1,336,769 

 318,159 

 257,892 

 15,516 

 107,035 

(2,233)

 11,876 

 88,759 

(3,872)

 11,029 

 10,194 

 1,156 

 1,711 

 19,952 

 36,021 

 1,347 

 301 

 4,858 

 36,899 

 9,884 

 8,115 

 -   

 682 

 -   

 1,711 

 -   

 -   

 16,353 

 25,179 

 -   

 840 

 -   

 301 

 -   

 -   

1,841,207

1,670,430

372,998

301,676

 24,774 

 25,069 

 4,548 

 5,375 

 4,622 

 3,588 

(156,641)

(127,278)

 1,160,627 

 1,122,364 

 357 

 4,548 

 26 

 -   

 -   

 45,500 

 -   

 45,500 

 418,920 

 330,607 

 1,271 

 1,225 

 -   

 -   

 349 

 4,622 

 19 

 -   

 -   

 -   

 -   

 -   

1,504,374

1,360,197

50,431

4,990

336,833

310,233

322,567

296,686

355,970

(23,659)

6,607

 -   

(2,085)

330,172

(25,254)

5,315

 -   

 -   

355,970

(52,672)

6,605

14,749

(2,085)

330,172

(52,672)

5,315

13,871

 -   

336,833

310,233

322,567

296,686

61     ClearView Annual Report 2015

ClearView Wealth LimitedExecutive 
share plan 
reserve

General 
reserve

Profit  
reserve

Retained 
losses

Attributable 
to the 
owners of 
the parent

$’000

$’000

$’000

$’000

Consolidated statement of changes in equity
For the year ended 30 June 2015

Consolidated

Balance at 1 July 2013

Profit for the year

Total comprehensive income for the year

Recognition of share based payments

Dividend paid

Dividend Reinvestment Plan

Capital raised (net of costs)

Share buyback (inclusive of costs)

ESP loans settled through dividend

ESP shares vested

Balance at 30 June 2014

Profit for the year

Total comprehensive income for the year

Recognition of share based payments

Dividend paid

Dividend Reinvestment Plan

Dividend Reinvestment Plan Costs

Performance based shares issued in relation 
to Matrix Holdings Limited acquisition

General reserve on aquisition of Matrix 
Holdings Limited

Shares issued during the year (Non ESP)

Shares issued during the year (ESP vested)

ESP loans settled through dividend

Share 
capital

$’000

277,565

 -   

 -   

 -   

 -   

 8,157 

 44,889 

(439)

 -   

 -   

330,172

 -   

 -   

 -   

 -   

 10,977 

(70)

 14,588 

$’000

4,127

 -   

 -   

 905 

 -   

 -   

 -   

 -   

 403 

(120)

5,315

 -   

 -   

 896 

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 250 

 53 

 -   

 -   

(154)

 550 

(2,085)

 -   

 -   

 -   

Balance at 30 June 2015

355,970

6,607

(2,085)

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

(30,977)

250,715

13,880

13,880

 -   

(8,157)

 -   

 -   

 -   

 -   

 -   

13,880

13,880

 905 

(8,157)

 8,157 

 44,889 

(439)

 403 

(120)

(25,254)

310,233

12,572

12,572

 -   

(10,977)

 -   

 -   

 -   

 -   

 -   

 -   

12,572

12,572

 896 

(10,977)

10,977

(70)

14,588

(2,085)

 250 

 (101) 

 550 

(23,659)

336,833

ClearView Annual Report 2015     62

ClearView Wealth LimitedConsolidated statement of changes in equity
For the year ended 30 June 2015

Continued

Company

Balance at 1 July 2013

Loss for the year

Total comprehensive loss for the year

Recognition of share based payments

Dividend paid

Dividend Reinvestment Plan

Capital raised (net of costs)

Share buyback (inclusive of costs)

ESP loans settled through dividend

ESP shares vested

Balance at 30 June 2014

Profit for the year

Total comprehensive income for the year

Recognition of share based payments

Dividend paid

Dividend Reinvestment Plan

Dividend Reinvestment Plan Costs

Performance based shares issued in relation 
to Matrix Holdings Limited acquisition

General reserve on aquisition of Matrix 
Holdings Limited

Shares issued during the year (Non ESP)

Shares issued during the year (ESP vested)

ESP loans settled through dividend

Share 
capital

$’000

277,565

 -   

 -   

 -   

 -   

 8,157 

 44,889 

(439)

 -   

 -   

330,172

 -   

 -   

 -   

 -   

 10,977 

(70)

 14,588 

Executive 
share plan 
reserve

$’000

4,127

 -   

 -   

905

 -   

 -   

 -   

 -   

 403 

(120)

5,315

 -   

 -   

 896 

 -   

 -   

 -   

 -   

General 
reserve

$’000

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 250 

 53 

 -   

 -   

(154)

 550 

(2,085)

 -   

 -   

 -   

Profit  
reserve

Retained 
losses

Attributable 
to the 
owners of 
the parent

$’000

$’000

22,028

(52,352)

251,368

 -   

 -   

 -   

(8,157)

 -   

 -   

 -   

 -   

 -   

(320)

(320)

 -   

 -   

 -   

 -   

 -   

 -   

 -   

(320)

(320)

905

(8,157)

8,157

44,889

(439)

403

(120)

13,871

(52,672)

296,686

 11,858 

11,858

 -   

(10,977)

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

11,858

11,858

 896 

(10,977)

 10,977 

(70)

 14,588 

(2,085)

250

 (101) 

 550 

Balance at 30 June 2015

355,970

6,607

(2,085)

14,749

(52,672)

322,567

63     ClearView Annual Report 2015

ClearView Wealth LimitedConsolidated statement of Cash Flows
For the year ended 30 June 2015

Cash flows from operating activities

Receipts from client and debtors

Payments to suppliers and other creditors

Receipts from/(payments to) Group entities

Withdrawals paid to life investment clients

Dividends and trust distributions received

Interest received

Interest on borrowings and other costs of finance

Consolidated

Note

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

385,911

215,189

 -   

 -   

(221,445)

(162,483)

 -   

 -   

(233,204)

(222,073)

14,941

33,152

(970)

14,702

31,831

 -   

(4,092)

12,799

 -   

 -   

279

(491)

(5,139)

3,704

 -   

 -   

419

(5)

3,090

2,069

Income taxes paid

(11,792)

(6,205)

(11,792)

Net cash (utilised)/generated by operating activities

32

(33,407)

(129,039)

(3,297)

Cash flows from investing activities

Net cash movement due to investment in subsidary

(4,970)

 -   

(44,750)

(23,000)

Payments for investment securities

(1,707,797)

(1,853,406)

(3,006)

Proceeds from sales of investment securities

Acquisition of property, plant and equipment

Acquisition of capitalised software

1,684,926

1,831,488

(452)

(6,375)

(570)

(4,702)

 -   

 -   

 -   

 -   

 -   

 -   

 -   

Fixed interest deposits (invested)/redeemed

(15,343)

(33,478)

17,583

(14,730)

Loans granted/redeemed 

Convertible note drawn down

Dividends received from subsidiary

Loans granted (redeemed) to Group entities

Net cash (utilised) by investing activities

(4,221)

(1,328)

 -   

 -   

(360)

(300)

 -   

 -   

 -   

(1,328)

13,500

8,499

 -   

(300)

 -   

(8,499)

(55,560)

(61,328)

(9,502)

(46,529)

Cash flows from financing activities

Net movement in liability of non-controlling interest in unit 
trusts

Proceeds from share issues (net of expenses)

Proceeds from loan borrowings

Proceeds from capital raising

Share buy back (net of costs)

Repayment of ESP loans 

Payments for ESP shares reallocated

Dividends Reinvestment Plan costs

Net cash generated by financing activities

Net increase/(decrease) in cash and cash equivalents

Cash and cash equivalents at the beginning of the financial 
year

 60,301 

95,251

 242 

 45,500 

 -   

 -   

 550 

(83)

(73)

 -   

 -   

44,889

(439)

403

(101)

 -   

106,437

17,470

140,003

(50,364)

15

183,299

233,663

Cash and cash equivalents at the end of the financial year

200,769

183,299

To be read in conjunction with the accompanying Notes.

 -   

 241 

 45,500 

 -   

 -   

 550 

(83)

(73)

46,135

33,336

1,111

34,447

 -   

 -   

 -   

 44,889 

(439)

403

(101)

 -   

44,752

292

819

1,111

ClearView Annual Report 2015     64

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

1. General information
ClearView Wealth Limited (the Company or Consolidated Entity) is a limited company incorporated in Australia. The address of 
its registered office is disclosed in the Directory at the back of the Annual Report. The principal activities of the Company and its 
subsidiaries (the Group) are described in Note 7. 

2. Application of new and revised accounting standards
The following new and revised Australian Accounting Standards and Interpretations have been adopted in the current year and 
have affected the amounts reported in these financial statements. 

2.1 New and revised AASBs affecting amounts reported and/or disclosures in the financial statements

In the current financial year, the Group has applied a number of new and revised AASBs issued by the Australian Accounting 
Standards Board (AASB) that are mandatorily effective for an accounting period that begins on or after 1 July 2014

AASB 2012-3 ‘Amendments to 
Australian Accounting Standards - 
Offsetting Financial Assets and Financial 
Liabilities’

Interpretation 21 ‘Levies’

AASB 2013-3 ‘Amendments to
AASB 136 – Recoverable Amount
Disclosures for Non-Financial
Assets’

AASB 2013-4 ‘Amendments to
Australian Accounting Standards
– Novation of Derivatives
and Continuation of Hedge
Accounting’

AASB 2013-5 ‘Amendments to
Australian Accounting Standards
– Investment Entities’

AASB 2012-3 adds application guidance to AASB 132 Financial Instruments: 
Presentation to address inconsistencies identified in applying some of the 
offsetting criteria of AASB 132.

As the Group does not have any offsetting arrangements in place, the application 
of the amendments has not had any material impact on the disclosures or on the 
amounts recognised in the consolidated financial statements.

This Interpretation confirms that a liability to pay a levy is only recognised when 
the activity that triggers the payment occurs.
The adoption of this amendment does not have any material impact on the Group.

AASB 2013-3 amends the disclosure requirements in AASB 136 Impairment of 
Assets.
The amendments include the requirement to disclose additional information 
about the fair value measurement when the recoverable amount of impaired 
assets is based on fair value less costs of disposal.
The adoption of this amendment does not have any material impact on the Group 
or its disclosures.

AASB 2013-4 amends AASB 139 to permit the continuation of hedge accounting 
in specified circumstances where a derivative, which has been designated as a 
hedging instrument, is novated from one counterparty to a central counterparty 
as a consequence of laws or regulations.
As the Group does not utilise hedge accounting, the application of the 
amendments has not had any material impact on the disclosures or on the 
amounts recognised in the consolidated financial statements.

These amendments define an investment entity and require that, with limited 
exceptions, an investment entity does not consolidate its subsidiaries or apply 
AASB 3 Business Combinations when it obtains control of another entity. These 
amendments require an investment entity to measure unconsolidated subsidiaries 
at fair value through profit or loss in its consolidated and separate financial 
statements. These amendments also introduce new disclosure requirements for 
investment entities to AASB 12 and AASB 127.
The Group has reviewed its classification of its subsidiaries and all have been 
identified and accounted for under AASB 3 Business Combinations. This change 
in the accounting standards has not changed the Group’s accounting for these 
entities. This change has therefore not had a material impact on the disclosures or 
on the amounts recognised in the consolidated financial statements.

65     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

2. Application of new and revised accounting standards continued

AASB 1031 ‘Materiality’

AASB 2013-9 ‘Amendments to
Australian Accounting Standards
– Conceptual Framework,
Materiality and Financial
Instruments’

The revised AASB 1031 is an interim standard that cross-references to other 
Standards and the Framework (issued December 2013) that contain guidance on 
materiality.
AASB 1031 will be withdrawn when references to AASB 1031 in all Standards and
Interpretations have been removed. The adoption of this amendment does not 
have any material impact on the Group or its disclosures. 

The Standard contains three main parts with Part A adopted in the FY14. Part 
B takes effect in the FY15. This makes amendments to particular Australian 
Accounting Standards to delete references to AASB 1031 and also makes minor 
editorial amendments to various other standards.
The adoption of this amendment does not have any material impact on the Group 
or its disclosures.

ClearView Annual Report 2015     66

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

AASB 2014-1 ‘Amendments to 
Australian Accounting Standards’ (Part 
A: Annual Improvements 2010-2012 
and 2011-2013 Cycles)

The Annual Improvements to AASBs 2010 - 2012 and 2011 – 2013 have made 
a number of amendments to AASBs. The amendments that are relevant to the 
Group are:
The amendments to AASB 2 (i) change the definitions of ‘vesting condition’ 
and  market condition’; and (ii) add definitions for ‘performance condition’ and 
‘service condition’ which were previously included within the definition of ‘vesting 
condition’. The amendments to AASB 2 are effective for sharebased payment 
transactions for which the grant date is on or after 1 July 2014.
The amendments to AASB 3 clarify that contingent consideration that is classified 
as an asset or a liability should be measured at fair value at each reporting date, 
irrespective of whether the contingent consideration is a financial instrument 
within the scope of AASB 9 or AASB 139 or a non-financial asset or liability. 
Changes in fair value (other than measurement period adjustments) should be 
recognised in profit and loss. The amendments to AASB 3 are effective for business 
combinations for which the acquisition date is on or after 1 July 2014.
The amendments to AASB 8 (i) require an entity to disclose the judgements made 
by management in applying the aggregation criteria to operating segments, 
including a description of the operating segments aggregated and the economic 
indicators assessed in determining whether the operating segments have ‘similar 
economic characteristics’; and (ii) clarify that a reconciliation of the total of the 
reportable segments’ assets to the entity’s assets should only be provided if the 
segment assets are regularly provided to the chief operating decision-maker.
The amendments to AASB 116 and AASB 138 remove perceived inconsistencies 
in the accounting for accumulated depreciation/amortisation when an item of 
property, plant and equipment or an intangible asset is revalued. The amended 
standards clarify that the gross carrying amount is adjusted in a manner 
consistent with the revaluation of the carrying amount of the asset and that 
accumulated  depreciation/amortisation is the difference between the gross 
carrying amount and the carrying amount after taking into account accumulated 
impairment losses.
The amendments to AASB 124 clarify that a management entity providing key 
management personnel services to a reporting entity is a related party of the 
reporting entity. Consequently, the reporting entity should disclose as related 
party transactions the amounts incurred for the service paid or payable to the 
management entity for the provision of key management personnel services. 
However, disclosure of the components of such compensation is not required
The adoption of these amending standards does not have a material impact on 
the consolidated financial statements.

67     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

2. Application of new and revised accounting standards continued

2.2 Standards and Interpretations in issue not yet adopted

At the date of authorisation of the financial statements, the Standards and Interpretations listed below were in issue but not 
yet effective.

Standard/Interpretation

AASB 9 ‘Financial Instruments’, and the relevant amending standards1

AASB 15 ‘Revenue from Contracts with Customers’ and AASB 2014-5 
‘Amendments to Australian Accounting Standards arising from AASB 15’

AASB 2014-3 ‘Amendments to Australian Accounting Standards – 
Accounting for Acquisitions of Interests in Joint Operations’

AASB 2014-4 ‘Amendments to Australian Accounting Standards – 
Clarification of Acceptable Methods of Depreciation and Amortisation’

AASB 2014-9 ‘Amendments to Australian Accounting Standards – Equity 
Method in Separate Financial Statements’

AASB 2014-10 ‘Amendments to Australian Accounting Standards – Sale 
or Contribution of Assets between an Investor and its Associate or Joint 
Venture’

AASB 2015-1 ‘Amendments to Australian Accounting Standards – Annual 
Improvements to Australian Accounting Standards 2012-2014 Cycle’

AASB 2015-2 ‘Amendments to Australian Accounting Standards – 
Disclosure Initiative: Amendments to AASB 101’

AASB 2015-3 ‘Amendments to Australian Accounting Standards arising 
from the Withdrawal of AASB 1031 Materiality’

AASB 2015-4 ‘Amendments to Australian Accounting Standards – Financial 
Reporting Requirements for Australian Groups with a Foreign Parent’

AASB 2015-5 ‘Amendments to Australian Accounting Standards – 
Investment Entities: Applying the Consolidation Exception’

Effective for annual 
reporting periods 
beginning on or after

Expected to be 
initially applied in the 
financial year ending

1 January 2018

1 January 2018

30 June 2019

30 June 2019

1 January 2016

30 June 2017

1 January 2016

30 June 2017

1 January 2016

30 June 2017

1 January 2016

30 June 2017

1 January 2016

30 June 2017

1 January 2016

30 June 2017

1 July 2015

30 June 2016

1 July 2015

30 June 2016

1 January 2016

30 June 2017

1 The AASB has issued the following versions of AASB 9 and the relevant amending standards; 
• 

• 

• 

 AASB 9 ‘Financial Instruments’ (December 2009), AASB 2009-11 ‘Amendments to Australian Accounting Standards arising from AASB 9’, AASB 2012-6 
‘Amendments to Australian Accounting Standards – Mandatory Effective Date of AASB 9 and Transition Disclosures’ 
 AASB 9 ‘Financial Instruments’ (December 2010), AASB 2010-7 ‘Amendments to Australian Accounting Standards arising from AASB 9 (December 2010)’, 
AASB 2012-6 ‘Amendments to Australian Accounting Standards – Mandatory Effective Date of AASB 9 and Transition Disclosure’. 
 In December 2014 the AASB issued AASB 2014-9 ‘Amendment to Australian Accounting Standards – Conceptual Framework, Materiality and Financial 
Instruments’, Part C – Financial Instruments. This amending standard has amended the mandatory effective date of AASB 9 to 1 January 2017. For annual 
reporting periods beginning before 1 January 2017, an entity may early adopt either AASB 9 (December 2009) or AASB 9 (December 2010) and the rele-
vant amending standards. 

At the date of publication, there have been no IASB standards or IFRIC interpretations that are issued but not effective. 

ClearView Annual Report 2015     68

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies

(a) Statement of compliance

These financial statements are general purpose financial 
statements which have been prepared in accordance with 
the Corporations Act 2001, Accounting Standards and 
Interpretations, and comply with other requirements of  
the law.

The financial statements comprise the consolidated financial 
statements of the Group. For the purpose of preparing the 
consolidated financial statements, the Company is a for-profit 
entity. Accounting Standards include Australia Accounting 
Standards. Compliance with Australian Accounting Standards 
ensures that the financial statements and notes of the 
Company and the Group comply with International Financial 
Reporting Standards (‘IFRS’). 

The financial statements were authorised for issue by the 
Directors on 25 August 2015

(b) Basis of preparation

The consolidated financial statements have been prepared on 
the basis of historical cost, except financial instruments that 
are measured at revalued amounts or fair values at the end of 
each reporting period, as explained in the accounting policies 
below. Historical cost is generally based on the fair values of 
the consideration given in exchange for goods and services. 
All amounts are presented in Australian dollars, unless 
otherwise noted. Fair value is the price that would be received 
to sell an asset or paid to transfer a liability in an orderly 
transaction between market participants at the measurement 
date, regardless of whether that price is directly observable or 
estimated using another valuation technique. In estimating 
the fair value of an asset or a liability, the Group takes into 
account the characteristics of the asset or liability if market 
participants would take those characteristics into account 
when pricing the asset or liability at the measurement date. 
Fair value for measurement and/or disclosure purposes in 
these consolidated financial statements is determined on 
such a basis, except for share-based payment transactions 
that are within the scope of AASB 2, leasing transactions that 
are within the scope of AASB 117, and measurements that 
have some similarities to fair value but are not fair value, such 
as net realisable value in AASB 2 or value in use in AASB 136. 

In addition, for financial reporting purposes, fair value 
measurements are categorised into Level 1, 2 or 3 based 
on the degree to which the inputs to the fair value 
measurements are observable and the significance of the 
inputs to the fair value measurement in its entirety, which are 
described as follows: 

69     ClearView Annual Report 2015

• 

• 

• 

 Level 1 inputs are quoted prices (unadjusted) in active 
markets for identical assets or liabilities that the entity can 
access at the measurement date; 

 Level 2 inputs are inputs, other than quoted prices 
included within Level 1, that are observable for the asset 
or liability, either directly or indirectly; and 

 Level 3 inputs are unobservable inputs for the asset  
or liability. 

The Company is a company of the kind referred to in ASIC 
Class Order 98/100, dated 10 July 1998, and in accordance 
with that Class Order amounts in the financial report are 
rounded off to the nearest thousand dollars, unless otherwise 
indicated. 

(c) Basis of consolidation

The consolidated financial statements incorporate the 
financial statements of the Company and entities controlled 
by the Company and its subsidiaries. Control is achieved when 
the Company: 

•  has power over the investee; 

• 

 is exposed, or has rights, to variable returns from its 
involvement with the investee; and 

•  has the ability to use its power to affect its returns. 

The Company reassesses whether or not it controls an 
investee if facts and circumstances indicate that there are 
changes to one or more of the three elements of control 
listed above. 

When the Company has less than a majority of the voting 
rights of an investee, it has power over the investee when 
the voting rights are sufficient to give it the practical ability to 
direct the relevant activities of the investee unilaterally. The 
Company considers all relevant facts and circumstances in 
assessing whether or not the Company’s voting rights in an 
investee are sufficient to give it power, including: 

• 

• 

• 

• 

 the size of the Company’s holding of voting rights relative 
to the size and dispersion of holdings of the other vote 
holders; 

 potential voting rights held by the Company, other vote 
holders or other parties; 

rights arising from other contractual arrangements; and 

 any additional facts and circumstances that indicate that 
the Company has, or does not have, the current ability 
to direct the relevant activities at the time that decisions 
need to be made, including voting patterns at previous 
shareholders’ meetings. 

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

Consolidation of a subsidiary begins when the Company 
obtains control over the subsidiary and ceases when the 
Company loses control of the subsidiary. Specifically, income 
and expenses of a subsidiary acquired or disposed of during 
the year are included in the consolidated statement of profit 
or loss and other comprehensive income from the date the 
Company gains control until the date when the Company 
ceases to control the subsidiary. 

Profit or loss and each component of other comprehensive 
income are attributed to the owners of the Company and to 
the non-controlling interests. Total comprehensive income of 
subsidiaries is attributed to the owners of the Company and 
to the non-controlling interests even if this results in the non-
controlling interests having a deficit balance. 

on initial recognition for subsequent accounting under AASB 
139, when applicable, the cost on initial recognition of an 
investment in an associate or a joint venture. 

(d) Business combinations

Acquisitions of businesses are accounted for using the 
acquisition method. The consideration transferred in a 
business combination is measured at fair value which is 
calculated as the sum of the acquisition-date fair values of 
assets transferred by the Group, liabilities incurred by the 
Group to the former owners of the acquiree and the equity 
instruments issued by the Group in exchange for control of 
the acquiree. Acquisition-related costs are recognised in profit 
or loss as incurred. 

When necessary, adjustments are made to the financial 
statements of subsidiaries to bring their accounting policies 
into line with the Group’s accounting policies. 

At the acquisition date, the identifiable assets acquired and 
the liabilities assumed are recognised at their fair value at the 
acquisition date, except that: 

All intragroup assets and liabilities, equity, income, expenses 
and cash flows relating to transactions between members of 
the Group are eliminated in full on consolidation.

Changes in the Group’s ownership interests in 
existing subsidiaries

Changes in the Group’s ownership interests in subsidiaries 
that do not result in the Group losing control over the 
subsidiaries are accounted for as equity transactions. The 
carrying amounts of the Group’s interests and the non-
controlling interests are adjusted to reflect the changes in 
their relative interests in the subsidiaries. Any difference 
between the amount by which the non-controlling interests 
are adjusted and the fair value of the consideration paid or 
received is recognised directly in equity and attributed to 
owners of the Company. 

When the Group loses control of a subsidiary, a gain or 
loss is recognised in profit or loss and is calculated as the 
difference between (i) the aggregate of the fair value of the 
consideration received and the fair value of any retained 
interest and (ii) the previous carrying amount of the assets 
(including goodwill), and liabilities of the subsidiary and any 
non-controlling interests. All amounts previously recognised 
in other comprehensive income in relation to that subsidiary 
are accounted for as if the Group had directly disposed of 
the related assets or liabilities of the subsidiary (that is, 
reclassified to profit or loss or transferred to another category 
of equity as specified/permitted by applicable AASBs). The 
fair value of any investment retained in the former subsidiary 
at the date when control is lost is regarded as the fair value 

• 

• 

• 

 deferred tax assets or liabilities and liabilities or assets 
related to employee benefit arrangements are recognised 
and measured in accordance with AASB 112 Income 
Taxes and AASB 119 Employee Benefits respectively; 

 liabilities or equity instruments related to share-based 
payment arrangements of the acquiree or share-
based payment arrangements of the Group entered 
into to replace share-based payment arrangements of 
the acquire are measured in accordance with AASB 2 
‘Share¬based Payment’ at the acquisition date; and 

 assets (or disposal groups) that are classified as held for 
sale in accordance with AASB 5 Non current assets Held 
for Sale and Discontinued Operations are measured in 
accordance with that Standard. 

Goodwill is measured as the excess of the sum of the 
consideration transferred, the amount of any non-controlling 
interests in the acquiree, and the fair value of the acquirer’s 
previously held equity interest in the acquiree (if any) over the 
net of the acquisition-date amounts of the identifiable assets 
acquired and the liabilities assumed. If, after reassessment, 
the net of the acquisition-date amounts of the identifiable 
assets acquired and liabilities assumed exceeds the sum 
of the consideration transferred, the amount of any non-
controlling interests in the acquiree and the fair value of the 
acquirer’s previously held interest in the acquiree (if any), the 
excess is recognised immediately in profit or loss as a bargain 
purchase gain. 

Non-controlling interests that are present ownership interests 
and entitle their holders to a proportionate share of the 

ClearView Annual Report 2015     70

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

entity’s net assets in the event of liquidation may be initially 
measured either at fair value or at the non-controlling 
interests’ proportionate share of the recognised amounts 
of the acquiree’s identifiable net assets. The choice of 
measurement basis is made on a transaction-by transaction 
basis. Other types of non-controlling interests are measured 
at fair value or, when applicable, on the basis specified in 
another Standard. 

Where the consideration transferred by the Group in a 
business combination includes assets or liabilities resulting 
from a contingent consideration arrangement, the contingent 
consideration is measured at its acquisition-date fair value. 

Changes in the fair value of the contingent consideration that 
qualify as measurement period adjustments are adjusted 
retrospectively, with corresponding adjustments against 
goodwill. Measurement period adjustments are adjustments 
that arise from additional information obtained during the 
“measurement period” (which cannot exceed one year from 
the acquisition date) about facts and circumstances that 
existed at the acquisition date. 

The subsequent accounting for changes in the fair value of 
contingent consideration that do not qualify as measurement 
period adjustments depends on how the contingent 
consideration is classified. Contingent consideration that 
is classified as equity is not remeasured at subsequent 
reporting dates and its subsequent settlement is accounted 
for within equity. Contingent consideration that is classified 
as an asset or liability is remeasured at subsequent reporting 
dates in accordance with AASB 139, or AASB 137 “Provisions, 
Contingent Liabilities and Contingent Assets”, as appropriate, 
with the corresponding gain or loss being recognised in profit 
or loss. 

Where a business combination is achieved in stages, the 
Group’s previously held equity interest in the acquiree is 
remeasured to fair value at the acquisition date (i.e. the date 
when the Group attains control) and the resulting gain or 
loss, if any, is recognised in profit or loss. Amounts arising 
from interests in the acquiree prior to the acquisition date 
that have previously been recognised in other comprehensive 
income are reclassified to profit or loss where such treatment 
would be appropriate if that interest were disposed of. 

If the initial accounting for a business combination is 
incomplete by the end of the reporting period in which the 
combination occurs, the Group reports provisional amounts 
for the items for which the accounting is incomplete. Those 
provisional amounts are adjusted during the measurement 

71     ClearView Annual Report 2015

period (see above), or additional assets or liabilities are 
recognised, to reflect new information obtained about facts 
and circumstances that existed as at the acquisition date 
that, if known, would have affected the amounts recognised 
as at that date.

(e) Goodwill

Goodwill arising on an acquisition of a business is carried 
at cost as established at the date of the acquisition of the 
business less accumulated impairment losses, if any. 

For the purposes of impairment testing, goodwill is allocated 
to each of the Group’s cash-generating units (or groups of 
cash-generating units) that is expected to benefit from the 
synergies of the combination. 

A cash-generating unit to which goodwill has been allocated 
is tested for impairment annually, or more frequently when 
there is indication that the unit may be impaired. If the 
recoverable amount of the cash-generating unit is less than 
its carrying amount, the impairment loss is allocated first 
to reduce the carrying amount of any goodwill allocated 
to the unit and then to the other assets of the unit pro rata 
based on the carrying amount of each asset in the unit. Any 
impairment loss for goodwill is recognised directly in the 
statement of profit or loss and other comprehensive income. 
An impairment loss recognised for goodwill is not reversed in 
subsequent periods. 

On disposal of the relevant cash-generating unit, the 
attributable amount of goodwill is included in the 
determination of the profit or loss on disposal. 

The Group’s policy for goodwill arising on the acquisition of an 
associate is described at (f) below. 

(f) Investments in associates and joint ventures

An associate is an entity over which the Group has significant 
influence. Significant influence is the power to participate in 
the financial and operating policy decisions of the investee 
but is not control or joint control over those policies. 

A joint venture is a joint arrangement whereby the parties 
that have joint control of the arrangement have rights to 
the net assets of the joint arrangement. Joint control is the 
contractually agreed sharing of control of an arrangement, 
which exists only when decisions about the relevant activities 
require unanimous consent of the parties sharing control. 

The results and assets and liabilities of associates or joint 
ventures are incorporated in these consolidated financial 
statements using the equity method of accounting, except 

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

when the investment, or a portion thereof, is classified as 
held for sale, in which case it is accounted for in accordance 
with AASB 5. Under the equity method, an investment 
in an associate or a joint venture is initially recognised in 
the consolidated statement of financial position at cost 
and adjusted thereafter to recognise the Group’s share of 
the profit or loss and other comprehensive income of the 
associate or joint venture. When the Group’s share of losses 
of an associate or a joint venture exceeds the Group’s interest 
in that associate or joint venture (which includes any long-
term interests that, in substance, form part of the Group’s net 
investment in the associate or joint venture), the Group 

discontinues recognising its share of further losses. Additional 
losses are recognised only to the extent that the Group has 
incurred legal or constructive obligations or made payments 
on behalf of the associate or joint venture. 

An investment in an associate or a joint venture is accounted 
for using the equity method from the date on which the 
investee becomes an associate or a joint venture. On 
acquisition of the investment in an associate or a joint 
venture, any excess of the cost of the investment over the 
Group’s share of the net fair value of the identifiable assets 
and liabilities of the investee is recognised as goodwill, which 
is included within the carrying amount of the investment. 
Any excess of the Group’s share of the net fair value of 
the identifiable assets and liabilities over the cost of the 
investment, after reassessment, is recognised immediately in 
profit or loss in the period in which the investment is acquired. 

The requirements of AASB 139 are applied to determine 
whether it is necessary to recognise any impairment loss with 
respect to the Group’s investment in an associate or a joint 
venture. When necessary, the entire carrying amount of the 
investment (including goodwill) is tested for impairment in 
accordance with AASB 136 Impairment of Assets as a single 
asset by comparing its recoverable amount (higher of value in 
use and fair value less costs to sell) with its carrying amount, 
Any impairment loss recognised forms part of the carrying 
amount of the investment. Any reversal of that impairment 
loss is recognised in accordance with AASB 136 to the extent 
that the recoverable amount of the investment subsequently 
increases. 

The Group discontinues the use of the equity method from 
the date when the investment ceases to be an associate or 
a joint venture, or when the investment is classified as held 
for sale. When the Group retains an interest in the former 
associate or joint venture and the retained interest is a 
financial asset, the Group measures the retained interest at 

fair value at that date and the fair value is regarded as its fair 
value on initial recognition in accordance with AASB 139. The 
difference between the carrying amount of the associate or 
joint venture at the date the equity method was discontinued, 
and the fair value of any retained interest and any proceeds 
from disposing of a part interest in the associate or joint 
venture is included in the determination of the gain or loss 
on disposal of the associate or joint venture. In addition, 
the Group accounts for all amounts previously recognised 
in other comprehensive income in relation to that associate 
or joint venture on the same basis as would be required 
if that associate or joint venture had directly disposed of 
the related assets or liabilities. Therefore, if a gain or loss 
previously recognised in other comprehensive income by 
that associate or joint venture would be reclassified to profit 
or loss on the disposal of the related assets or liabilities, the 
Group reclassifies the gain or loss from equity to profit or loss 
(as a reclassification adjustment) when the equity method is 
discontinued. 

The Group continues to use the equity method when an 
investment in an associate becomes an investment in a 
joint venture or an investment in a joint venture becomes an 
investment in an associate. There is no remeasurement to fair 
value upon such changes in ownership interests. 

When the Group reduces its ownership interest in an 
associate or a joint venture but the Group continues to use 
the equity method, the Group reclassifies to profit or loss 
the proportion of the gain or loss that had previously been 
recognised in other comprehensive income relating to that 
reduction in ownership interest if that gain or loss would be 
reclassified to profit or loss on the disposal of the related 
assets or liabilities. 

When a group entity transacts with an associate or a joint 
venture of the Group, profits and losses resulting from 
the transactions with the associate or joint venture are 
recognised in the Group’s consolidated financial statements 
only to the extent of interests in the associate or joint venture 
that are not related to the Group.

(g) Revenue recognition

Revenue is measured at the fair value of the consideration 
received or receivable. Fee revenue is recognised when: 

•  The amount can be measured reliably; 

• 

 It is probable that the future economic benefit associated 
with transactions will flow to the entity; and 

•  The stage of completion can be measured reliably. 

ClearView Annual Report 2015     72

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

Premium revenue

Dividend and interest revenue

Premium revenue only arises in respect of life insurance 
contracts. Premiums with a regular due date are recognised 
as revenue on a due basis. Premiums with no due date are 
recognised as revenue on a cash received or receivable basis. 

Unpaid premiums are only recognised as revenue during 
the days of grace and are included as Premiums Receivable 
(part of Receivables) in the statement of financial position. 
Premiums due after, but received before, the end of the 
financial year are shown as Life Insurance Premium in 
Advance (part of Payables) in the statement of financial 
position. 

Premiums and contributions on life investment contracts are 
treated as deposits and are reported as a movement in life 
investment contract liabilities. 

Dividend revenue from investments is recognised when the 
Group’s right to receive payment has been established. 

Interest revenue is recognised when it is probable that the 
economic benefits will flow to the Group and the amount of 
revenue can be measured reliably. Interest revenue is accrued 
on a time basis, by reference to the principal outstanding and 
at the effective interest rate applicable, which is the rate that 
exactly discounts estimated future cash receipts through the 
expected life of the financial asset to that asset’s net carrying 
amount on initial recognition. 

Investment Income

Income on investment units and shares is deemed to accrue 
on the date the distributions are declared to be effective. 

Management fee revenue

Distribution income

Fee revenue comprising management fee revenue with 
respect to life investment contracts is recognised in the 
statement of profit or loss and other comprehensive 
income on an accrual basis as the services are provided. 
A single management fee is applied for each Investment 
Option, which is based on the value of the assets held in 
each Investment Option. The fee is calculated each time 
an Investment Option is valued, but before the unit price is 
declared. The fee is treated as a reduction in the investment 
contract liabilities. 

Trustee and administration fee revenue earned on the Wrap 
platform is recognised on an accrual basis to the extent that it 
is probable that the income benefit will flow to the Group and 
the revenue can be reliably measured. Ongoing fee revenue is 
recorded over the effective period in which customers’ funds 
are invested in products on the Wrap platform.

Financial advice revenue

Financial advice revenue is recognised on an accrual basis 
to the extent that it is probable that the income benefit will 
flow to the Group and the revenue can be reliably measured. 
Ongoing trail revenue is recorded over the effective period in 
which customers’ funds are invested in products. 

Distribution income from investments in unit trusts is 
recognised on a receivable basis as of the date the unit value 
is quoted ex-distribution. 

Rental Income

The Group’s policy for recognition of revenue from operating 
leases is described in (h) below. 

(h) Leasing

Leases are classified as finance leases whenever the terms 
of the lease transfer substantially all the risks and rewards 
of ownership to the lessee. All other leases are classified as 
operating leases. 

The Group as lessee

Operating lease payments are recognised as an expense 
on a straight-line basis over the lease term, except where 
another systematic basis is more representative of the time 
pattern in which economic benefits from the leased asset are 
consumed. Contingent rentals arising under operating leases 
are recognised as an expense in the period in which they are 
incurred. 

In the event that lease incentives are received to enter 
into operating leases, such incentives are recognised as a 
liability. The aggregate benefit of incentives is recognised as 
a reduction of rental expense on a straight-line basis, except 
where another systematic basis is more representative of 
the time pattern in which economic benefits from the leased 
asset are consumed. 

73     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

(i) Goods and services tax

Revenues, expenses and assets are recognised net of the 
amount of goods and services tax (GST), except: 

• 

• 

 Where the amount of GST incurred is not recoverable  
from the taxation authority, it is recognised as part of  
the cost of acquisition of an asset or as part of an item  
of expense; or

 For receivables and payables which are recognised 
inclusive of GST.

The net amount of GST recoverable from, or payable to, 
the taxation authority is included as part of receivables or 
payables.

Cash flows are included in the cash flow statement on  
a gross basis. The GST component of cash flows arising from 
investing and financing activities which is recoverable from, 
or payable to, the taxation authority is classified within 
operating cash flows. 

(j) Principles underlying the conduct of life  
insurance business

The life insurance operations of the Group are conducted 
within separate statutory funds as required by the Life 
Insurance Act 1995 (Life Act) and are reported in aggregate 
with the shareholders’ funds in the statement of profit or 
loss and other comprehensive income, statement of financial 
position, statement of changes in equity and statement 
of cash flows. The life insurance operations consist of the 
provision of life insurance and life investment contracts. 

Life insurance contracts involve the acceptance of significant 
insurance risk. Insurance risk is defined as significant if, 
and only if, an insured event could cause an insurer to pay 
significant benefits in any scenario, excluding scenarios that 
lack commercial substance. Insurance contracts include 
those where the insured benefit is payable on the occurrence 
of a specified event such as death, injury or disability caused 
by accident or illness. The insured benefit is not linked to the 
market value of the investments held by the Group, and the 
financial risks are substantially borne by the Group. 

Any contracts issued by the Group and regulated under the 
Life Act that do not meet the definition of a life insurance 
contract are classified as life investment contracts. Life 
investment contracts include investment-linked contracts 
where the benefit is directly linked to the market value of 
the investments held in the particular investment linked 

fund. While the underlying assets are registered in the name 
of ClearView Life Assurance Limited (ClearView Life) and 
the investment-linked policy owner has no direct access to 
the specific assets, the contractual arrangements are such 
that the investment-linked policy owner bears the risks and 
rewards of the fund’s investment performance. 

A component of the life investment contracts includes a 
minimum unit price guarantee. ClearView Life derives fee 
income from the administration of investment linked funds. 
Life investment contracts do not contain any discretionary 
participation features (i.e. those where the amount or timing 
of allocation of the profit from the underlying investments is 
at the discretion of the insurer). 

In accordance with AASB 1038 “Life Insurance Contracts”, 
financial assets backing policy liabilities are designated at fair 
value through profit and loss. ClearView Life has determined 
that all assets held within the statutory funds back policy 
liabilities. Financial assets backing policy liabilities consist of 
high quality investments such as cash, equities, fixed income 
securities, property trusts and infrastructure assets. The 
management of financial assets and policy liabilities is closely 
monitored to ensure that investments are appropriate given 
the expected pattern of future cash flows arising from the 
policy liabilities.

(k) Claims

Life insurance contracts

Claims incurred relate to life insurance contracts and are 
treated as expenses. Claims are recognised upon notification 
of the insured event. The liability in respect of claims includes 
an allowance (estimate) for incurred but not reported claims 
and an allowance (estimate) for expected declinature of 
notified claims. Claims are shown gross of reinsurance 
recoverable. Any reinsurance recoveries applicable to the 
claims are included in receivables. 

Life investment contracts

There is no claims expense in respect of life investment 
contracts. Surrenders and withdrawals which relate to life 
investment contracts are treated as a movement in life 
investment contract liabilities. Surrenders and withdrawals 
are recognised as at the date of redemption of policy units, 
which occurs once all documentation has been provided and 
completed. 

ClearView Annual Report 2015     74

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

(l) Reinsurance

Amounts paid to reinsurers under life insurance contracts 
held by the Company are recorded as an outward reinsurance 

expense and are recognised in the statement of profit or 
loss and other comprehensive income from the reinsurance 
premium payment due date. Reinsurance recoveries 
receivable on claims incurred are recognised as revenue. 
Recoveries are assessed in a manner similar to the 
assessment of life insurance contract liabilities. Recoveries 
are measured as the present value of the expected future 
receipts, calculated on the same basis as the life insurance 
contract liabilities. 

(m) Policy acquisition costs

The policy acquisition costs incurred are recorded in the 
statement of profit or loss and other comprehensive income 
and represent the fixed and variable costs of acquiring new 
business. The policy acquisition costs include commission, 
policy issue and underwriting costs, and related costs. 
The acquisition costs incurred in relation to life insurance 
contracts are capitalised in the valuation of policy liabilities. 

(n) Basis of expense apportionment

All expenses of the life insurance business incurred by 
ClearView Life and charged to the statement of profit or loss 
and other comprehensive income have been apportioned in 
accordance with Part 6, Division 2 of the Life Act. 

The basis is as follows: 

• 

• 

 Expenses relating specifically to either the ClearView 
Life shareholder’s fund or a particular statutory fund are 
allocated directly to the respective funds. Such expenses 
are apportioned between policy acquisition costs and 
policy maintenance costs with reference to the objective 
when each expense is incurred and the outcome achieved. 

 Other expenses are subject to apportionment under 
section 80 of the Life Act and are allocated between the 
funds in proportion to the activities to which they relate. 
They are apportioned between policy acquisition costs 
and policy maintenance costs in relation to their nature as 
either acquisition or maintenance activities. Activities are 
based on direct measures such as time, head counts and 
business volumes. 

• 

 Life investment contracts are held within statutory funds 
No.2 and No.4. Life insurance contracts are principally 

75     ClearView Annual Report 2015

held within statutory fund No.1, except for a small, closed 
book of rider insurance covers held in statutory fund 
No.2. The allocation of expenses between the primary life 
investment or life insurance contracts is inherent in the 
allocation to the statutory funds, as described above. The 
apportionment basis is in line with the principles set in 
the Life Insurance Prudential Standard valuation standard 
(Prudential Standard LPS340 Valuation of Policy Liabilities). 
All expenses relate to non-participating business as the 
Company only writes this category of business. 

(o) Policy liabilities

Policy liabilities consist of life insurance policy liabilities and 
life investment policy liabilities. 

Life insurance contracts

The value of life insurance policy liabilities is calculated 
using the Margin on Services methodology. Under this 
methodology, planned profit margins and an estimate of 
future liabilities are calculated separately for each related 
product group, with future cash flows determined using 
best estimate assumptions and discounted to the reporting 
date. Profit margins are systemically released over the 
term of the policies in line with the pattern of services to be 
provided. The future planned profit margins are deferred and 
recognised over time by including the value of the future 
planned profit margins within the value of the policy liabilities. 
Further details of the actuarial assumptions used in these 
calculations are set out in Note 4. 

Life investment contracts

Life investment policy liabilities are valued at fair value, 
which is based on the valuation of the assets held within the 
unitised investment linked policy investment pools. 

(p) Cash and cash equivalents

Cash comprises cash on hand and demand deposits. Cash 
equivalents are short-term, highly liquid investments that 
are readily convertible to known amounts of cash, which are 
subject to an insignificant risk of changes in value. 

(q) Employee benefits

A liability is recognised for benefits accruing to employees in 
respect of wages and salaries, annual leave and long service 
leave when it is probable that settlement will be required and 
they are capable of being measured reliably. 

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

Liabilities recognised in respect of short-term employee 
benefits, are measured at their nominal values using the 
remuneration rate expected to apply at the time  
of settlement. 

Liabilities recognised in respect of long term employee 
benefits are measured as the present value of the estimated 
future cash outflows to be made by the Group in respect of 
services provided by employees up to reporting date. 

Termination benefit

A liability for a termination benefit is recognised at the earlier 
of when the entity can no longer withdraw the offer of the 
termination benefit and when the entity recognises any 
related restructuring costs. 

(r) Share based payment arrangements

Share-based payment transactions of the Company

Equity-settled share-based payments to employees and 
others providing similar services are measured at the fair 
value of the equity instruments at the grant date. Details 
regarding the determination of the fair value of equity-settled 
share-based transactions are set out in Note 29. 

The fair value determined at the grant date of the equity-
settled share-based payments is expensed on a straight-
line basis over the vesting period, based on the Group’s 
estimate of equity instruments that will eventually vest, 
with a corresponding increase in equity. At the end of each 
reporting period, the Group revises its estimate of the number 
of equity instruments expected to vest. The impact of the 
revision of the original estimates, if any, is recognised in profit 
or loss such that the cumulative expense reflects the revised 
estimate, with a corresponding adjustment to the equity-
settled employee benefits reserve. 

Equity-settled share-based payment transactions with 
parties other than employees are measured at the fair value 
of the goods or services received, except where that fair 
value cannot be estimated reliably, in which case they are 
measured at the fair value of the equity instruments granted, 
measured at the date the entity obtains the goods or the 
counterparty renders the service.

(s) Taxation 

Income tax expense represents the sum of the tax currently 
payable and deferred tax. 

Current Tax 

The tax currently payable is based on taxable profit for the 
year. Taxable profit differs from profit before tax as reported 
in the consolidated statement of profit or loss and other 
comprehensive income because of items of income or 
expense that are taxable or deductible in other years and 
items that are never taxable or deductible. The Group’s 
current tax is calculated using tax rates that have been 
enacted or substantively enacted by the end of the  
reporting period. 

Deferred tax 

Deferred tax is recognised on temporary differences 
between the carrying amounts of assets and liabilities in the 
consolidated financial statements and the corresponding tax 
bases used in the computation of taxable profit. Deferred tax 
liabilities are generally recognised for all taxable temporary 
differences. Deferred tax assets are generally recognised for 
all deductible temporary differences to the extent that it is 
probable that taxable profits will be available against which 
those deductible temporary differences can be utilised. Such 
deferred tax assets and liabilities are not recognised if the 
temporary difference arises from the initial recognition (other 
than in a business combination) of assets and liabilities in 
a transaction that affects neither the taxable profit nor the 
accounting profit. In addition, deferred tax liabilities are not 
recognised if the temporary difference arises from the initial 
recognition of goodwill. 

Deferred tax liabilities are recognised for taxable temporary 
differences associated with investments in subsidiaries and 
associates, and interests in joint ventures, except where 
the Group is able to control the reversal of the temporary 
difference and it is probable that the temporary difference will 
not reverse in the foreseeable future. Deferred tax assets 

arising from deductible temporary differences associated 
with such investments and interests are only recognised 
to the extent that it is probable that there will be sufficient 
taxable profits against which to utilise the benefits of the 
temporary differences and they are expected to reverse in the 
foreseeable future. 

The carrying amount of deferred tax assets is reviewed at the 
end of each reporting period and reduced to the extent that 
it is no longer probable that sufficient taxable profits will be 
available to allow all or part of the asset to be recovered. 

Deferred tax assets and liabilities are measured at the tax 
rates that are expected to apply in the period in which the 

ClearView Annual Report 2015     76

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

liability is settled or the asset realised, based on tax rates (and 
tax laws) that have been enacted or substantively enacted by 
the end of the reporting period. The measurement of deferred 
tax liabilities and assets reflects the tax consequences that 
would follow from the manner in which the Group expects, 
at the end of the reporting period, to recover or settle the 
carrying amount of its assets and liabilities. 

on a straight-line basis over their estimated useful lives. The 
estimated useful life and amortisation method are reviewed 
at the end of each reporting period, with the effect of any 
changes in estimate being accounted for on a prospective 
basis. Intangible assets with indefinite useful lives that are 
acquired separately are carried at cost less accumulated 
impairment losses. 

Deferred tax liabilities and assets are offset when there is a 
legally enforceable right to set off current tax assets against 
current tax liabilities and when they relate to income taxes 
levied by the same taxation authority and the Group intends 
to settle its current tax assets and liabilities on a net basis. 

Current and deferred tax for the year 

Current and deferred tax are recognised in profit or loss, 
except when they relate to items that are recognised in other 
comprehensive income or directly in equity, in which case 
the current and deferred tax are also recognised in other 
comprehensive income or directly in equity, respectively. 
Where current tax or deferred tax arises from the initial 
accounting for a business combination, the tax effect is 
included in the accounting for the business combination. 

(t) Property, plant and equipment 

Fixtures and equipment are stated at cost less accumulated 
depreciation and accumulated impairment losses. 

Depreciation is recognised so as to write off the cost or 
valuation of assets (other than freehold land and properties 
under construction) less their residual values over their useful 
lives, using the straight-line method. The estimated useful 
lives, residual values and depreciation method are reviewed 
at the end of each reporting period, with the effect of any 
changes in estimate accounted for on a prospective basis. 

An item of property, plant and equipment is derecognised 
upon disposal or when no future economic benefits are 
expected to arise from the continued use of the asset. Any 
gain or loss arising on the disposal or retirement of an item 
of property, plant and equipment is determined as the 
difference between the sales proceeds and the carrying 
amount of the asset and is recognised in profit or loss. 

(u) Intangible assets - Software 

Intangible assets acquired separately 

Intangible assets with finite lives that are acquired separately 
are carried at cost less accumulated amortisation and 
accumulated impairment losses. Amortisation is recognised 

77     ClearView Annual Report 2015

Internally-generated intangible assets - research 
and development expenditure 

Expenditure on research activities is recognised as an expense 
in the period in which it is incurred. 

An internally-generated intangible asset arising from 
development (or from the development phase of an internal 
project) is recognised if, and only if, all of the following have 
been demonstrated: 

• 

• 

 The technical feasibility of completing the intangible asset 
so that it will be available for use or sale; 

 The intention to complete the intangible asset and use or 
sell it; 

•  The ability to use or sell the intangible asset; 

• 

• 

• 

 How the intangible asset will generate probable future 
economic benefits; 

 The availability of adequate technical, financial and other 
resources to complete the development and to use or sell 
the intangible asset; and 

 The ability to measure reliably the expenditure 
attributable to the intangible asset during its 
development. 

The amount initially recognised for internally-generated 
intangible assets is the sum of the expenditure incurred from 
the date when the intangible asset first meets the recognition 
criteria listed above. Where no internally-generated intangible 
asset can be recognised, development expenditure is 
recognised in profit or loss in the period in which it is incurred. 

Subsequent to initial recognition, internally-generated 
intangible assets are reported at cost less accumulated 
amortisation and accumulated impairment losses, on the 
same basis as intangible assets that are acquired separately. 

Amortisation is charged to the statement of profit or loss and 
other comprehensive income on a straight-line basis over 
periods generally ranging from 3 to 5 years. Management 
reviews the appropriateness of the amortisation period on an 
annual basis. 

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

Derecognition of intangible assets 

An intangible asset is derecognised on disposal, or when no 
future economic benefits are expected from use or disposal. 
Gains or losses arising from derecognition of an intangible 
asset, measured as the difference between the net disposal 
proceeds and the carrying amount of the asset are recognised 
in profit or loss when the asset is derecognised. 

carrying amount that would have been determined had 
no impairment loss been recognised for the asset (or cash-
generating unit) in prior years. A reversal of an impairment 
loss is recognised immediately in profit or loss, unless the 
relevant asset is carried at a revalued amount, in which case 
the reversal of the impairment loss is treated as a revaluation 
increase. 

(v) Impairment of tangible and intangible assets other 
than goodwill 

At the end of each reporting period, the Group reviews the 
carrying amounts of its tangible and intangible assets to 
determine whether there is any indication that those assets 
have suffered an impairment loss. If any such indication 
exists, the recoverable amount of the asset is estimated 
in order to determine the extent of the impairment loss (if 
any). When it is not possible to estimate the recoverable 
amount of an individual asset, the Group estimates the 
recoverable amount of the cash-generating unit to which 
the asset belongs. When a reasonable and consistent basis 
of allocation can be identified, corporate assets are also 
allocated to individual cash-generating units, or otherwise 
they are allocated to the smallest group of cash-generating 
units for which a reasonable and consistent allocation basis 
can be identified. Intangible assets with indefinite useful lives 
and intangible assets not yet available for use are tested 
for impairment at least annually, and whenever there is an 
indication that the asset may be impaired. 

Recoverable amount is the higher of fair value less costs to 
sell and value in use. In assessing value in use, the estimated 
future cash flows are discounted to their present value using 
a discount rate that reflects current market assessments 
of the time value of money and the risks specific to the 
asset for which the estimates of future cash flows have 
not been adjusted. If the recoverable amount of an asset 
(or cash-generating unit) is estimated to be less than its 
carrying amount, the carrying amount of the asset (or cash-
generating unit) is reduced to its recoverable amount. 

An impairment loss is recognised immediately in profit or loss, 
unless the relevant asset is carried at a revalued amount, in 
which case the impairment loss is treated as a revaluation 
decrease. 

When an impairment loss subsequently reverses, the carrying 
amount of the asset (or cash generating unit) is increased 
to the revised estimate of its recoverable amount, but so 
that the increased carrying amount does not exceed the 

(w) Provisions 

Provisions are recognised when the Group has a present 
obligation (legal or constructive) as a result of a past event, 
it is probable that the Group will be required to settle the 
obligation, and a reliable estimate can be made of the 
amount of the obligation. 

The amount recognised as a provision is the best estimate 
of the consideration required to settle the present obligation 
at the end of the reporting period, taking into account the 
risks and uncertainties surrounding the obligation. When a 
provision is measured using the cash flows estimated to settle 
the present obligation, its carrying amount is the present 
value of those cash flows (where the effect of the time value 
of money is material). 

When some or all of the economic benefits required to settle 
a provision are expected to be recovered from a third party, 
a receivable is recognised as an asset if it is virtually certain 
that reimbursement will be received and the amount of the 
receivable can be measured reliably. 

Onerous contracts 

Present obligations arising under onerous contracts are 
recognised and measured as provisions. An onerous contract 
is considered to exist where the Group has a contract under 
which the unavoidable costs of meeting the obligations under 
the contract exceed the economic benefits expected to be 
received from the contract. 

Restructurings 

A restructuring provision is recognised when the Group has 
developed a detailed formal plan for the restructuring and 
has raised a valid expectation in those affected that it will 
carry out the restructuring by starting to implement the plan 
or announcing its main features to those affected by it. The 
measurement of a restructuring provision includes only the 
direct expenditures arising from the restructuring, which 
are those amounts that are both necessarily entailed by the 
restructuring and not associated with the ongoing activities 
of the entity. 

ClearView Annual Report 2015     78

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

(x) Financial instruments 

Financial assets and financial liabilities are recognised 
when a group entity becomes a party to the contractual 
provisions of the instrument. Financial assets and financial 
liabilities are initially measured at fair value. Transaction costs 
that are directly attributable to the acquisition or issue of 
financial assets and financial liabilities (other than financial 
assets and financial liabilities at fair value through profit or 
loss) are added to or deducted from the fair value of the 
financial assets or financial liabilities, as appropriate, on 
initial recognition. Transaction costs directly attributable to 
the acquisition of financial assets or financial liabilities at fair 
value through profit or loss are recognised immediately in 
profit or loss. 

Financial Assets 

Financial assets are classified into the following specified 
categories: financial assets ‘at fair value through profit or 
loss’ (FVTPL), ‘held-to-maturity’ investments, ‘available¬for-
sale’ (AFS) financial assets and ‘loans and receivables’. The 
classification depends on the nature and purpose of the 
financial assets and is determined at the time of initial 
recognition. All regular way purchases or sales of financial 
assets are recognised and derecognised on a trade date 
basis. Regular way purchases or sales are purchases or sales 
of financial assets that require delivery of assets within the 
time frame established by regulation or convention in the 
marketplace. 

Effective interest method 

The effective interest method is a method of calculating the 
amortised cost of a debt instrument and of allocating interest 
income over the relevant period. The effective interest rate is 
the rate that exactly discounts estimated future cash receipts 
(including all fees on points paid or received that form an 
integral part of the effective interest rate, transaction costs 
and other premiums or discounts) through the expected 
life of the debt instrument, or (where appropriate) a shorter 
period, to the net carrying amount on initial recognition. 

Income is recognised on an effective interest basis for debt 
instruments other than those financial assets classified as at 
FVTPL. 

• 

• 

• 

• 

• 

 It has been acquired principally for the purpose of selling it 
in the near term; or 

 On initial recognition it is part of a portfolio of identified 
financial instruments that the Group manages together 
and has a recent actual pattern of short-term profit-
taking; or 

• 

 It is a derivative that is not designated and effective as 
a hedging instrument. A financial asset other than a 
financial asset held for trading may be designated as 
at FVTPL upon initial recognition if: 

 Such designation eliminates or significantly reduces a 
measurement or recognition inconsistency that would 
otherwise arise; or 

 The financial asset forms part of a group of financial 
assets or financial liabilities or both, which is managed 
and its performance is evaluated on a fair value basis, 
in accordance with the Group’s documented risk 
management or investment strategy, and information 
about the grouping is provided internally on that basis; or 

 It forms part of a contract containing one or more 
embedded derivatives, and AASB 139 Financial 
Instruments: Recognition and Measurement permits 
the entire combined contract (asset or liability) to be 
designated as at FVTPL. 

Financial assets at FVTPL are stated at fair value, with any 
gains or losses arising on remeasurement recognised in 
profit or loss. The net gain or loss recognised in profit or 
loss incorporates any dividend or interest earned on the 
financial asset and is included in the “net fair value gains and 
losses” line item in the statement of profit or loss and other 
comprehensive income. Fair value is determined based on the 
bid price determined at 7:00pm in accordance with the policy 
adapted by the custodian on the reporting date. 

Held-to-maturity investments 

Bills of exchange and debentures with fixed or determinable 
payments and fixed maturity dates that the Group has the 
positive intent and ability to hold to maturity are classified as 

held-to maturity investments. Held-to-maturity investments 
are measured at amortised cost using the effective interest 
method less any impairment. 

Financial assets at FVTPL 

Available for sale financial assets 

Financial assets are classified as at FVTPL when the financial 
asset is either held for trading or it is designated as at FVTPL. 

A financial asset is classified as held for trading if: 

Listed shares and listed redeemable notes held by the Group 
that are traded in an active market are classified as AFS and 
are stated at fair value. The Group also has investments in 

79     ClearView Annual Report 2015

ClearView Wealth Limited 
Notes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

unlisted shares that are not traded in an active market but 
that are also classified as AFS financial assets and stated at 
fair value (because the directors consider that fair value can 
be reliably measured). Fair value is determined in the manner 
described in Note 5. Gains and losses arising from changes in 
fair value are recognised in other comprehensive income and 
accumulated in the investments revaluation reserve, with the 
exception of impairment losses, interest calculated using the 
effective interest method, and foreign exchange gains and 
losses on monetary assets, which are recognised in profit or 
loss. Where the investment is disposed of or is determined 
to be impaired, the cumulative gain or loss previously 
accumulated in the investments revaluation reserve is 
reclassified to profit or loss. 

Dividends on AFS equity instruments are recognised in profit 
or loss when the Group’s right to receive the dividends is 
established. 

The fair value of AFS monetary assets denominated in a 
foreign currency is determined in that foreign currency and 
translated at the spot rate at the end of the reporting period. 
The foreign exchange gains and losses that are recognised in 
profit or loss are determined based on the amortised cost of 
the monetary asset. Other foreign exchange gains and losses 
are recognised in other comprehensive income. 

Loans and receivables 

Trade receivables, loans, and other receivables that have 
fixed or determinable payments that are not quoted in an 
active market are classified as “loans and receivables”. Loans 
and receivables are measured at amortised cost using the 
effective interest method, less any impairment. Interest 
income is recognised by applying the effective interest 
rate, except for short-term receivables when the effect of 
discounting is immaterial. 

Impairment of financial assets 

Financial assets, other than those at FVTPL, are assessed for 
indicators of impairment at the end of each reporting period. 
Financial assets are considered to be impaired when there is 
objective evidence that, as a result of one or more events that 
occurred after the initial recognition of the financial asset, 
the estimated future cash flows of the investment have been 
affected. 

For financial assets carried at amortised cost, the amount of 
the impairment loss recognised is the difference between the 
asset’s carrying amount and the present value of estimated 

future cash flows, discounted at the financial asset’s original 
effective interest rate. 

For financial assets that are carried at cost, the amount of 
the impairment loss is measured as the difference between 
the asset’s carrying amount and the present value of the 
estimated future cash flows discounted at the current market 
rate of return for a similar financial asset. Such impairment 
loss will not be reversed in subsequent periods. 

The carrying amount of the financial asset is reduced by 
the impairment loss directly for all financial assets with the 
exception of trade receivables, where the carrying amount 
is reduced through the use of an allowance account. When 
a trade receivable is considered uncollectable, it is written 
off against the allowance account. Subsequent recoveries 
of amounts previously written off are credited against the 
allowance account. Changes in the carrying amount of the 
allowance account are recognised in profit or loss. 

When an AFS financial asset is considered to be impaired, 
cumulative gains or losses previously recognised in other 
comprehensive income are reclassified to profit or loss in the 
period. 

For financial assets measured at amortised cost, if, in a 
subsequent period, the amount of the impairment loss 
decreases and the decrease can be related objectively to an 
event occurring after the impairment was recognised, the 
previously recognised impairment loss is reversed through 
profit or loss to the extent that the carrying amount of the 
investment at the date the impairment is reversed does not 
exceed what the amortised cost would have been had the 
impairment not been recognised. 

In respect of AFS equity securities, impairment losses 
previously recognised in profit or loss are not reversed 
through profit or loss. Any increase in fair value subsequent 
to an impairment loss is recognised in other comprehensive 
income and accumulated under the heading of investments 
revaluation reserve. In respect of AFS debt securities, 
impairment losses are subsequently reversed through profit 
or loss if an increase in the fair value of the investment can be 
objectively related to an event occurring after the recognition 
of the impairment loss. 

Derecognition of financial assets 

The Group derecognises a financial asset when the 
contractual rights to the cash flows from the asset expire, or 
when it transfers the financial asset and substantially all the 
risks and rewards of ownership of the asset to another party. 

ClearView Annual Report 2015     80

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

If the Group neither transfers nor retains substantially all the 
risks and rewards of ownership and continues to control the 
transferred asset, the Group recognises its retained interest 
in the asset and an associated liability for amounts it may 
have to pay. If the Group retains substantially all the risks 
and rewards of ownership of a transferred financial asset, 
the Group continues to recognise the financial asset and 
also recognises a collateralised borrowing for the proceeds 
received. 

On derecognition of a financial asset in its entirety, the 
difference between the asset’s carrying amount and the 
sum of the consideration received and receivable and 
the cumulative gain or loss that had been recognised in 
other comprehensive income and accumulated in equity is 
recognised in profit or loss. 

On derecognition of a financial asset other than in its entirety 
(e.g. when the Group retains an option to repurchase part of 
a transferred asset), the Group allocates the previous carrying 
amount of the financial asset between the part it continues 
to recognise under continuing involvement, and the part it 
no longer recognises on the basis of the relative fair values 
of those parts on the date of the transfer. The difference 
between the carrying amount allocated to the part that is no 
longer recognised and the sum of the consideration received 
for the part no longer recognised and any cumulative gain 
or loss allocated to it that had been recognised in other 
comprehensive income is recognised in profit or loss. A 
cumulative gain or loss that had been recognised in other 
comprehensive income is allocated between the part that 
continues to be recognised and the part that is no longer 
recognised on the basis of the relative fair values of those 
parts. 

Financial liabilities and equity instruments 

Classification as debt or equity 

Debt and equity instruments are classified as either financial 
liabilities or as equity in accordance with the substance of the 
contractual arrangement. 

Equity instruments 

An equity instrument is any contract that evidences a 
residual interest in the assets of an entity after deducting all 
of its liabilities. Equity instruments issued by the Group are 
recognised as equal to the proceeds received, net of direct 
issue costs. 

81     ClearView Annual Report 2015

Repurchase of the Company’s own equity instruments is 
recognised and deducted directly in equity. No gain or loss 
is recognised in profit or loss on the purchase, sale, issue or 
cancellation of the Company’s own equity instruments. 

Financial liabilities 

Financial liabilities are classified as either financial liabilities 
“at FVTPL” or “other financial liabilities”. 

Financial liabilities at FVTPL 

Financial liabilities are classified at FVTPL when the financial 
liability is either held for trading or it is designated as at 
FVTPL. A financial liability is classified as held for trading if: 

• 

• 

 It has been incurred principally for the purpose of 
repurchasing it in the near term; or 

 On initial recognition it is part of a portfolio of identified 
financial instruments that the Group manages together 
and has a recent actual pattern of short-term profit 
taking; or 

It is a derivative that is not designated and effective as a 
hedging instrument. A financial liability other than a financial 
liability held for trading may be designated as at FVTPL upon 
initial recognition if: 

• 

• 

• 

 Such designation eliminates or significantly reduces a 
measurement or recognition inconsistency that would 
otherwise arise; or 

 The financial liability forms part of a group of financial 
assets or financial liabilities or both, which is managed 
and its performance is evaluated on a fair value basis, 
in accordance with the Group’s documented risk 
management or investment strategy, and information 
about the grouping is provided internally on that basis; or 

 It forms part of a contract containing one or more 
embedded derivatives, and AASB 139 “Financial 
Instruments: Recognition and Measurement” permits 
the entire combined contract (asset or liability) to be 
designated at FVTPL. 

Financial liabilities at FVTPL are stated at fair value, with 
any gains or losses arising on remeasurement recognised in 
profit or loss. The net gain or loss recognised in profit or loss 
incorporates any interest paid on the financial liability and 
is included in the “other gains and losses” line item in the 
statement of profit or loss. Fair value is determined in the 
manner described in Note 36. 

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

3. Significant accounting policies continued

Other financial liabilities 

between acquisition and maintenance costs; 

Other financial liabilities, including borrowings, are initially 
measured at fair value, net of transaction costs. 

•  Assets arising from reinsurance contracts; 

•  Recoverability of intangible assets; 

Other financial liabilities are subsequently measured at 
amortised cost using the effective interest method, with 
interest expense recognised on an effective yield basis. 

• 

Impairment of goodwill; 

•  Deferred tax assets; and

The effective interest method is a method of calculating the 
amortised cost of a financial liability and of allocating interest 
expense over the relevant period. 

The effective interest rates is the rate that exactly discounts 
estimated future cash payments through the expected life of 
the financial liability, or where appropriate a shorter period, to 
the net carrying amount on initial recognition. 

Derecognition of financial liabilities 

The Group derecognises financial liabilities when, and only 
when, the Group’s obligations are discharged, cancelled or 
they expire. The difference between the carrying amount of 
the financial liability derecognised and the consideration paid 
and payable is recognised in profit or loss. 

4. Critical accounting judgments and 
key sources of estimation uncertainty
In the application of the Group’s accounting policies the 
Directors are required to make judgments, estimates and 
assumptions about carrying values of assets and liabilities 
that are not readily apparent from other sources. The 
estimates and associated assumptions are based on historical 
experience and various other factors that are believed to be 
reasonable under the circumstances, the results of which 
form the basis of making the judgments. Actual results may 
differ from these estimates. 

The estimates and underlying assumptions are reviewed 
on an ongoing basis. Revisions to accounting estimates are 
recognised in the period in which the estimate is revised if the 
revision affects only that period or in the period of the revision 
and future periods if the revision affects both current and 
future periods. 

The critical judgments that the Directors have made in the 
process of applying the Group’s accounting policies and in 
the application of Australian Accounting Standards that have 
a significant effect on the financial report and estimates 
include: 

• 

 Life insurance policy liabilities, including the actuarial 
methods and assumptions and allocation of expenses 

• 

 Contingent consideration for the acquisition of Matrix 
Holdings Limited.

Life insurance policy liabilities 

Life insurance policy liabilities are, in the majority of cases, 
determined using an individual policy-by-policy calculation. 
Where material liabilities are not determined by individual 
policy valuation, they are computed using statistical 
or mathematical methods, which are expected to give 
approximately the same results as if an individual liability 
were calculated for each contract. The calculations are made 
by suitably qualified personnel on the basis of recognised 
actuarial methods, with due regard to relevant actuarial 
principles. The methodology takes into account the risks 
and uncertainties of the particular classes of life insurance 
business written. 

The key factors that affect the estimation of these liabilities 
and related assets are: 

• 

• 

• 

• 

 The cost of providing benefits and administering these 
insurance contracts; 

 The costs incurred in acquiring the policies, including 
commissions, underwriting and policy issue costs; 

 Mortality and morbidity experience on life insurance 
products; and 

 Discontinuance experience, which affects ClearView Life’s 
ability to recover the cost of acquiring new business over 
the term of the contracts. 

In addition, factors such as regulation, competition, interest 
rates, taxes, securities market conditions and general 
economic conditions affect the level of these liabilities. Details 
of specific actuarial policies and methods are set out further 
below. 

Assets arising from reinsurance contracts 

Assets arising from reinsurance contracts are computed using 
the same methods as used for insurance policy liabilities. 
In addition, the recoverability of these assets is assessed 
on a periodic basis to ensure that the balance is reflective 
of the amounts that will ultimately be received, taking into 

ClearView Annual Report 2015     82

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

4. Critical accounting judgments and key sources of estimation uncertainty continued

consideration factors such as reinsurer counterparty and 
credit risk. 

Impairment is recognised where there is objective evidence 
that the Company may not receive amounts due to it and 
these amounts can be reliably measured. 

Recoverability of acquired intangible assets 

The carrying amount of intangible assets acquired in a 
business combination at the financial position date was  
$26.1 million (2014: $30.1 million). 

Intangible assets acquired in a business combination are 
identified and recognised separately from goodwill where 
they satisfy the definition of an intangible asset. Subsequent 
to initial recognition, intangible assets acquired in a 
business combination are reported at cost less accumulated 
amortisation and accumulated impairment losses, on the 
same basis as intangible assets acquired separately. 

At each reporting date ClearView is required to assess 
whether there is any indication that the intangibles may be 
impaired. Triggers for impairment are identified and approved 
for each cash generating unit (CGU). Further details have been 
provided in each relevant section below. 

Client Book – Intangible 

The carrying amount of the Client Book - Intangible as at the 
financial position date was $25.9 million (2014: $30.1 million). 
These intangible assets arose on the acquisition of ClearView 
Group Holdings Pty Limited (CVGH), Community and Corporate 
Pty Limited (CCFA) and Matrix Holdings Limited (Matrix 
Holdings). The intangibles represent the value of the in-force 
insurance and investment contracts, and value of the existing 
financial advice and funds management revenues (the Client 
Books). Each Client Book has its own assessment of useful life 
depending on the nature of the clients in each segment and 
their relative characteristics, based on age, demographics 
and type of product to which it relates. The policy adopted to 
write-off the Client Books resembles the anticipated ageing 
profile of the revenue stream. ClearView identifies its CGUs at 
the segment reporting level (lowest level of cash generating 
units). The CGUs identified are as follows: 

useful life and amortisation method. As a result of the annual 
assessment, the useful life of the Life Insurance Client Book 
has been changed from 12 years to 8 years due to a change 
in the lapse rate assumption at 30 June 2014 on the pre 
2011 Life Insurance in-force portfolio and therefore in the 
estimated ageing profile of the book. In line with the Group’s 
accounting policy, this has been accounted for prospectively, 
and will be written off over the remaining 4 years of its useful 
life. This has resulted in an increase in the amortisation 
expense for the period of $1.4 million. The carrying value 
of the Life Insurance Client Book as at 30 June 2015 is $8.5 
million.

Triggers considered in testing for annual impairment for the 
Life Insurance Client Book are as follows:

•  Mortality and morbidity (claims);

•  Maintenance costs;

•  Persistency (lapse); and

•  Discount rates.

The Wealth Management Client Book is written off at 15% 
per annum on a straight line basis. The carrying value is $6.3 
million at 30 June 2015. Triggers that need to be considered 
in testing for annual impairment for the Wealth Client Book 
are as follows: 

• 

Investment returns; 

•  Maintenance costs; 

•  Outflows; and

•  Discount rates.

The Financial Advice Client Book is written off on a straight 
line basis over 10 years. The carrying value is $11.1 million at 
30 June 2015.

Triggers that need to be considered in testing for annual 
impairment for the Financial Advice Client Book are as follows: 

• 

Investment returns; 

•  Maintenance costs; 

•  Outflows; and

•  Discount rates.

•  Life Insurance; 

•  Wealth Management; and 

• 

Financial Advice. 

The Life Insurance Client Book had, until 30 June 2014,  
been written off on a straight line basis over 12 years.  
At each reporting date, an assessment is made of both the 

ClearView prepares an Embedded Value for the Group at 
each reporting period. The Embedded Value is prepared 
at a reportable segment level (CGUs). The Embedded 
Value measure is used as a proxy for the value in use. The 
Embedded Value methodology is used to test the acquired 
intangibles for any impairment triggers. As at 30 June 2015, 
based on the EV calculations, no impairment was required to 

83     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

4. Critical accounting judgments and key sources of estimation uncertainty continued

the carrying value of the intangible assets. 

Goodwill 

Further information about the Embedded Value (and the 
movement over the year) is provided in the “Operating and 
Financial Review” in the Directors Report and further details 
on intangible assets is detailed in Note 20. 

Recoverability of internally generated software 
intangibles 

The carrying amount of internally generated capitalised 
software at the financial position date was $9.9 million (2014: 
$6.8 million) 

At each reporting period the internally generated software 
is assessed for any impairment triggers. If any such 
indication exists, the recoverable amount of the asset shall 
be estimated. The impairment indicators for the software 
intangible are defined as: 

• 

• 

• 

• 

 The ability of the software to provide the functionality 
required from the business to use the asset; 

 The software is being utilised for the purposes that it was 
designed; 

 The availability of alternative software that the business 
has available; and 

 Product mix - The entity no longer sells the products that 
are administered on the policy administration system or 
utilises the provided functionality. 

Capitalised software costs include those associated with the 
implementation of a new compliant and functional wealth 
platform and the launch of WealthFoundations that is hosted 
on the new platform. The intention is to migrate the Master 
Trust and  MIS products onto the new platform in due course.

No impairment was required to the carrying values of 
internally generated software as at 30 June 2015. 

Impairment of Goodwill 

The carrying amount of goodwill at the reporting date was 
$20.0 million (2014: $4.9 million). 

Determining whether goodwill is impaired requires an 
estimation of the value-in-use of the cash-generating units 
to which the goodwill has been allocated. The value-in-use 
calculation requires the entity to estimate the future cash 
flows expected to arise from the cash-generating unit and 
a suitable discount rate in order to determined the present 
value of those cash flows. 

CFA acquired the business of CCFA on 9 April 2009. 

Goodwill arose in respect of the amount of consideration 
paid that related to the expected cost synergies, revenue 
growth, improved referral source penetration, future market 
development and the assembled work force and ingrained 
experience of personnel. These assets are not recognised 
separately from goodwill as the future economic benefits 
arising from them are not capable of being measured 
separately. 

CCFA was acquired in 2009 as the first step of the Group 
in developing a presence in the wealth management and 
financial advice industry. The goodwill that arose on the 
acquisition has at the reporting date been allocated to the 
Financial Advice CGU. The Group tests for impairment at each 
reporting date. 

The Company acquired Matrix Holdings Limited (Matrix 
Holdings) and its subsidiaries Matrix Planning Solutions 
Limited (MPS or Matrix) and Matrix Planning Investments Pty 
Ltd (MPI) on 10 October 2014. 

Goodwill arose in respect of the amount of consideration paid 
attributable to the expected revenue synergies and other 
benefits from combining the assets and activities of Matrix 
with those of the Group. The expanded number of supportive 
advisers has the potential to deliver revenue synergies given 
ClearView’s market proven products. The impact of achieving 
the revenue targets (in accordance with the deal) is also 
expected to result in the increased profitability of the dealer 
group. The goodwill that arose on acquisition has at reporting 
date been allocated across the financial advice, life insurance 
and wealth management CGU’s of the Group.

The Board believes that any reasonable possible change in  
the key assumptions on which the recoverable amount is 
based would not cause the aggregate carrying amount 
to exceed the aggregate recoverable amount of the cash 
generating unit. 

The FoFA reforms became effective on 1 July 2013 and 
focussed on improving the quality of financial advice, 
particularly product recommendations to retail clients.  
To further progress and clarify the initial reforms, the 
Government introduced certain regulations which came into 
effect in July 2014 which were subsequently disallowed on 
19 November 2014.  Only certain provisions contained in 
the disallowed regulations were later released and became 
effective on 15 December 2014, resulting in the following:

ClearView Annual Report 2015     84

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

4. Critical accounting judgments and key sources of estimation uncertainty continued

• 

• 

• 

• 

 Grandfathering concession – which clarifies that when 
advisers move between licensees with their clients, they 
can continue to receive grandfathered remuneration;

 Fee disclosure statements – advisers must provide an 
annual Fee Disclosure Statement to all clients with whom 
they have an ongoing service arrangement, regardless of 
the date the relationship commenced (this was previously 
limited to post 1 July 2013 clients under the disallowed 
regulations);

 Opt-in requirement –which requires an adviser to seek 
confirmation from the client every two years that they are 
happy to renew their ongoing fee arrangement is now in 
effect (it was previously postponed under the disallowed 
regulations).  This requirement only applies to clients who 
commenced with their adviser on or after 1 July 2013. The 
first opt-in notices were required to be issued from 1 July 
2015; and

 Best interest duty – reverted to its original drafting by 
reinstating the ‘catch all’ element of the ‘safe harbour’ 
provision (previously the ‘catch-all’ element was removed 
under the disallowed regulations).

The progress of the implementation of the regulatory reforms 
will continue to be monitored and the impact assessed as 
these regulations are rolled out and the practicalities of the 
reforms unfold.

ClearView prepares an Embedded Value for the Group at 
each reporting period. The Embedded value is prepared at a 
reportable segment level (CGU).  

The goodwill recognised in the Financial Advice CGU is 
tested for impairment triggers using the Embedded Value 
methodology. 

The goodwill recognised on acquisition of Matrix within the 
Life Insurance and Wealth Management CGU's is tested for 
impairment triggers by comparing the carrying value of the 
goodwill to the forecast incremental Value of New Business 
expected to be generated in the Life Insurance and Wealth 
Management CGU’s based on the anticipated new business 
flows in accordance with the approved Business Plan. As at 30 
June 2015, no impairment was required to the carrying value 
of the goodwill.

Further information about Goodwill is detailed in Note 19.

Deferred tax asset – Timing Differences 

The Board has considered that it is probable that sufficient 
taxable income will be available against which deductible 
temporary differences can be utilised. 

Deferred tax asset – Capital Losses 

ClearView Life has amounts of realised and unrealised capital 
losses within its superannuation business in its No. 2 and 
No.4 Statutory Funds. The Board has considered the likelihood 
of the recovery of these losses and their fair value, and has 
concluded that it is appropriate to reduce the deferred tax 
asset (DTA) held in respect of those capital losses below the 
nominal full recovery amount. This has been implemented 
via placing a cap on the recognised DTA. The DTA relating to 
capital losses are estimated to be utilised in the foreseeable 
future and is expressed as a percentage of the value of 
investments held. The same methodology has been adopted 
for unit pricing purposes and this financial report. 

In addition to the above, the Group has accumulated capital 
losses that arose within the parent entity related to the losses 
realised on the historic disposal of a subsidiary entity. At the 
current time, no DTA is recognised in respect of these losses. 
This is discussed further in Note 24. 

Contingent consideration for the acquisition of Matrix 
Holdings Limited

As part of the Merger Implementation Deed entered into 
between the parties on 29 August 2014, a component of the 
purchase consideration was determined to be contingent 
on the satisfaction of a number of Performance Conditions 
(including the performance of the acquired entity). 

The initial measurement of the fair value of contingent 
consideration is based on an assessment of the facts and 
circumstances that existed at acquisition date. As the 
consideration is contingent upon a number of performance 
factors, each factor is given weighting depending on the 
probability of each criterion being achieved.  The probability-
weighted average of payouts associated with each possible 
outcome (‘probability-weighted payout approach’ ) requires 
taking into account the range of possible outcomes, the 
payouts associated with each possible outcome and the 
probability of each outcome arising.

85     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

4. Critical accounting judgments and key sources of estimation uncertainty continued

The table below outlines the performance conditions and probability of each outcome arising:

Performance Condition

At least 75% of  Matrix representatives at the date of the offer remain Matrix representative for 3 years 
after the completion of the transaction

At least 90% of Matrix representatives adopt the following common processes:

Probability

100%1

100%2

•  Utilisation of the ClearView dealergroup platform; and

•  Adoption of common advice processes

Achievement of  Gross Annual Revenue (GAR) targets by Matrix representatives  in accordance with the 
Merger Implementation Deed

85.72%3

1 Probability assumed to be 100% as 90% of advisers have signed on for a 3 year period as part of the bid conditions.
2 Probability assumed to be 100% as an integration program is in place to move over 90% of Matrix advisers to the CWT X Plan system by 31 December 2015.
3 This probability is calculated as the likelihood that the GAR targets will be met under various scenarios.

The fair value of contingent consideration as at the financial position date was $12.5 million. This includes a fair value 
adjustment of $2.1 million which has been determined by application of the probability of the likelihood of occurrence to the 
total possible contingent consideration. 

Actuarial methods and assumptions 

The effective date of the actuarial report on life insurance policy liabilities and life investment policy liabilities is 30 June 2015. 
The actuarial report was prepared by the ClearView Life Appointed Actuary, Ashutosh Bhalerao. The actuarial report indicates 
that the Appointed Actuary is satisfied as to the accuracy of the data upon which the policy liabilities have been determined.

The methods used for the major product groups are as follows:

Related Product Group

Fund 1 Old Book Lump Sum

Fund 1 Old Book Income Protection

Fund 1 Non-Advice Lump Sum 

Fund 1 LifeSolutions Lump Sum Ordinary

Fund 1 LifeSolutions Lump Sum Super

Fund 1 LifeSolutions Income Protection Ordinary

Fund 1 LifeSolutions Income Protection Super

Fund 2 Old Book Lump Sum

Fund 2 Investments

Fund 4 Investments

Method

Profit carrier

Projection 

Projection

Projection 

Projection 

Projection

Projection

Projection

Projection

Accumulation

Accumulation

Premiums

Premiums

Premiums

Premiums

Premiums

Premiums

Premiums

Premiums

n/a

n/a

These life insurance and life investment policy liability 
determinations are also consistent with the requirements of 
the relevant Prudential Standards and the Life Insurance Act 
1995. Life insurance policy liabilities have been calculated 
in a way which allows for the systematic release of planned 
margins as services are provided to policyholders and 
premiums are received. 

The projection method uses the discounted value of future 
policy cash flows (premiums, expenses and claims) plus a 
reserve for expected future profits. The policy liabilities for life 
investment contracts are determined as the fair value of the 
policyholders’ accounts under the accumulation method with 
no future profit reserve.

ClearView Annual Report 2015     86

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

4. Critical accounting judgments and key sources of estimation uncertainty continued

(b) Actuarial assumptions used in the valuation of 
life insurance policy liabilities

(c) Effects of changes in actuarial assumptions (over 
12 months to 30 June 2015)

Key assumptions used in the calculations of life insurance 
policy liabilities are as follows: 

Discount rates: Discount rates are based on a yield curve 
derived from Commonwealth Government bond market 
yields as at the valuation date, plus an illiquidity adjustment 
based on the difference between these yields and BBSW swap 
rates as at the valuation date. As an indication, the resulting 
average effective discount rate adopted was 3.6% (2014: 
4.1%). 

Acquisition expenses: Per policy acquisition expense 
assumptions were based on the actual acquisition expenses 
incurred for the 12 months to 30 June 2015. 

Maintenance expense and inflation: The per policy 
maintenance expense assumptions were based on the longer 
term per policy unit costs implied by ClearView Life’s 2015 
business plan (2014: Based on the 2014 business plan). 
Expense inflation of 2.5% p.a. (2014: 2.5% p.a.) was assumed. 

Lapses: Rates adopted vary by product, duration, age and 
premium frequency, and have been based on an analysis of 
ClearView Life’s experience over recent years with allowance 
for expected trends. 

Mortality: Rates adopted vary by product, age, gender, and 
smoking status and have been based on ClearView Life’s 
mortality experience. The underlying mortality table used was 
IA95-97, including allowance for selection. 

Morbidity (TPD and Trauma): Rates adopted vary by age, 
gender, and smoking status and have been based on 
known industry experience plus advice from ClearView Life’s 
reinsurers.

Effect on 
profit margins 
Increase/
(decrease)

Effect on policy 
liabilities 
Increase/
(decrease)

$’000

$’000

7,438

-

(207)

 -   

 7,231 

(4,290)

 -   

 -   

 -   

(4,290) 

Assumption category

Discount rates and 
inflation

Maintenance expenses

Lapses

Mortality and 
morbidity

Total

(d) Processes used to select assumptions

Discount rate 

Benefits under life insurance contracts are not contractually 
linked to the performance of the assets held. As a result, the 
life insurance policy liabilities are discounted for the time 
value of money using discount rates that are based on current 
observable, objective rates that relate to the nature, structure 
and term of the future obligations. The discount rate is based 
on Commonwealth Government bond rates adjusted for the 
value of the illiquidity of the policy liability. The effect of this 
approach is unchanged from that adopted last valuation. 

Maintenance expenses and inflation 

Maintenance expenses are set having regard to the cost base 
in the three year Board adopted business plan excluding short 
term growth and development costs. 

Per policy maintenance expenses are assumed to increase in 
the future with inflation, at a rate that allows for basic price 
increases (CPI). 

Acquisition expenses 

Per policy acquisition expenses were derived from the analysis 
of acquisition expenses adopted for this financial report. 

Taxation 

It has been assumed that current tax legislation and rates 
continue unaltered. 

87     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

4. Critical accounting judgments and key sources of estimation uncertainty continued

Mortality and morbidity 

Appropriate base tables of mortality and morbidity are 
chosen for the type of products written. An investigation into 
the actual experience of the insurance portfolio over recent 
years is performed annually and the Company’s mortality 
and morbidity experience is compared against the rates 
in the base tables. Where the data is sufficient to be fully 
statistically credible, the base table is adjusted to reflect the 
portfolio’s experience. Where data is insufficient to be fully 
statistically credible, the base table is adjusted having regard 

to the extent of the credibility of the portfolio’s experience, 
the overall experience of the industry known and advice from 
ClearView’s reinsurers. 

Lapse 

An investigation into the actual lapse experience of ClearView 
Life over the most recent years is performed and statistical 
methods are used to determine appropriate lapse rates. An 
allowance is then made for any trends in the data to arrive at 
a best estimate of future lapse rates. 

(e) Sensitivity analysis 

The Company conducts sensitivity analyses to quantify the exposure to risk of changes in the key underlying variables such as 
discount rates, expenses, mortality, morbidity and lapses. The valuations included in the reported results and ClearView Life’s 
best estimate of future performance are calculated using certain assumptions about these variables. The movement in any 
key variable may impact the reported performance and net assets of ClearView Life and the consolidated entity and as such 
represents a risk. 

Variable

Impact of movement in underlying variable

Interest Rate Risk

Expense Risk

Mortality Rates

Morbidity Rates

Lapses

The life insurance policy liabilities are calculated using a discount rate that is derived from market 
interest rates. Changes in market interest rates will affect the present value of cash flows and profit 
margins in the policy liabilities, which in turn will affect the profit and shareholder equity. The change 
in interest rates would also impact the emerging profit via its impact on the investment returns on the 
assets held to back the liabilities. 

An increase in the level (or inflation) of expenses over the assumed levels will decrease emerging profit. 
However, a change in the base expense assumptions adopted for the policy liability is unlikely to impact 
the current policy liability determination as such a change is absorbed into the policy liability profit 
margin reserve in the first instance. 

For life insurance contracts providing death benefits an increased rate of mortality would lead to higher 
levels of claims, increasing associated claims cost and thereby reducing emerging profit. However, a 
change in the mortality assumptions adopted for the policy liability is unlikely to directly impact the 
current policy liability determination as such a change is absorbed into the policy liability profit margin 
reserve in the first instance. 

The cost of claims under TPD and trauma cover depends on the incidence of policyholders becoming 
totally and permanently disabled or suffering a “trauma” event such as a heart attack or stroke. Higher 
incidence would increase claim costs, thereby reducing profit and shareholder equity. The impact on the 
policy liability of a change in morbidity assumptions is as per mortality above. 

Lapse risk represents the extent to which policyholders choose not to renew their policy, and allow it to 
lapse. An increase in the lapse rates will have a negative effect on emerging profit owing to the loss of 
future revenue, including that required to recover acquisition costs. The impact on the policy liability of a 
change in lapse assumptions is as per mortality above. 

ClearView Annual Report 2015     88

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

4. Critical accounting judgments and key sources of estimation uncertainty continued

The table below illustrates how outcomes during the financial year ended 30 June 2015 in respect of the key actuarial 
variables, would have impacted the reported life insurance policy liabilities, profit and equity for that financial year.

Variable

Interest rates

Mortality and morbidity

Lapses

Maintenance expenses

Impact on policy liabilities

Impact on net profit and 
shareholder equity

Gross of 
reinsurance

Net of 
reinsurance

Gross of 
reinsurance

Net of 
reinsurance

$’000

13,409

$’000

11,229

(15,397)

(12,844)

-

-

-

-

-

-

-

-

-

-

-

-

$’000

(9,386)

10,778

(2,307)

2,307

(1,566)

1,566

(1,288)

1,288

$’000

(7,860)

8,991

(1,256)

1,256

(1,392)

1,392

(1,288)

1,288

Change in 
variable

+100bp

-100bp

110.0%

90.0%

110.0%

90.0%

110.0%

90.0%

*   Note: The interest rate sensitivities show the change to policy liabilities and profit from a change in the discount rate by adding or subtracting 1% from the yield 

curve adopted. The other sensitivities show how different the policy liabilities and reported profit would have been if the Company’s experience in the current year 
in relation to those variables had been higher or lower by 10% of that experienced.

5. Risk Management
The Group’s activities expose it to a variety of risks, both 
financial and non-financial. Key risks include: 

controls identified as part of the risk assessment process. 
KPMG is retained to provide outsourced internal audit services. 

• 

 Asset risks, including market risk (interest rate risk and 
equity price risk), credit risk and liquidity risk; 

The RMS and RMF considers the key stakeholders in the Group, 
beyond the shareholders, including: 

• 

Insurance risk; 

•  Asset-liability mismatch risks; 

• 

 Expense risks; and client discontinuance (lapses, 
withdrawals and lost client) risks; and 

•  Operational risk, compliance risk and strategic risk. 

• 

• 

 The benefit, security and expectations of policyholders, 
members of the ClearView Retirement Plan and 
investment product and advice clients. 

 Risk impacts on and from our staff, our distribution 
partners and suppliers and counterparties. 

•  Requirements and objectives of our regulators. 

Risk management strategy, roles and responsibilities 

Risk management is an integral part of the Group’s 
management process. The Group’s Board has adopted a 
formal Risk Management Strategy (RMS) and structured risk 
management framework (RMF) to assist it in identifying and 
managing the key risks to achieving the Group’s objectives. 
The RMS and RMF are fundamental to the business decisions 
of the Group, including resource allocation decisions and 
prioritisation of activities. 

The Risk and Compliance Committee, on behalf of the Board, 
monitors the operation of the RMF and facilitates review of 
the key process and procedures underlying the RMF. Internal 
audit activities are focused on key risks and on the key risk 

The RMS specifies the Board’s risk appetite and tolerance 
standard which guides the Group in its decisions as to the 
acceptance, management and rejection of risks. A risk register 
is maintained that identifies the key risks of the Group by 
type, impact and likelihood, and indicates the key process and 
mechanisms to control, mitigate or transfer those risks within 
the allowed tolerances. The RMS and RMF includes suitable 
monitoring mechanisms. 

As part of the RMS and RMF, the Group has adopted an 
Internal Capital Adequacy Assessment Process (ICAAP) with 
respect to supporting the residual risk exposures retained by 
the Group and the ongoing capital needs of the Group. 

The key risks are discussed in more detail below: 

89     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

5. Risk Management continued

Asset risks 

The primary asset risks borne by the Group relate to the 
financial assets of the Company and its operating subsidiaries 
excluding those in the non-guaranteed investment linked 
funds in ClearView Life’s statutory fund No.4 (referred to 
below as ClearView assets). The primary financial risks related 
to the financial assets in the non-guaranteed investment 
linked funds in ClearView Life’s statutory fund No.4 are borne 

Insurance risk 

by policyholders as the investment performance on those 
assets is passed through, in full, to the policyholders (referred 
to below as Policyholder assets). Nonetheless, the Company 
has a secondary exposure to the Policyholder assets and off-
balance sheet client funds, via the impact on the fees charged 
by the Group which vary with the level of Policyholder and 
client funds under management and under administration, 
as well as related reputational exposure (for further detail on 

Asset risks refer to Note 36 Financial Instruments). 

The risks under the life insurance contracts written by the Company are exposed to various key variables. The table below 
provides an overview of the key insurance contract types and exposure variables.

Type of contract

Detail of contract workings

Nature of compensation  
for claims

Key variables that affect the 
timing and uncertainty

Non-participating life insurance 

Benefits paid on death or ill 

Benefits defined by the 

contracts with fixed terms 

health that are fixed and not at 

insurance contract are 

(Term Life and Disability)

the discretion of the issuer

determined by the contract 

obligation of the issuer and 

Mortality

Morbidity

Discontinuance rates

are not directly affected by the 

Expenses

performance of the underlying 

assets or the performance of 

the contracts as a whole

Policy Terms

Premium Rates

Insurance risks are controlled through the use of underwriting procedures, appropriate premium rating methods and 
approaches, appropriate reinsurance arrangements, effective claims management procedures and sound product terms and 
conditions due diligence. 

(a) Risk management objectives and policies for 
mitigating insurance risk 

are members of large international groups with sound credit 
ratings. 

ClearView Life issues term life insurance contracts and 
disability insurance contracts. The performance of the 
Company and its continuing ability to write business depends 
on its ability to manage insurance risk. The Company’s RMS 
summarises its approach to insurance risk management. 

(b) Methods to limit manage or transfer insurance 
risk exposures 

Reinsurance 

ClearView Life purchases reinsurance to limit its exposure to 
accepted insurance risk. ClearView Life cedes to specialist 
reinsurance companies a proportion of its portfolio for certain 
types of insurance risk. This serves primarily to reduce the 
net liability on large individual risks and provide protection 
against large losses. The reinsurers used are regulated by 
the Australian Prudential Regulation Authority (APRA) and 

ClearView Life periodically reviews its reinsurance 
arrangements and retention levels. 

Underwriting procedures 

Underwriting decisions are made using the underwriting 
procedures reflected in ClearView Life’s underwriting systems 
and detailed in ClearView Life’s underwriting manual. Such 
procedures include limits as to delegated authorities and 
signing powers. The underwriting process is subject to 
ClearView Life’s internal control processes and is subject to 
review by the reinsurers from time to time. 

Claims management 

Strict claims management procedures help ensure the timely 
and correct payment of claims in accordance with policy 
conditions, as well as limiting exposure to inappropriate and 
fraudulent claims. 

ClearView Annual Report 2015     90

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

5. Risk Management continued

(c) Concentration of insurance risk 

The insurance business of the Company is principally 
written on individual lives (not group business). Individual 
business is not expected to provide significant exposure to 
risk concentration. Nonetheless, the residual risk exposure 
is reduced through the use of reinsurance and is subject to 
review by the reinsurer’s from time to time.

(d) Pricing risk, and terms and conditions of 
insurance contracts 

The key risk controls in respect of pricing and policy terms and 
conditions include: 

• 

• 

• 

• 

• 

 Review of product pricing by the Appointed Actuary of 
ClearView Life, including annual analysis of experience 
and product line profitability in the annual ClearView Life 
Financial Condition Report; 

 Formal Appointed Actuary Board reporting on new product 
pricing, reinsurance and terms and conditions; 

 Assessment by the Company’s reinsurers of the pricing 
adopted, including the offer of corresponding reinsurance 
terms; 

 Formal internal policy document and Product Disclosure 
Statement due diligence review and sign-off processes; 
and 

 The ability to re-price products (change premium rates 
and fees) on most products in the event of adverse claims 
and/or other product experience. 

It is noted that similar processes and controls apply to the 
pricing and terms and conditions applicable to the investment 
products issued by the Company. 

Asset-Liability Mismatch Risk 

Asset-liability mismatch risk arises to the extent to which 
the assets held by the Group to back its liabilities (especially 
its policy liabilities and investment contract liabilities) do 
not closely match the nature and term of those liabilities. 
In practice, the market risk and credit risk exposures of the 
Group primarily relate to the extent that the Group retains a 
net exposure with respect to these risks – that is the extent 
to which the liabilities and their values do not mirror the 
variation in asset values. In this context it is noted: 

• 

 The investment linked liabilities of the ClearView Life 
directly link the underlying assets held to support those 

91     ClearView Annual Report 2015

• 

• 

liabilities, with the primary market risks and credit risks 
passed on to the policyholder and unit trust investors (as 
discussed above). 

 The assets held to support the capital guaranteed units 
in the ClearView Life No.2 and No.4 statutory funds are 
maintained, in accordance with the Board’s investment 
Policy and Guidelines, in high quality, short dated fixed 
interest assets and cash. Asset-liability risk is substantially 
reduced via this means. 

 Similarly, assets held to support the policy liabilities and 
risk capital of the ClearView Life No.1 statutory fund are 
maintained, in accordance with the Board’s investment 
Policy and Guidelines, in high quality, short dated fixed 
interest assets and cash that closely match those policy 
liabilities and capital reserves. 

Expense and Discontinuance Risks 

Expense risks and discontinuance risks involve: 

• 

• 

 The extent to which the expenses of the business are not 
maintained at a level commensurate with premium and 
fee flows of the business, including the level of business 
growth and new business and client acquisition;  

 The extent to which the rate of loss of policyholders, 
investment clients and other customers exceed 
benchmark standards and pricing targets, result in the loss 
of future profit margins, current period expense support, 
and loss of opportunity to recover historic acquisition costs 
incurred. 

The risks are principally managed via the Group’s: 

• 

• 

 Budgeting and expense management reporting and 
management processes; 

 Modelling of anticipated client loss rates and ongoing 
monitoring of discontinuance rates; 

• 

 Adoption of appropriate business retention strategies; and 

•  Maintaining strong distribution partner relationships. 

Non-Financial Risks – Compliance, Operational  

& Strategic Risks 

The Company has exposure to a number of operational, 
compliance and strategic risks. The management of these 
risks forms a substantial part of the focus of the RMS and RMF. 
Key elements of the RMF include: 

• 

 Formal internal Risk and Compliance functions within the 

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Advice and Matrix Planning Solutions are also required to 
maintain minimum regulatory capital as required by ASIC. 

• 

 ClearView Life Nominees is required to maintain an 
Operational Risk Financial Requirement (ORFR) as 
determined in accordance with Superannuation Prudential 
Standard 114. SPS 114 requires that the trustee maintains 
adequate financial resources to address losses arising 
from the operational risks that may affect the ClearView 
Retirement Plan. 

Nonetheless, the Group maintains additional capital reserves 
in accordance with its Board adopted ICAAP that retains 
capital reserves to support its retained risk exposures, ensures 
there is a low likelihood that the Group (and its regulated) 
subsidiaries will breach their regulatory requirements, and has 
sufficient capital to manage its near term business plans and 
provide a buffer (capital and time) to take action to deal with 
reasonably foreseeable adverse events that may impact the 
businesses. These additional reserves are partly held within 
the subsidiaries where the key risks reside, and partly in a 
central reserve within the parent entity. 

Continued

5. Risk Management continued

Group; 

• 

• 

• 

• 

• 

• 

• 

 A specific focus area of the Risk and Compliance 
Committee; 

 A risk and control self assessment process undertaken by 
each business unit. 

 Detailed compliance registers, reporting timetables, 
breach and incident reporting and due diligence 
processes; 

 Internal audit, whistleblowing policy and facilities, 
detailed financial reconciliations and unit pricing.  
Checking processes, detail IT development and  
implementation processes; 

 Maintain sound process documentation and monitoring  
of outsource service provider service performance  
and standards; 

 Comprehensive internal management information 
reporting and monitoring, emerging risk exposures 
reporting, staff training programs, staff recruitment 
standards (including fit and proper standards); and 

 Maintaining an appropriate risk culture within the 
business, including Board and Senior Management 
Team focus, and including risk management as a formal 
part of all key business decisions, and appropriate risk 
management supporting remuneration structures. Within 
this content the business operates a Risk Management 
and Compliance Committee and a Risk Management 
Forum with representatives from across the business. 

Capital management and reserving 

In terms of regulatory requirements: 

• 

 ClearView Life is subject to minimum regulatory capital 
requirements, as determined by the Appointed Actuary 
in accordance with APRA Life Insurance Prudential 
Standards, in respect of the principal financial risks 
exposures retained by ClearView Life. 

• 

 ClearView Financial Management, ClearView Financial 

ClearView Annual Report 2015     92

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

6. Capital adequacy

ClearView Life Assurance is subject to minimum capital regulatory capital requirements in accordance with Australian 
Prudential Regulation Authority (APRA) Life Insurance Prudential Standards. ClearView Life is required to maintain adequate 
capital against the risks associated with its business activities and measure its capital to the “Prudential Capital Requirement” 
(PCR). 

ClearView Life has in place an Internal Capital Adequacy Assessment Process (ICAAP), approved by the Directors, to ensure it 
maintains required levels of capital within each of its statutory and general funds. The capital adequacy position at balance 
date for ClearView Life, in accordance with the APRA requirements, is as follows:  

Capital position

Statutory fund

Statutory fund

Statutory fund

No. 1

No. 2

No. 4

Shareholder’s 
Fund

Australian non-
participating

Australian non-
participating

Australian non-
participating

2015 
$’000

6,246

-

6,246

-

(2,950)

2015 
$’000

247,649

(5,260)

242,389

(352)

-

-

(186,033)

3,296

(734)

2,562

4.5

56,004

(5,766)

50,237

9.7

2015 
$’000

3,039

-

3,039

(2)

-

(162)

2,875

(561)

2,314

5.1

2015 
$’000

10,839

(4,694)

6,145

(66)

-

-

6,079

(2,939)

3,140

2.1

Net Assets (Common Equity Tier 1 Capital)

Goodwill and intangibles

Net tangible assets

Capital base adjustments

Deferred tax assets

Investment in subsidiaries

Policy liability

Regulatory capital base

Prescribed Capital Amount (PCA)

Available Enterprise Capital (AEC)

Capital Adequacy Multiple

Prescribed capital amount comprises:

Insurance Risk

Asset Risk

                        -   

(1,895)

                        -   

                        -   

(20)

(852)

(399)

(172)

Asset Concentration Risk

                        -   

                        -   

                        -   

                        -   

ClearView Life 
Assurance 
Limited

2015 
$’000

267,772

(9,954)

257,818

(420)

(2,950)

(186,195)

68,253

(10,000)

58,253

6.8

(1,895)

(1,444)

-

Operational Risk

Aggregation benefit

LPS110 CLAL Minimum

Prescribed Capital Amount

                        -   

(3,538)

(162)

(2,767)

(6,466)

                        -   

519                         -   

                        -   

(714)

                        -   

                        -   

                        -   

519

(714)

(734)

(5,766)

(561)

(2,939)

(10,000)

93     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

6. Capital adequacy continued

Statutory fund

Statutory fund

Statutory fund

No. 1

No. 2

No. 4

Shareholder’s 
Fund

Australian non-
participating

Australian non-
participating

Australian non-
participating

Net Assets (Common Equity Tier 1 Capital)

Goodwill and intangibles

Net tangible assets

Capital base adjustments

Deferred tax assets

Investment in subsidiaries

Policy liability

Regulatory capital base

Prescribed Capital Amount (PCA)

Available Enterprise Capital (AEC)

Capital Adequacy Multiple

Prescribed capital amount comprises:

Insurance Risk

Asset Risk

Asset Concentration Risk

Operational Risk

Aggregation benefit

LPS110 CLAL Minimum

Prescribed Capital Amount

2014 
$’000

4,649

 -   

4,649

 -   

(1,450)

2014 
$’000

201,713

(5,480)

196,233

(382)

 -   

 -   

(146,767)

3,199

(2,363)

836

1.4

 -   

(77)

 -   

 -   

 -   

(2,286)

(2,363)

49,084

(4,088)

44,996

12.0

(1,247)

(576)

 -   

(2,614)

349

 -   

2014 
$’000

2,455

 -   

2,455

(2)

 -   

(84)

2,369

(626)

1,743

3.8

 -   

(440)

 -   

(186)

 -   

 -   

2014 
$’000

9,848

(1,241)

8,607

(59)

 -   

 -   

8,548

(2,923)

5,625

2.9

 -   

(267)

 -   

(2,656)

 -   

 -   

ClearView Life 
Assurance 
Limited

2014 
$’000

218,665

(6,721)

211,944

(443)

(1,450)

(146,851)

63,200

(10,000)

53,200

6.3

(1,247)

(1,360)

 -   

(5,456)

349

(2,286)

(10,000)

(4,088)

(626)

(2,923)

ClearView Annual Report 2015     94

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

7. Segment information
AASB 8 requires operating segments to be identified on the 
basis of internal reports about components of the Group that 
are regularly reviewed by the chief operating decision maker 
in order to allocate resources to the segment and to assess its 
performance. 

The information reported to the Group’s Board of Directors, 
being the chief operating decision maker, for the purpose 
of resource allocation and assessment of performance is 
focused on the products and services of each reporting 
segment. 

The principal activities and the Group’s reportable segments 
under AASB 8 are as follows: 

•  Life Insurance; 

•  Wealth Management; 

• 

Financial Advice; and 

•  Listed Entity/Other. 

(a) Life Insurance (“protection” products) 

ClearView provides life insurance protection products through 
its wholly owned subsidiary ClearView Life. The products 
provided by ClearView Life include: 

• 

• 

 A comprehensive range of life protection products 
distributed via both CFA and Matrix financial advisers and 
third party, external advisers (IFAs). The product suite, 
LifeSolutions, was launched in December 2011 and is a 
high quality advice based product suite, providing top 
quartile benefits and terms at market competitive prices. 
LifeSolutions includes term life, permanent disability, 
trauma and critical illness benefits, parent cover, child 
cover, accident covers, income protection and business 
expense covers. Policies can be issued directly or via the 
ClearView Retirement Plan as superannuation; 

 A range of Non-Advice life protection products sold 
through direct marketing, telemarketing, call centre 
referrals, or online. Products include term life, accidental 
death, injury covers, trauma and critical illness and funeral 
insurance. 

(b) Wealth Management (“investment” products) 

ClearView provides wealth management products via four 
primary avenues:

• 

 Master Trust - Life investment contracts issued by 
ClearView Life. Products include ordinary savings, 
superannuation and allocated pension products, with the 
latter two provided via the ClearView Retirement Plan;

95     ClearView Annual Report 2015

• 

• 

• 

 WealthSolutions - A superannuation and retirement 
income wrap (issued via the ClearView Retirement Plan) 
and an Investor Directed Portfolio Service (IDPS) Wrap 
(provided by CFML). This is offered via the WealthSolutions 
platform which was launched in December 2011. 
WealthSolutions includes a menu of approximately 
250 investment funds, ASX listed shares, term deposits 
and seven ClearView managed funds. It also provides a 
number of model portfolios managed by ClearView for 
superannuation investors;

 WealthFoundations - Life investment contracts issued 
by ClearView Life. Products include superannuation and 
allocated pension products, issued via the ClearView 
Retirement Plan. This is offered via the WealthFoundations 
platform which was launched in October 2014.  
WealthFoundations includes a menu of 16 investment 
options with transparent investment in underlying funds; 
and

 Managed Investment Schemes (MIS) - Products are 
issued via ClearView Financial Management Limited 
(CFML) as the ASIC licensed Responsible Entity and include 
MIS products available on ClearView’s WealthSolutions 
platform.

(c) Financial Advice 

ClearView provides financial advice services through its wholly 
owned subsidiaries ClearView Financial Advice (CFA) and 
Matrix Planning Solutions (MPS). CFA has historically employed 
a number of salaried financial advisers. CFA and MPS provide 
dealer group services to a number of self employed financial 
advisers.

(d) Listed Entity/Other 

This represents the investment earnings on the cash and 
investments held in the listed and central services entities 
and in the shareholders fund of ClearView Life, less the costs 
associated with maintaining a listed entity and interest 
expense on corporate debt. The Group manages capital at the 
listed entity level in accordance with its ICAAP policy. 

Asset segment information has not been disclosed because 
the allocation of assets is not used for evaluating segment 
performance and deciding the allocation of resources to 
segments. 

Asset segment information is critical to the performance of 
each company and their respective regulatory obligations and 
is managed at a company level. 

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

7. Segment information continued

Information regarding these segments is provided on the following page. Segment profit or loss represents the profit or loss 
earned by each segment including the allocation of directly attributable costs of each segment and an allocation of central 
services costs according to an expense allocation model which allocates costs across each segment. The allocation model 
excludes the allocation of investment revenue as these are directly recorded against the relevant segments. This is the 
measure reported to the Board for the purposes of resource allocation and assessment of segment performance. 

The accounting policies of the reportable segments are the same as the Company’s accounting policies described in Note 3.

Segment revenue

Life Insurance

Wealth Management

Financial Advice

Listed entity/Other

External Revenue

Inter-Segment

2015 
$’000

2014  
$’000

2015 
$’000

2014 
$’000

2015 
$’000

89,802

98,521

64,050

1,267

68,744

91,717

28,733

1,107

 -   

2,776

19,679

 -   

 -   

89,802

 1,778 

101,297

17,174

 -   

83,729

1,267

Total

2014  
$’000

68,744

93,494

45,907

1,107

Consolidated segment revenue

253,640

190,301

22,455

18,952

276,095

209,252

2015

Total operating earnings after tax

Interest expense on corporate debt  
(after tax)

Underlying net profit/(loss) after tax

Amortisation of acquired intangibles

AIFRS policy liability discount rate effect

Matrix deal and integration costs

Income tax effect

Reported profit/(loss)

2014

Underlying net profit/(loss) after tax

Amortisation of acquired intangibles

AIFRS policy liability discount rate effect

Income tax effect

Reported profit/(loss)

Life 
Insurance

Wealth 
Management

Financial 
Advice

Listed Entity/
Other

15,278

 -  

15,278

(2,833)

4,162

 -   

(1,248)

15,359

10,845

(1,417)

2,202

(661)

10,969

1,801

 -  

1,801

(5,256)

 -   

 -   

 -  

(3,455)

5,873

(5,256)

 -   

 -   

617

4,398

 -  

4,398

(914)

 -   

(434)

130

3,180

3,466

(796)

 -   

70

(610)

(334)

(944)

 -   

 -   

(1,824)

 256

(2,512)

(446)

 -   

 -   

 -   

2,740

(446)

Total

20,867

(334)

20,533

(9,003)

4,162

(2,258)

(862)

12,572

19,738

(7,469)

2,202

(591)

13,880

The policy liability discount rates effect is the result of the changes in long term discount rates used to determine the insurance policy liabilities. The life insurance 
policy liability (based on AIFRS) is discounted using market discount rates that typically vary at each reporting date and create volatility in the policy liabilities and 
consequently earnings.  ClearView separately reports this volatility which represents a timing difference in the release of profit and has no impact on underlying 
earnings. This movement in policy liability creates a cash flow tax effect. 

ClearView Annual Report 2015     96

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

8. Fee and other revenue

Financial advice fees

Funds management fees

Other income

Total fee and other revenue

9. Investment income

Interest income

Dividend income

Distribution income

Total investment income

10.  Operating expenses

Administration expenses

Administration and other operational costs

Custody and investment management expenses

Total administration expenses

Employee costs and directors' fees

Employee expenses

Share based payments

Employee termination payments

Directors’ fees

Total employee costs and directors’ fees

Other expenses

Interest expense

Total other expenses

Total operating expenses

Depreciation and amortisation expenses

Depreciation expenses

Software amortisation

Amortisation of Acquired Intangibles

Total amortisation and depreciation expenses

97     ClearView Annual Report 2015

Consolidated

2015 
$’000

63,658

31,249

106

2014 
$’000

28,514

30,445

139

95,013

59,098

Company

2014 
$’000

2015 
$’000

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

Consolidated

Company

2015 
$’000

36,169

14,941

20,713

71,823

2014 
$’000

34,159

14,702

15,901

64,762

2015 
$’000

899

13,500

 -   

2014 
$’000

687

 -   

 -   

14,399

687

Consolidated

2015 
$’000

2014 
$’000

26,923

7,217

34,140

20,160

6,115

26,275

44,102

32,514

896

590

1,050

46,638

477

477

905

152

884

34,455

 2 

2

Company

2014 
$’000

341

 -   

341

20

 -   

 -   

784

804

 -   

-

2015 
$’000

1,290

 -   

1,290

423

 -   

 -   

833

1,256

477

477

81,255

60,732

3,023

1,145

 653 

 3,190 

 9,004 

 475 

 2,880 

 7,468 

12,847

10,823

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

10.  Operating expenses continued

Remuneration of auditors

Auditor of the parent entity

Audit and review of financial reports

Audit of APRA and ASIC regulatory returns

Audit of Managed Investment Schemes

Total remuneration for audit services

Preparation and lodgement of tax returns

Other non-audit services - taxation advice

Other non-audit services - compliance

Other non-audit services - consulting

Total remuneration for non-audit services

Total remuneration

11.  Income tax

a) Income tax recognised in profit or loss

Income Tax (benefit)/expense comprises:

Current tax expense

Deferred tax expense

Over provided in prior years – Current tax expense

Under provided in prior years – Deferred tax expense

Income tax expense/(benefit)

Deferred income tax expense/(benefit) included in income tax 
expense comprises:

(Increase)/decrease in deferred tax asset

Increase in deferred tax liability

b) Tax losses

Unused tax losses for which no deferred tax asset has been 
recognised

Consolidated

2015 
$

2014 
$

2015 
$

Company

2014 
$

 293,700   

265,700

100,000

95,000

98,700

107,600

86,100

98,200

 -   

 -   

 -   

 -   

500,000

450,000

 100,000   

95,000

 97,000   

 32,500   

103,500

 -   

 -   

 20,000 

 160,000   

 130,000 

289,500

253,500

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 789,500   

703,500

 100,000   

95,000

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

12,021

(682)

(83)

(40)

11,216

(761)

38

(723)

8,961

(144)

(1,178)

(36)

7,603

(258)

78

(180)

(639)

157

 -   

 -   

(391)

253

 -   

 -   

(482)

(138)

157

 -   

157

253

 -   

253

88,291

104,156

32,635

32,635

Potential tax benefit

15,372

16,959

9,790

9,790

ClearView Annual Report 2015     98

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

11.  Income Tax continued

The prima facie income tax expense/(benefit) on pre-tax accounting profit from operations reconciles to the income tax 
expense in the financial statements as follows: 

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

c) Reconiliation of income tax expense to prima facie tax payable

Profit before income tax expense

Policyholder tax (expense) credit recognised as part of the change in 
policyholder liabilities in determining profit before tax

Profit before income tax excluding tax charged to policyholders

Prima facie tax calculated at 30%

Tax effect of amounts which are non deductible/assessable in 
calculating taxable income:

Shareholder impact of life insurance tax treatment

Franking credits on dividends received

Non-deductible transaction costs

Non assessable income

Non deductible expenses

Non-deductible amortisation expenses

Other

Income tax expense/(benefit) attributable to shareholders

Income tax expense/(benefit) attributable to policyholders

Income tax expense/(benefit)

23,789

(1,600)

22,189

6,656

(22)

 -   

156

(199)

408

2,701

(84)

9,616

1,600

11,217

21,484

1,481

22,966

6,890

11,376

 -   

11,376

3,413

(458)

 -   

(458)

(138)

 -   

 -   

 -   

 -   

 -   

 -   

 -   

(2)

 -   

 -   

 -   

(4,051)

156

 -   

 -   

 -   

 -   

(295)

320

2,170

-

9,083

(1,481)

7,603

(482)

(138)

 -   

 -   

(482)

(138)

The ability of the Company to continue to pay franked dividends is dependent upon the receipt of franked dividends from its 
investment assets and the group itself paying tax.   

Franking account

The balance of the franking account after allowing for tax payable in 
respect of the current year’s profit, the receipt of franked dividends 
recognised as receivables and the payment of any dividends 
recognised as a liability at the reporting date.

Relevance of tax consolidation to the Group 

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

16,065

10,562

16,065

10,562

ClearView Wealth Limited and its wholly-owned Australian resident entities have formed a tax consolidated group with 
effect from 1 February 2007 and are therefore taxed as a single entity from that date. The members in the ClearView tax 
consolidated group are identified in Note 33. 

Under the Tax Act, ClearView Wealth Limited being the head company of the tax consolidated group is treated as a life 
insurance company for income tax purposes as one of the subsidiary members of the tax consolidated group is a life insurance 
company. 

99     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

11.  Income tax continued

Entities within the tax consolidated group have entered into a tax sharing and funding agreement with the head entity. This 
agreement has been amended to reflect the changes in the structure of the tax consolidated group and a life insurer becoming 
part of the group. These amendments were executed on 20 August 2010. 

Under the terms of the tax funding arrangement, ClearView Wealth Limited and each of the entities in the tax consolidated 
group has agreed to pay a tax equivalent payment to or from the head entity, based on the current tax liability or current tax 
asset of the entity. 

The tax funding agreement also provides for the head entity to make payments for tax losses of a group member that is 
determined in accordance with the provisions of the agreement. Settlement for these amounts is based on the extent to which 
the losses are utilised. 

The tax sharing arrangement between members of the tax consolidated group provides for the determination of the allocation 
of income tax liabilities between the entities should the head entity default on its tax payment obligations or if an entity should 
leave the tax-consolidated group. The effect of the tax sharing agreement is that each member’s liability for tax payable by the 
tax consolidated group is limited to the amount payable to the head entity under the tax funding arrangement.

On 10 October 2014, Matrix Planning Solutions Limited and Matrix Planning Investments Pty Limited joined the ClearView 
Wealth Limited tax consolidated Group. Both entities have also adhered to the ClearView Wealth Limited Tax Sharing and 
Funding Agreement on the same day. 

12.  Movements in reserves

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

Retained losses

Balance at the beginning of the financial year

(25,254)

(30,977)

(52,672)

(52,352)

Net profit/(loss) attributable to members of the parent entity

Dividend paid during the year

Balance at the end of the financial year

Executive share plan reserve

12,572

(10,977)

13,880

(8,157)

-

-

(320)

 -   

(23,659)

(25,254)

(52,672)

(52,672)

Balance at the beginning of the financial year

5,315

4,127

5,315

4,127

Recognition of share based payments

ESP loans settled through dividend

ESP shares vested

Balance at end of the financial year

Profit Reserve

Balance at the beginning of the financial year

Net profit attributable to the parent entity

Dividend paid during the year

Balance at end of the financial year

General Reserve

Balance at the beginning of the financial year

Retained earnings reserve on Aquisition of Matrix

Balance at end of the financial year

896

550

(154)

6,607

905

403

(120)

5,315

896

550

(154)

6,607

905

403

(120)

5,315

 -   

 -   

 -   

 -   

 -   

(2,085)

(2,085)

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 13,871 

 11,858 

22,028

 -   

(10,977)

(8,157)

 14,749 

 13,871 

 -   

(2,085)

(2,085)

 -   

 -   

 -   

ClearView Annual Report 2015     100

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

13.  Sources of profit

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

Components of profit related to movements in life insurance 
liabilities

Planned profit margins released

Profit arising from difference between actual investment income 
and expected interest on policy liabilities

Profit arrising from the difference between actual and expected 
experience

Impact of IFRS change in economic assumptions

Life insurance

Components of profit related to movements in life investment 
liabilities

Expected profit margin

Life investment

Profit for the statutory funds

Profit for the shareholders fund

13,741

4,786

10,669

3,963

(4,628)

(5,017)

4,293

18,192

2,772

12,387

819

819

19,011

 97 

6,291

 6,291 

18,678

122

Profit for ClearView Life Assurance Limited

19,108

18,800

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

101     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

14.  Earnings per share

Earnings per share

Basic earnings (cents)

Diluted earnings (cents)

Basic earnings per share

Consolidated

2015

2014

2.43

2.36

3.13

3.10

The earnings and weighted average number of ordinary shares used in the calculation of basic earnings per share are as 
follows:

Profit for the year attributable to owners of the Company ($'000)

Earnings used in the calculation of basic earnings per share ($'000)

12,572

12,572

13,880

13,880

Weighted average number of ordinary shares for the purpose of basic earnings per share ('000's)

517,261

442,878

Diluted earnings per share

The earnings used in the calculation of diluted earnings per share are as follows:

Profit for the year attributable to owners of the Company ($'000)

Interest on ESP loans after tax ($'000)

Earnings used in the calculation of total diluted earnings per share

12,572

13,880

 -   

 -   

12,572

13,880

The weighted average number of ordinary shares for the purposes of diluted earnings per share reconciles to the weighted 
average number of ordinary shares used in the calculation of basic earnings per share as follows: 

Weighted average number of ordinary shares used in the calculation of basic earnings per  
share (000's)

Shares deemed to be dilutive in respect of the employee share plan (000's)

Weighted average number of ordinary shares used in the calculation of diluted earnings per 
share (all measures) (000's)

517,261

442,878

15,693

5,088

532,954

447,966

15.  Cash and cash equivalents

Cash at bank

Total cash and cash equivalents

Consolidated

Company

2015 
$’000

2014 
$’000

200,769

183,299

200,769

183,299

2015 
$’000

34,447

34,447

2014 
$’000

1,111

1,111

ClearView Annual Report 2015     102

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

16.  Investments

Equity securities

Investment in Group Companies

Held directly

Held indirectly via unit trust

Debt securities/fixed interest securities

Held directly

Held indirectly via unit trust

Property/Infrastructure

Held directly

Held indirectly via unit trust

Total investments

17.  Receivables

Trade receivables

Outstanding life insurance premium receivable

Provision for outstanding life insurance premiums

Accrued dividends

Investment income receivable

Outstanding settlements

Prepayments

Receivables from controlled entities

Other debtors

Loans receivable

Total receivables

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

 -   

 -   

 318,159 

 257,892 

 222,891 

 233,817 

315,081

 266,685 

 -   

 -   

 -   

 -   

537,972

500,502

 318,159 

257,892

661,976

609,402

29,213

32,008

691,189

641,410

 -   

 -   

221,090

194,857

221,090

194,857

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

1,450,251

1,336,769

 318,159 

257,892

Consolidated

2015 
$’000

 984 

 2,935 

(683)

 1,883 

 886 

 2,671 

 2,874 

 -   

 831 

 3,135 

2014 
$’000

 436 

 2,140 

(656)

 1,851 

 1,014 

 3,057 

 2,294 

 -   

 891 

849

Company

2014 
$’000

2015 
$’000

 -   

 -   

 -   

 -   

 -   

 -   

 131 

 -   

 -   

 -   

 -   

 -   

 -   

 7 

 9,753 

 16,346 

 -   

 -   

 -   

 -   

15,516

11,876

9,884

16,353

$2.0 million (2014: $0.4 million) of Total consolidated receivables are expected to be recovered more than 12 months from the 
reporting date and nil (2014: nil) of Total receivables for the Company are expected to be recovered more than 12 months from 
the reporting date.

103     ClearView Annual Report 2015

ClearView Wealth Limited   
   
   
   
Notes to the Financial Statements
For the year ended 30 June 2015

Continued

18.  Fixed interest deposits

Fixed interest bank term deposits

Consolidated

2015 
$’000

2014 
$’000

 107,035 

88,759

Company

2014 
$’000

25,179

2015 
$’000

 8,115 

Fixed interest term deposits, held at year end, yield an average fixed interest rate of 3.11% (2014: 3.55%)

19.  Goodwill

Gross carrying amount

Balance at the beginning of the financial year

Additional amount recognised through acquisition of business1

Balance at the end of the financial year

Net book value

Balance at the beginning of the financial year

Balance at the end of the financial year

Consolidated

2015 
$’000

4,858

15,094

19,952

4,858

19,952

2014 
$’000

4,858

 -   

4,858

4,858

4,858

Company

2014 
$’000

2015 
$’000

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

1 

 On 10 October 2014 the company acquired Matrix Holding Limited. $15.1 million of goodwill was recognised on the acquisition. Further details have been 
provided in Note 4.

As required under accounting standards at each reporting date the Company assesses whether there is an indication of 
impairment. Further details have been provided in Note 4. 

ClearView Annual Report 2015     104

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

20.  Intangible assets

Capitalised 
software 
$’000

CWT 
software 
$’000

Client  
book 
$’000

Matrix 
Website 
$’000

Matrix 
Brand 
$’000

Total 
$’000

Consolidated

Balance at the beginning of the year

 4,957 

1,500

28,467

2015

Gross carrying amount

Balance at the beginning of the financial 
year

Acquired directly during the year

Balance at the end of the financial year

Accumulated amortisation and 
impairment losses

Amortisation expense in the current 
year

Balance at the end of the financial year

Net book value

Balance at the beginning of the financial 
year

Balance at the end of the financial year

2014

Gross carrying amount

Balance at the beginning of the financial 
year

Acquired directly during the year

Balance at the end of the financial year

Accumulated amortisation and 
impairment losses

 11,727 

 1,500 

 58,596 

6,375

18,102

 -   

1,500

 4,721 

63,317

3,190

8,147

6,770

9,955

-

1,500

8,994

37,461

 -   

 -   

30,129

25,856

 7,024 

4,703

11,727

1,500

58,596

 -   

 -   

1,500

58,596

Balance at the beginning of the year

 2,077 

1,268

21,231

Amortisation expense in the current 
year

Balance at the end of the financial year

Net book value

Balance at the beginning of the financial 
year

Balance at the end of the financial year

 2,880 

 4,957 

232

1,500

7,236

28,467

 4,947 

 6,770 

232

 -   

37,365

30,129

 -   

 20 

20

 -   

 10 

10

 -   

10

 -   

 200 

200

 -   

 -   

-

71,823

11,316

83,139

34,924

12,194

47,118

 -   

200

36,899

36,021

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

67,120

4,703

71,823

24,576

10,348

34,924

42,544

36,899

$’000

$’000

$’000

$’000

$’000

$’000

As part of the purchase of Matrix during the period, a number of additional intangible assets were purchased. This included an 
additional client book, and the Matrix brand and website. As the brand has an indefinite life, this will not be amortised, however 
will be assessed for impairment at each reporting date. For further details on the acquisition of Matrix, refer to Note 34.

The intangible assets are amortised over their expected useful lives. As required under accounting standards at each reporting 
date the Company assesses whether there is an indication of impairment. Further details have been provided in Note 4.  

105     ClearView Annual Report 2015

ClearView Wealth Limited 
 
 
Notes to the Financial Statements
For the year ended 30 June 2015

Continued

21.  Property, plant and equipment

2015

Gross carrying amount

Balance at the beginning of the financial 
year

Acquired on acquisition of subsidiary

Additions

Balance at the end of the financial year

Accumulated depreciation/
amortisation and impairment

Balance at the beginning of the financial 
year

Acquired on aquisition of subsidiary

Depreciation expense

Balance at the end of the financial year

Net book value

Balance at the end of the financial year

2014

Gross carrying amount

Balance at the beginning of the financial 
year

Additions

Written off

Balance at the end of the financial year

Accumulated depreciation/
amortisation and impairment

Balance at the beginning of the financial 
year

Depreciation expense

Balance at the end of the financial year

Net book value

Balance at the end of the financial year

No property, plant and equipment is held in the Company.

Office 
furniture

Office 
equipment

Computer 
hardware

Leasehold 
improvements

$’000

$’000

$’000

$’000

Consolidated

Total

$’000

502

 -   

5

507

274

 -   

91

365

142

28

-

14

42

22

2

4

28

14

1,026

2,160

3,716

-

263

1,289

669

 -   

193

862

427

10

172

2,342

10

454

4,180

1,404

2,369

 -   

365

1,769

2

653

3,024

573

1,156

$’000

$’000

$’000

$’000

$’000

474

28

 -   

502

182

92

274

228

23

 5 

 -   

28

21

1

22

6

676

351

(1) 

1,026

569

100

669

357

1,974

186

 -   

2,160

1,122

282

1,404

3,147

570

(1)

3,716

1,894

475

2,369

756

1,347

ClearView Annual Report 2015     106

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

22.  Payables

Trade payables

Reinsurance premium payable

Employee entitlements

Life insurance premiums in advance

Life investment premium deposits

Lease incentive in advance

Outstanding investment settlements

Amounts in controlled entities

Other creditors

Total payables

Consolidated

2015 
$’000

7,180

5,142

6,162

613

701

943

3,834

 -   

199

2014 
$’000

4,700

3,749

4,902

641

2,544

1,135

7,233

 -   

165

24,774

25,069

Company

2014 
$’000

67

 -   

18

 -   

 -   

 -   

 -   

264

 -   

349

2015 
$’000

295

 -   

12

 -   

 -   

 -   

 -   

-

 50 

357

$0.5 million (2014: $0.9 million) of Total consolidated payables are expected to be settled more than 12 months from the 
reporting date and nil (2014: nil) of total payables of the Company are expected to be settled more than 12 months from the 
reporting date.

107     ClearView Annual Report 2015

ClearView Wealth LimitedConsolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

Notes to the Financial Statements
For the year ended 30 June 2015

Continued

23.  Provisions

Current and non current

Make good provision

Provision for restructuring

Employee leave provisions

Other provisions

Total

Make good provision 1

Balance at the beginning of the financial year

Provision acquired in a business combination

Additional provisions raised

Utilised during the period

Non-utilised provisions transferred

Balance at the end of the financial year

Provision for restructuring 2

Balance at the beginning of the financial year 

Additional provisions raised 

Utilised during the period 

Balance at the end of the financial year 

Employee leave provision 3

432

122

3,392

1,429

5,375

316

21

438

(343)

-

432

 155 

 50 

(83)

122

316

155

2,772

345

3,588

310

 -   

 119 

(16)

(97)

413

 768 

 -   

(613)

 155 

Balance at the beginning of the financial year 

 2,772 

2,303

Provision acquired in a business combination

Additional provisions raised 

Utilised during the period 

Balance at the end of the financial year 

Other provisions 4

Balance at the beginning of the financial year

Provision acquired in a business combination

Additional provisions raised

Unutilised provisions reversed during the period

Unutilised provisions transferred during the period 

Balance at the end of the financial year

50

2,052

(1,482)

3,392

345

82

1,336

 -   

(334)

1,429

 -   

804

(335)

2,772

93

 -   

232

20

 -   

345

1 

2 
3 

4 

 The provision for make good represents the accrued liability for expected costs in relation to the restoration of leased premises on the termination of the lease. 
The provisions are expected to be settled on vacating the leased premises on expiration of the relevant lease.
 The provision for restructuring relates to the expected cost of rebranding the financial advice business.
 The provision for employee leave represents annual leave and long service leave entitlements accrued by employees. The provisions are expected to be utilised 
in accordance with the pattern of consumption of employees utilising their leave entitlements.
 Other provisions relate to provision for future project work that has been commissioned and for which the work is yet to commence. This relates predominantly 
to the migration of the old Wealth Management portfolio to the new weath platform.

ClearView Annual Report 2015     108

 -   

 -   

 -   

 26 

 26 

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

19

 -   

7

 -   

 -   

26

 -   

 -   

 -   

19

19

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

64

 -   

(45)

 -   

 -   

19

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

24.  Deferred tax balances

Deferred tax

Deferred tax assets

Deferred tax liabilities

Deferred tax assets

Amounts recognised in profit or loss

Accruals not currently deductible

Depreciable and amortisable assets

Provisions not currently deductible

Unrealised losses carried forward

Capital business expense

Rental lease incentives

Other

Deferred tax asset

Deferred tax liabilities

Amounts recognised in profit or loss

Unrealised gains on investments

Prepaid expenses

Deferred tax liability

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

11,029

1,271

10,194

1,225

682

 -   

840

 -   

418

318

3,248

6,206

586

253

-

597

202

2,258

6,119

858

160

 -   

11,029

10,194

 823 

 448 

877

348

1,271

1,225

35

 -   

 -   

 -   

 570 

 -   

 77 

682

 -   

 -   

 -   

15

 -   

 -   

 -   

825

 -   

 -   

840

 -   

 -   

 -   

109     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

24.  Deferred tax balances continued

2015

Gross deferred tax liabilities

Gross deferred tax assets

Total

2014

Gross deferred tax liabilities

Gross deferred tax assets

Total

2015

Gross deferred tax liabilities

Gross deferred tax assets

Total

2014

Gross deferred tax liabilities

Gross deferred tax assets

Total

Consolidated

Opening 
balance 
$’000

Transfers 
from  
subsidiaries 
$’000

(Charge)/
Credit to 
income 
$’000

(1,225)

10,194

8,969

$’000

(1,147)

9,937

8,790

 (8)   

 74   

66

(38)

761

723

$’000

$’000

 -   

 -   

 -   

(78)

257

179

Closing 
balance 
$’000

(1,271)

11,029

9,758

$’000

(1,225)

10,194

8,969

Company

$’000

$’000

$’000

$’000

 -   

840

840

 -   

 -   

 -   

$’000

$’000

 -   

1,093

1,093

 -   

 -   

0

 -   

(158)

(158)

$’000

 -   

(253)

(253)

 -   

682

682

$’000

 -   

840

(840)

Deferred income tax assets are recognised for tax losses carried forward to the extent that the realisation of the related tax 
benefit through future taxable profits is probable. Unused tax losses for which no deferred tax assets have been recognised are 
attributable to tax losses of a capital nature of $88.2 million (tax effected $15.4 million) consolidated and $32.6 million (tax 
effected $9.8 million) for the Company. Refer to Note 11 for further details. 

25.  Convertible note

Convertible note

Convertible note

Consolidated

Company

2015 
$’000

1,711

1,711

2014 
$’000

 301 

 301 

2015 
$’000

1,711

1,711

2014 
$’000

 301 

 301 

The Company has entered into a Convertible Note (CN) agreement with Your Insure Pty Limited (Your Insure) to provide funding 
by way of a convertible note up to an amount of $3.3 million. The funding is provided on a draw down basis based on the 
achievement of pre determined milestones. The CN allows for the Company to convert into a shareholding of 50% in Your 
Insure at the discretion of the Company, but not before the business of Your Insure becomes self funding for a period of 6 
months. The CN has an expiry date of 30 June 2019. 

The CN is accounted for as a debt instrument with an embedded equity derivative. As the business of Your Insure has recently 
commenced (start up operation) no value has been attributed to the embedded equity derivative as the equity value of the 
business does not exceed the face value of the debt instrument. 

Refer Note 40 for the funding commitment profile and for further details. 

ClearView Annual Report 2015     110

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

26.  Policy liabilities

(a) Reconciliation of movements in policy liabilities

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

Life investment policy liabilities

Opening gross life investment policy liabilities

Net increase in life investment policy liabilities reflected in the 
income statement

1,122,364

1,175,346

109,198

126,385

Decrease in life investment policy liabilities due to management fee 
reflected in the income statement

(24,207)

(25,154)

Life investment policy contributions recognised in policy liabilities

188,091

67,859

Life investment policy withdrawals recognised in policy liabilities

(234,819)

(222,072)

Closing gross life investment policy liabilities

1,160,627

1,122,364

Life insurance policy liabilities

Opening gross life insurance policy liabilities

Movement in outstanding claims

Decrease in life insurance policy liabilities reflected in the income 
statement

Closing gross life insurance policy liabilities

Total gross policy liabilities

Reinsurers' share of life insurance policy liabilities

Opening balance

Movement in outstanding reinsurance

Decrease/(increase) in reinsurance assets reflected in the income 
statement

Closing balance

Net policy liabilities at balance date

Current

Non-current

(127,278)

(97,734)

11,588

4,684

(40,951)

(34,228)

(156,641)

(127,278)

1,003,986

995,086

3,872

(9,006)

7,367

(1,072)

(5,050)

9,994

2,233

3,872

1,006,219

998,958

1,152,578

1,110,035

(146,359)

(111,076)

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

Included in life investment policy liabilities are contracts for which there is a guarantee that the unit price will not fall. The 
amount of the gross policy liabilities for such contracts is $74.4 million (2014: $87.7 million).  

(b) Components of net life insurance policy liabilities

Future policy benefits

Future expenses and commissions

Less future revenues

Best estimate liability

Present value of future planned profit margins

Net life insurance policy liabilities 

111     ClearView Annual Report 2015

Consolidated

2015 
$’000

184,563

165,342

2014 
$’000

190,442

119,872

(709,743)

(588,548)

(359,838)

(278,234)

205,430

154,827

(154,408)

(123,407)

Company

2014 
$’000

2015 
$’000

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

ClearView Wealth Limited 
 
 
Notes to the Financial Statements
For the year ended 30 June 2015

Continued

26.  Policy liabilities continued

(c) Disclosures on asset restrictions, managed assets and trustee activities 

Restrictions on assets

Investments held in the life statutory funds (Funds) can only be used within the restrictions imposed under the Life Insurance 
Act 1995. The main restrictions are that the assets in a Fund can only be used to meet the liabilities and expenses of that 
Fund, to acquire investments to further the business of the Fund or as a distribution when solvency and capital adequacy 
requirements are met for that Fund. The shareholder can only receive a distribution from a Fund if the capital adequacy 
requirements continue to be met after the distribution. 

27.  Issued capital

Issued and fully paid ordinary shares

Balance at the beginning of the financial year

495,044,922

330,172 411,312,192

277,565

2015

2015

2014

No. of Shares

$’000 No. of Shares

Company

2014

$’000

Dividend Reinvestment Plan

Dividend Reinvestment Plan Costs

Share buy back (inclusive of costs)

Share Placement

Enitlement Offer

Capital raising costs (net of tax)

Subscription for shares by O&B Limited

Shares issued during the year (ESP vested)

Balance at the end of the financial year

Executive share plan

13,724,628

10,977

14,064,082

 8,157 

 -   

 -   

 -   

 -   

 -   

(70)

 -   

 -   

(510,252)

 -    30,769,232

 -    39,192,724

 -   

 -   

 -   

 -   

216,944

 -   

(439)

 20,000 

 25,475 

(586)

 -   

 -   

 -   

308,542

100,000

 250 

 53 

524,610,834

355,970 495,044,922

330,172

Performance based shares issued in relation to Matrix acquisition

15,432,742

 14,588 

Balance at the beginning of the year

49,381,666

 -    41,867,333

Shares granted under employee share plan (Note 29)

Shares forfeited during the year

Shares reallocated during the year

Shares exercised during the year

9,493,682

(104,000)

(300,000)

(100,000)

 -   

-

 -   

 -   

7,731,277

-

 -   

(216,944)

Executive balance at the end of the year

58,371,348

 -    49,381,666

 -   

 -   

-

 -   

 -   

 -   

In accordance with AASB 2, Share-Based Payments the shares issued under the Executive Share Plan are treated as options and 
are accounted for as set out in Note 29. 

The Company does not have a limited amount of authorised capital and issued shares do not have a par value. Fully paid ordinary 
shares carry one vote per share and carry the rights to dividends. 

ClearView Annual Report 2015     112

ClearView Wealth Limited 
 
 
Notes to the Financial Statements
For the year ended 30 June 2015

Continued

28.  Borrowings

Bank loan - secured1

Total borrowings

Current

Non-current

Consolidated

2015 
$’000

45,500

45,500

 -   

45,500

2014 
$’000

 -   

 -   

 -   

 -   

2015 
$’000

45,500

45,500

 -   

45,500

Company

2014 
$’000

 -   

 -   

 -   

 -   

1 

 On the 18 December 2014 the Company entered into a three year $50 million facility agreement with the Commonwealth Bank of Australia. As at the reporting 
date, the Company has drawn down $45.5 million on the facility, with $4.5 million of unused credit facilities available for immediate use. Interest on the loan 
accrues at BBSY plus a margin of 0.7% per annum, and is payable monthly. Furthermore, a line fee of 0.4% per annum is payable on the facility on a quarterly 
basis. The facility is secured by a number of cross guarantees, refer to Note 42 for details.

29.  Share-based payments
ClearView operates the ClearView Executive Share Plan 
(ESP or Plan). In accordance with the provisions of the Plan, 
as approved by shareholders at the 2012 Annual General 
Meeting, the ownership-based compensation scheme allows 
participation in the Plan of: 

• 

• 

 Employee Participants - These participants are key 
managers, members of the Senior Management Team 
and the Managing Director; and 

 Contractor Participants - These participants are financial 
advisers. 

Eligible Employees under the Plan Rules therefore include 
both Employee Participants and Contractor Participants of 
the Company and its related bodies corporate. Non-executive 
Directors are ineligible to participate in the Plan in accordance 
with the Plan Rules. 

Offer and Consideration

Under the ESP, the Board may invite Eligible Employees to 
participate in an offer (Offer) of fully paid ordinary shares 
in ClearView, subject to the terms of conditions of the ESP. 
Each Share is issued at a price to be determined by the 
Board prior to making an Offer and this price is set out in the 
invitation (Invitation) to Eligible Employees. This price may be 
the market price of a Share (as defined in the ESP Rules) on 
the date of the Invitation. Taking into account the liquidity, 
volatility, and the average trading activities of the ClearView 
Shares, the Board determined in February 2013 that it is 
appropriate and reasonable for ClearView to adopt the 
Volume Weighted Average Price (VWAP) over a 90 day period 
to determine the market value of the ClearView Shares for the 
purposes of ESP issues. This has been implemented for all ESP 
Share issues since that date. Prior to this, no ESP Shares were 
issued at a price below 50 cents per share, being the price at 
which the original capital raising was completed in June 2010.

113     ClearView Annual Report 2015

Restrictions on Offer

Shares may not be offered under the ESP to an Eligible 
Employee if that Eligible Employee would hold, after the 
issue of the Shares, an interest in more than 5% of the issued 
Shares of ClearView or be able to control the voting rights of 
more than 5% of the votes that might be cast at a general 
meeting of ClearView. 

As at the date of this Report, the Board has not set a limit 
on the number of Shares that may be issued under the 
Plan. The Board or Board Authorised Delegates approve the 
issue of new ESP shares and monitors the overall quantum 
of ESP shares on issue, relative to the interests of existing 
shareholders and the overall objectives of the business. 

Financial Assistance

The Company may provide financial assistance to an Eligible 
Employee for the purposes of subscribing for Shares under the 
ESP. The financial assistance will be a limited recourse loan 
equal to the purchase value of the Shares and is repayable as 
follows: 

• 

• 

 • 

 For Share issues prior to 14 February 2013 - within 60 
days (or a longer period determined by the Board in its 
discretion) after the 5th anniversary of the grant of the 
financial assistance (unless it is required to be repaid at an 
earlier date owing to the operation of the Rules); or

 For Share issues after 14 February 2013 - within 60 
days (or a longer period determined by the Board in its 
discretion) after all performance and vesting criteria  
have been met; or

 For Shares issues after 1 May 2014, 2 months (or a period 
determined by the Board at it's discretion) immediately 
following the 6th anniversary of the grant of the financial 
assistance.

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

29.  Share-based payments continued

The financial assistance will become immediately repayable 
in the event of certain “disqualifying circumstances” including 
failure to meet performance or vesting conditions, cessation 
of the Employee Participant’s employment in circumstances 
defined in the ESP Rules or termination of the Contractor 
Participant’s contract with a Group Company for the provision 
of services. For Employee Participants, the financial assistance 
is secured over the shares and rights attached to the shares. 

The Board has delegated authority to Mr Swanson and Mr 
Thomson to approve granting an extension to the loan 
term of all ESP participants who remain employees at the 
expiration of their loan term for a period until a Change in 
Control of the Company (as defined in the ESP Rules). 

Until 14 February 2013, the interest rate on the loans was 
the Reserve Bank of Australia cash rate plus a margin of 25 
basis points per annum, compounded semi annually. Interest 
until this date has been capitalised and treated as part of the 
limited recourse principal, except that after tax dividends on 
shares issued under the ESP is applied towards reduction of 
the loan balance. 

In February 2013 the Board decided to remove the interest 
rate on the loans for all Participants (other than the Managing 
Director that required Shareholder approval) given that the 
interest imposed was significantly diluting the efficacy of the 
ESP as an employee retention tool, in particular for those staff 
receiving the earlier grants of ESP shares. On 6 November 
2013, at the 2013 AGM, Shareholders approved the removal 
of interest on the Managing Directors loan, so as to align with 
the interest rate which applies to equivalent loans made to 
other participants in the Plan. 

Holding Lock

The shares granted under the ESP to participants are subject 
to a holding lock restricting the holder from dealing with the 
shares. Where all performance conditions and/or vesting 
conditions (if any) attaching to the Shares issued prior to 14 
February 2013 have been satisfied (or waived) a holding lock 
will cease to have effect if: 

• 

 The Board accepts a disposal request (as defined in the 
ESP Rules) (Disposal Request); or 

•  5 years have passed from the Acquisition Date; or 

 If the Participant: 

• 

• 

 is an Employee Participant, their employment with the 
Group ceases, or 

 is a Contractor Participant, their contractor agreement is 
terminated; or 

•  The ESP is terminated, or 

•  The holding lock period otherwise ceases; 

provided that the Financial Assistance and any interest that 
has been accrued have been repaid. 

For shares issues from 14 February 2014 the Holding Lock 
ceases on vesting or forfeiture of Shares.

The holding lock is imposed through the share registry and in 
accordance with the ASX Listing Rules. Participants will not be 
able to sell their shares on ASX or have an off-market transfer 
registered (and are also otherwise prohibited from dealing in 
the shares) while the holding lock is in place. 

If the participant is a Contractor Participant, following the 
removal of the holding lock over the Shares of the participant, 
the participant may not sell, or otherwise deal with, any such 
Shares without the prior written consent of the Company, 
which consent the Company may give or withhold in its 
absolute discretion and which consent may be given subject 
to conditions. 

Eligible Employees are entitled under the ESP Rules to make 
a Disposal Request provided the performance and vesting 
conditions have been met (or waived). The holding lock 
applicable to their ESP shares will cease to have effect upon 
the Board (in its absolute discretion) accepting the Disposal 
Request. ClearView may dispose of these ESP shares on behalf 
of the participant in one or more of the following ways (at the 
discretion of the Board): 

• 

• 

 Reallocate the Shares to give effect to acquisitions by 
other Eligible Employees under the ESP; 

 Sell to the Company in accordance with buy-back 
provisions of the Corporations Act; or 

•  Offer or sell to buyers on the ASX. 

The amount payable by these Eligible Employees to ClearView 
following such a disposal is the amount outstanding in 
relation to the financial assistance, including accrued interest. 
The Eligible Employees may retain any surplus proceeds. 
There are no Disposal Requests outstanding as at the date of 
this report.

Change of Control

Under the ESP Rules, all performance and vesting conditions 
in relation to Shares held by an Eligible Employee who is an 
Employee Participant are deemed to have been satisfied 
upon a Change of Control unless stated otherwise in the 
participants invitation offer. A Change of Control is defined 
under the ESP Rules as being: 

ClearView Annual Report 2015     114

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

29.  Share-based payments continued

(a) Until 14 February 2013:

Administration of the ESP 

• 

• 

• 

 A person who did not Control the Company at the date of 
issue of the Plan Shares gains Control of the Company (but 
only if the person is not itself Controlled by another person 
who Controlled the Company at the date of issue); or 

 Other circumstances occur which the Board determines 
in its absolute discretion are analogous to a Control 
transaction and justify removal of Performance Conditions 
and/or Vesting Conditions, 

 “Control” is defined as where a person and its related 
bodies corporate holds more than 50% of the Shares in 
ClearView. 

The ESP is administered by the Board. The Board may make 
rules and regulations for its operation that are consistent 
with the rules of the ESP. The Company pays all costs and 
expenses of operating the ESP. Employees are liable for any 
brokerage and tax payable associated with their participation 
in the ESP. 

Termination of the ESP 

The Board may resolve at any time to terminate, suspend or 
reinstate the operation of the ESP for the issue of shares in 
future. 

(b) After 14 February 2013:

•  12 months after a Change of Control; or 

• 

• 

 Circumstances occur which the Board determines in its 
absolute discretion are analogous to a Control transaction 
and justify removal of Performance Conditions and/or 
Vesting Conditions. 

 “Control” is defined as Crescent Capital Partners and its 
Associated Entities no longer holding 20% of the voting 
rights of the Company. 

The above provisions concerning change of control apply 
only to Employee Participants and not Contractor Participants 
under the ESP. 

(c) After 1 July 2015:

• 

 For ESP Shares issued to employee participants after 1 July 
2015, unless stated otherwise in the participants invitation 
offer, all performance and vesting conditions in relation to 
these shares, are not deemed to have been met upon a 
Change of Control. 

115     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015
Continued

29.  Share-based payments continued

Share-based payment arrangements 

The following share-based payment arrangements were in existence during the current and comparative reporting periods:

Series

Issue Date

Type of  
Arrangement9

Number Grant date Expiry date

Series 6 1,2,6,8

30/06/2008 KMP

500,000

30/06/2008

Change in 
Control

Series 7 1,2,6,8

29/09/2009 KMP and SM

3,500,000

29/09/2009

29/09/2014

Series 10 1,3,6,8

25/06/2010 MD

2,000,000

25/06/2010

26/03/2015

Series 11 1,4,6,8

25/06/2010 MD

4,000,000

25/06/2010

26/03/2015

Series 12 1,5,6,8

25/06/2010 MD

4,000,000

25/06/2010

26/03/2015

Series 13 5

25/06/2010 SM

400,000

25/06/2010

1/06/2015

Series 14

Series 15 5

Series 16 5

Series 17 5

Series 18

Series 19

Series 20

Series 21

Series 22

Series 23

1/11/2010 SM

18/08/2011 SM

6/10/2011 SM

1/03/2012 SM

1/03/2012 CP

3/04/2012 CP

3/04/2012 CP

25/05/2012 CP

29/06/2012 CP

6/08/2012 CP

3,000,000

25/10/2010

1/10/2015

3,000,000

1/07/2011

1/07/2016

3,950,000

1/09/2011

1/09/2016

2,150,000

1/03/2012

1/03/2017

2,500,000

10/02/2012

10/02/2017

600,000

15/03/2012

15/03/2017

700,000

3/04/2012

3/04/2017

2,325,000

7/05/2012

7/05/2017

1,000,000

29/06/2012

29/06/2017

4,600,000

6/08/2012

6/08/2017

Series 24 5

22/08/2012 SM

450,000

22/08/2012

22/08/2017

Series 25

21/12/2012 CP

1,300,000

21/12/2012

21/012/2017

Series 26 7

16/04/2013 SM

2,650,000

12/04/2013

Series 27

16/04/2013 SM

150,000

12/04/2013

50% Change 
in Control; 
50% 1 year 
after

1 year post 
Change in 
Control

Series 28

Series 29

Series 30

Series 31

16/04/2013 CP

31/05/2013 CP

27/06/2013 CP

14/10/2013 SM

566,667

12/04/2013

12/04/2018

1,700,000

31/05/2013

31/05/2018

750,666

27/06/2013

27/06/2018

1,175,000

14/10/2013

Series 32

14/10/2013 SM

1,175,000

14/10/2013

Series 33

29/11/2013 SM

75,000

29/11/2013

Series 34

29/11/2013 SM

75,000

29/11/2013

Change in 
Control

1 year post 
Change in 
Control

Change in 
Control

1 year post 
Change in 
Control

Fair value 
at grant 
date (pre 
modifica-
tion1)  
$

Fair value 
at grant 
date (post 
modifica-
tion1)  
$

Issue price 
at grant 
date  
$

0.59

0.49

0.50

0.58

0.65

0.53

0.50

0.50

0.50

0.50

0.50

0.50

0.50

0.50

0.50

0.54

0.55

0.58

0.57

0.57

0.69

0.68

0.64

0.61

0.61

0.61

0.61

0.10

0.07

0.11

0.08

0.06

0.10

0.07

0.10

0.11

0.09

0.12

0.12

0.13

0.13

0.13

0.17

0.16

0.16

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

0.10

0.10

0.11

0.08

0.06

0.15

0.09

0.13

0.13

0.11

0.15

0.16

0.17

0.17

0.16

0.21

0.19

0.20

0.29

0.27

0.22

0.22

0.21

0.17

0.19

0.16

0.19

ClearView Annual Report 2015     116

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

29.  Share-based payments continued

Series

Series 35

Issue Date

Type of  
Arrangement9

Number Grant date Expiry date

31/01/2014 SM

75,000

31/01/2014

Series 36

31/01/2014 SM

75,000

31/01/2014

Change in 
Control

1 year post 
Change in 
Control

Series 37

Series 38

Series 39

Series 40

Series 41

Series 42

Series 43

Series 44

Series 44

Series 45

Series 46

Series 47

Series 47

Series 48

31/01/2014 CP

30/05/2014 SM

30/05/2014 SM

30/05/2014 SM

30/05/2014 CP

9/07/2014 CP

2,453,333

31/01/2014

31/01/2019

737,000

30/05/2014

30/05/2018

737,000

30/05/2014

30/05/2019

737,000

30/05/2014

30/05/2020

1,950,000

30/05/2014

30/05/2019

4,560,760

9/07/2014

08/07/2019

26/11/2014 SM including KMP

181,518

26/11/2014

25/11/2018

26/11/2014 CP

2,413,368

26/11/2014

25/11/2019

26/11/2014 SM including KMP

181,518

26/11/2014

25/11/2019

26/11/2014 SM including KMP

181,518

26/11/2014

25/11/2020

30/03/2015 SM including KMP

141,667

30/03/2015

30/03/2019

30/03/2015 SM including KMP

141,667

30/03/2015

30/03/2020

30/03/2015 CP

1,550,000

30/03/2015

30/03/2020

30/03/2015 SM including KMP

141,666

30/03/2015

30/03/2021

Fair value 
at grant 
date (pre 
modifica-
tion1)  
$

Fair value 
at grant 
date (post 
modifica-
tion1)  
$

Issue price 
at grant 
date  
$

0.65

0.65

0.65

0.75

0.75

0.75

0.75

0.79

1.01

1.01

1.01

1.01

1.00

1.00

1.00

1.00

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

0.18

0.20

0.18

0.17

0.19

0.22

0.19

0.20

0.15

0.18

0.18

0.21

0.22

0.25

0.25

0.28

1 

2 

3 
4 
5 
6 
7 

 On the 14th February 2013, the Board approved a change to the rules of the ESP which changed the interest rate charged on the financial assistance granted 
to the ESP Participants from the RBA official cash rate plus 25 basis points to zero percent. This resulted in changes to the inputs of the option pricing model 
which had an impact on the fair value of the option at the date of the change.
 A Change of Control provision was triggered on 23 October 2009 by GPG increasing its shareholding above 50%. As a result, the vesting conditions for employ-
ees that were issued shares prior to the date of change of control were accelerated. 
Shares vested 1 year from date of commencement of employment on 26 March 2011.
Shares vested 2 years from date of commencement of employment on 26 March 2012.
Change of control provision was triggered on 26 September 2012 by CCP Bidco obtaining a shareholding above 50%.
The Board approved granting an extension of the loan term until such time as there is a change of control in the Company.
 Special condition relating to shares issued to KMP in Series 26: the shares may be sold on change of control with 50% of the funds held for in escrow for a 
period of 12 months.
Vesting conditions have been met up to the date of this report.

8 
9   KMP = Key Management Personnel, SM = Senior Management, MD = Managing Director, CP = Contractor Participant 

Inputs into the model

Grant date share price ($)

Anticipated vesting price ($)

Expected volatility (%)

Anticipated option life (years)

Inputs into the model

Grant date share price ($)

Anticipated vesting price ($)

Expected volatility (%)

Anticipated option life (years)

117     ClearView Annual Report 2015

Series 6

Series 7

Series 10

Series 11

Series 12

 0.59 

 0.58 

 25.26 

 3.00 

 0.49 

 0.55 

 30.24 

 1.75 

 0.50 

 0.54 

 28.78 

 2.75 

 0.58 

 0.63 

 28.78 

 2.75 

 0.65 

 0.71 

 28.78 

 2.75 

Series 13

Series 14

Series 15

Series 16

Series 17

 0.53 

 0.57 

 28.78 

 2.94 

 0.50 

 0.52 

 29.71 

 2.94 

 0.50 

 0.50 

 31.49 

 3.00 

 0.50 

 0.51 

 35.35 

 3.00 

 0.50 

 0.50 

 36.70 

 3.00 

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

29.  Share-based payments continued

Inputs into the model

Grant date share price ($)

Anticipated vesting price ($)

Expected volatility (%)

Anticipated option life (years)

Inputs into the model

Grant date share price ($)

Anticipated vesting price ($)

Expected volatility (%)

Anticipated option life (years)

Inputs into the model

Grant date share price ($)

Anticipated vesting price ($)

Expected volatility (%)

Anticipated option life (years)

Inputs into the model

Grant date share price ($)

Anticipated vesting price ($)

Expected volatility (%)

Anticipated option life (years)

Inputs into the model

Grant date share price ($)

Anticipated vesting price ($)

Expected volatility (%)

Anticipated option life (years)

Inputs into the model

Grant date share price ($)

Anticipated vesting price ($)

Expected volatility (%)

Anticipated option life (years)

Inputs into the model

Grant date share price ($)

Anticipated vesting price ($)

Expected volatility (%)

Anticipated option life (years)

Series 18

Series 19

Series 20

Series 21

Series 22

 0.50 

 0.50 

 37.06 

 4.95 

 0.50 

 0.50 

 36.47 

 4.95 

 0.50 

 0.50 

 36.61 

 5.00 

 0.50 

 0.49 

 36.94 

 4.95 

 0.50 

 0.49 

 37.33 

 5.00 

Series 23

Series 24

Series 25

Series 26

Series 27

 0.54 

 0.53 

 37.85 

 5.00 

 0.55 

 0.54 

 37.99 

 3.00 

 0.58 

 0.58 

 35.21 

 5.00 

 0.57 

 0.57 

 35.92 

 5.99 

 0.57 

 0.57 

 35.92 

 4.99 

Series 28

Series 29

Series 30

Series 31

Series 32

 0.69 

 0.69 

 35.92 

 4.99 

 0.68 

 0.68 

 36.81 

 5.00 

 0.64 

 0.64 

 36.90 

 5.00 

 0.61 

 0.61 

 22.20 

 5.00 

 0.61 

 0.61 

 22.20 

 6.00 

Series 33

Series 34

Series 35

Series 36

Series 37

 0.61 

 0.61 

 22.11 

 5.00 

 0.61 

 0.61 

 22.11 

 6.00 

 0.65 

 0.65 

 22.01 

 5.00 

 0.65 

 0.65 

 22.01 

 6.00 

 0.65 

 0.65 

 22.01 

 5.00 

Series 38

Series 39

Series 40

Series 41

Series 42

 0.75 

 0.75 

 21.12 

 4.00 

 0.75 

 0.75 

 21.12 

 5.00 

 0.75 

 0.75 

 21.12 

 6.00 

 0.75 

 0.75 

 21.12 

 5.00 

0.79

0.79

 16.78 

 5.00 

Series 43

Series 44

Series 45

Series 46

Series 47

 1.01 

1.01

19.79

 5.00 

 1.01 

1.01

19.79

 6.00 

 1.00 

1.00

20.84

 4.00 

 1.00 

1.00

20.84

 5.00 

 1.01 

1.01

19.79

 4.00 

Series 48

 1.00 

1.00

20.84

 6.00 

The shares were priced using a binomial option pricing model with volatility based on the historical volatility of the share price.

ClearView Annual Report 2015     118

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

29.  Share-based payments continued

Balance at the beginning of the financial year

Issued during the financial year

Forfeited during the year

Exercised during the year

Reallocated during the year

2015

Weighted 
average 
exercise 
price

Number of 
shares

0.56

41,867,333

0.90

0.74

0.55

0.55

7,731,277

-

(216,944)

 -   

Number of 
shares 

49,381,666

9,493,682

(104,000)

(100,000)

(300,000)

Balance at the end of the financial year

58,371,348

0.61 49,381,666

2014

Weighted 
average 
exercise 
price

0.54

0.70

-

0.65

 -   

0.56

The above reconciles the outstanding shares granted under the executive share plan at the beginning and end of the  
financial year.

Shares that were granted in the current year 

9,493,682 shares granted issued during the year of which 404,000 were reallocated from other series existing at the  
beginning of the year and 100,000 were exercised during the year. The net shares issued on the ASX were therefore  
8,989,682 ESP shares. 

The following table outlines the vesting conditions and performance conditions of share based payment arrangements in 
existence during the period. 

Series

Vesting conditions 1

Performance 
conditions

Series 18 – 1 March 2012 Issue 

Series 19 – 3 April 2012 Issue 

Series 20– 3 April 2012 Issue 

Series 21– 25 May 2012 Issue 

4 years and 346 days from the date of issue and achievement of 
specific sales target

4 years and 346 days from the date of issue and achievement of 
specific sales target

5 years from the date of issue and achievement of specific sales 
target

4 years and 347 days from the date of issue and achievement of 
specific sales target

No

No

No

No

Series 22– 29 June 2012 Issue 

5 years from the date of issue and achievement of specific sales target

No

Series 23– 6 August 2012 Issue 

5 years from the date of issue and achievement of specific sales target

Series 25– 21 December 2012 Issue  5 years from the date of issue and achievement of specific sales target

Series 28– 16 April 2013 Issue 

4 years and 361 days from the date of issue and achievement of 
specific sales target

Series 29– 31 May 2013 Issue 

5 years from the date of issue and achievement of specific sales target

Series 30– 27 June 2013 Issue 

5 years from the date of issue and achievement of specific sales target

Series 37– 31st January 2014 Issue  5 years from the date of issue and achievement of specific sales target

Series 41– 30th May 2014 Issue 

5 years from the date of issue and achievement of specific sales target

Series 42– 9th July 2014 Issue 

5 years from the date of issue and achievement of specific sales target

Series 44– 26th November 2014 
Issue 

5 years from the date of issue and achievement of specific sales target

No

No

No

No

No

No

No

No

No

Series 47– 30th March 2015 Issue 

5 years from the date of issue and achievement of specific sales target

No

1  

 Subject to qualifying circumstances as outlined in the ESP Plan Rules. 

119     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

The vesting conditions in the ESP stipulate that shares issued in terms of the Plan to employees participants will automatically 
vest with a change of control of the Company. The change of control provisions do not apply to shares issued in terms of the 
plan to contractor participants or shares issued to employee participants subsequent to 1 July 2015.

On 26 September 2012, CCP Bidco’s off-market takeover bid for all the ordinary shares in ClearView became unconditional 
which resulted in accelerating the vesting of the shares in the ESP at that time, including all Series 10 to 24 which had been 
issued to employee participants prior to the change of control. Series 7 was issued prior to 23 October 2009, where the change 
of control provision was triggered upon GPG obtaining control of ClearView. 

Continued Shares that were cancelled during the year 

No shares were cancelled during the year.

The following table shows the shares that were reallocated due to the cessation of the employment of a participant  
of the plan. 

Date

26/11/2014

30/03/2015

30/03/2015

30/03/2015

Number of shares reallocated

Reallocated from

Reallocated to

 300,000 

 34,667 

 34,667 

 34,666 

 404,000 

Series 13 Series 43, 44 and 45

Series 38

Series 39

Series 40

Series 46

Series 46 and 47

Series 48

30.   Shares granted under the executive share plans
In accordance with the provisions of the ESP, as at 30 June 2015, key management, members of the senior management 
team, the managing director and contractor participants have acquired 58,371,348 (2014: 49,381,666) ordinary shares. Shares 
granted under the ESP carry rights to dividends and voting rights. Financial assistance amounting to $36,464,292 (2014: 
28,744,723) was made available to executives, senior employees and contractor participants to fund the acquisition of shares 
under the ESP. For details of the ESP refer to Note 29. 

31.  Dividends

Dividend payments on Ordinary shares

2014 final dividend (2014: 2013 final dividend)

Total dividends on ordinary shares paid to owners of the Company

Dividends not recognised in the consolidated statement of 
financial position

Dividends declared since balance  date

Consolidated and Company

Per share

2015

$’000

Per share

2.0

2.0

 10,977 

 10,977 

 1.8 

 1.8 

2014

$’000

 8,157 

 8,157 

2015 final dividend (2014: 2014 final dividend)

2.1

12,301

2.0

 10,980 

Dividend franking account

Amount of franking credit available for use in subsequent  
financial years

-

 16,065 

-

 10,562 

1  

2  

 The impact on the dividend franking account for the final dividend declared is expected to reduce the franking account by $5.2 million (2014: $4.7 million). 
There are no other income tax consequences for dividends not recognised in the statement of financial position. 
 The total 2015 final dividend declared but not recognised in the statement of financial position is estimated based on the total number of ordinary shares on 
issue as at the date of this report. The actual amount recognised in the consolidated financial statements for the year ending 30 June 2015 will be based on 
the actual number of ordinary shares on issue on the record date. 

The Directors declared that there will be a final fully franked dividend paid for the year ended 30 June 2015 of $12.30 million 
(2014 : $10.98 million). 

ClearView Annual Report 2015     120

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

32.   Reconciliation of net profit for the year to net cash flows from  

operating activities

Consolidated

Company

2014 
$’000

(320)

 -   

 -   

 -   

905

 -   

 -   

(269)

 -   

202

253

259

 -   

1,039

2,069

Net profit/(loss) for the year

Fair value gains on financial assets at fair value through profit and 
loss

Loss on disposal of property, plant and equipment

Amortisation and depreciation

Employee share plan expense

Other non cash items

Interest and dividend received from controlled entity

Reinvested trust distribution income/interest income

Movements in liabilities to non-controlling interest in controlled unit 
trust

Decrease/(increase) in receivables

Decrease/(increase) in deferred tax asset

Increase/(decrease) in payables

Increase/(decrease) in policy liabilities

Increase/(decrease) in current tax liability

2015 
$’000

2014 
$’000

2015 
$’000

12,572

13,880

11,858

 -   

 -   

 -   

896

 -   

(72,818)

(80,442)

 28 

 -   

12,847

10,823

896

 27 

 -   

905

130

 -   

(13,500)

(23,675)

(17,863)

27,968

15,651

(2,119)

(789)

3,077

8,653

(74)

1,695

(179)

1,071

(75,749)

1,039

(620)

 -   

(1,906)

158

(109)

 -   

(74)

Net cash (utilised)/generated by operating activities

(33,407)

(129,039)

(3,297)

121     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

33.   Subsidiaries

Name of Entity

Parent entity

Principal Activity

Parent 
Entity

Country of 
incorporation

2015 
%

2014 
%

Ownership interest

ClearView Wealth Limited (CWL)

Holding Company

-

Australia

Subsidiaries

ClearView Group Holdings Pty Limited  (CGHPL)

Holding Company

CWL

Australia

ClearView Life Assurance Limited (CLAL)

Life Company

CGHPL

Australia

ClearView Financial Management Limited (CFML)

Responsible Entity

CGHPL

Australia

ClearView Life Nominees Pty Limited (CLNPL)

Trustee

ClearView Administration Services Pty Limited  (CASPL)

ClearView Financial Advice Pty Limited (CFAPL)

Matrix Planning Solutions Limited (MPS)

Affiliate Financial Planning Pty Limited

Controlled unit trusts

International Fixed Interest Fund

Fund of Funds Australian Equity Fund

Bond Fund

Fund of Funds International Equity Fund

Property Fund

Money Market Fund

Infrastructure Fund

Emerging Markets Fund

CVW Platinum International Shares Fund

CVW Hyperion Australian Shares Fund

CVW Vanguard Listed International Infrastructure 
Fund

CVW Vanguard Emerging Markets Fund

CVW Plato Australian Shares Fund

CVW MFS International Shares Fund

Administration 
Service Entity

Financial Advice

Financial Advice

Dormant

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

Wholesale Fund

CLAL

CWL

CWL

CWL

CFA

CLAL

CLAL

CLAL

CLAL

CLAL

CLAL

CLAL

CLAL

CLAL

CLAL

CLAL

CLAL

CLAL

CLAL

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

Australia

100

100

100

100

100

100

100

100

95

59

68

93

83

81

69

72

98

84

96

97

79

64

100

100

100

100

100

100

-

100

95

67

73

90

86

84

76

77

-

-

-

-

-

-

ClearView Administration Services Pty Limited was incorporated to centralise the administrative responsibilities of the group 
which include salary disbursements and settling all non-directly attributable overhead expenditure. ClearView Administration 
Services Pty Limited recoups all expenditure by virtue of a management fee from the various group companies and operates on 
a cost recovery basis (in accordance with an inter group agreement). 

ClearView Annual Report 2015     122

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

34. Business Combinations

Acquisition of Matrix Holdings Limited
On 10 October 2014, the Company acquired 100% of the voting shares of Matrix Holdings Limited (Matrix Holdings), a company 
based in Australia specialising in financial advice. Matrix Holdings held two wholly owned subsidiaries, Matrix Planning Solutions 
Limited (MPS or Matrix) and Matrix Planning Investments Pty Ltd (MPI). 

The Company acquired Matrix Holdings, as the dealer group (operated through MPS) will expand the Group’s financial advice 
business. The consolidated financial statements include the results of Matrix for the period from acquisition date on 10th 
October 2014. The Company entered into a pre-acquisition Put Option Deed with O&B Limited (O&B) with the ability to put 
100% of Matrix Holdings shares back to O&B for a nominal amount. Per the Put Option Deed, the Company was required to 
restructure the entities before the option could be exercised (resulting in MPS being directly owned by the Company). The 
entities were restructured and the put option was exercised on the 27th November 2014. As at 30 June 2015, the Company 
owns 100% of MPS and MPI and retains no interest in Matrix Holdings.

Settlement of the acquisition occurred on 10 October 2014, with the issuance of ClearView shares into trust held by Pacific 
Custodians Pty Limited (a subsidiary of Link Market Services Limited) and the cash payment being made to Pacific Custodians 
Pty Limited. The consideration paid was as follows:

Purchase consideration

Cash to acquire shares

Contingent Consideration – ClearView shares

Total purchase consideration

Fair Value of net assets acquired

Goodwill on acquisition

$’000

7,750

12,511

20,261

(5,167)

15,094

As part of the Merger Implementation Deed entered into the by the parties on 29 August 2014, a component of the purchase 
consideration was determined to be contingent based on a number of Performance Conditions (including the performance 
of the acquired entity). A fair value adjustment has been made to the value of the shares as part of the purchase due to 
these contingencies. The fair value adjustment totalled $2.1 million and has been included (as a deduction) in the contingent 
consideration value disclosed above.

The assets and liabilities arising from the acquisition are as follows:

Fair Value 
$’000

2,780

110

1,299

75

38

20,035

24,337

Assets

Cash and cash equivalents 

Fixed interest deposits

Receivables

Deferred tax asset

Property, plant and equipment

Goodwill and Intangibles

Total assets

123     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

34. Business Combinations continued

Liabilities

Payables

Deferred tax liability

Provisions

Borrowings

Total liabilities

Net assets

Analysis of cash flows on acquisition

Net cash acquired with the subsidiary

Cash paid

Net cash outflow

Fair Value 
$’000

408

10

658

3,000

4,076

20,261

Fair Value 
$’000

2,780

(7,750)

(4,970)

Goodwill and intangibles include the value of in-force business (Client Book), brand and website, broken down as follows:

Goodwill and intangibles

Client Book

Brand

Website

Goodwill

Total

Fair Value 
$’000

4,720

200

20

15,094

20,034

From the date of acquisition, Matrix has contributed $27.1 million of revenue, $0.8 million in underlying net profit after tax, 
and a reported net profit of $0.5 million after tax. The reported profit includes $0.4 million ($0.3 million net of tax) in one-
off expenses in relation to the acquisition. If the acquisition had taken place at the beginning of the period, revenue from 
continuing operations would have been $38.3 million and a loss from continuing operations for the period after tax would have 
been $0.7 million. This loss included $0.9 million ($0.6 million net of tax) in one-off expenses in relation to the purchase before 
acquisition date and $0.4 million ($0.3 million net of tax) after acquisition date as noted above.

The goodwill recognised is primarily attributed to the expected revenue synergies and other benefits from combining the assets 
and activities of Matrix with those of the Group. The achievement of the performance based revenue targets are expected to 
result in the increased profitability of the dealer group. The goodwill recognised, has therefore been allocated across the three 
cash-generating units (CGU’s) of the Group, based on the expected benefits for each CGU. For further details regarding the 
expected benefits of the acquisition, refer to the Directors’ Report.

The total transaction costs of $2.3 million (pre-tax) have been expensed across the Group and are included in operating 
expenses in the statement of profit or loss and are part of the operating cash flows in the statement of cash flows.

ClearView Annual Report 2015     124

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

35.   Related party transactions

(a) Equity interests in related parties

Equity interests in subsidiaries

Details of the percentage of ordinary shares held in subsidiaries are disclosed in Note 33 to the financial statements. 

(b) Transactions with KMP

Key management personnel compensation

Details of Key Management Personnel compensation are disclosed in the Directors’ Report on pages 42 to 57 of the Annual 
Report. The aggregate compensation made to Key Management Personnel (KMP) of the Company and the Group is set out 
below:  

Short-term employee benefits 

Post-employment benefits

Share based payments 

Total

(c) Transactions between the Group and its related parties

Other related parties include: 

•  Entities with significant influence over the Group 

•  Associates, and 

•  Subsidiaries 

Consolidated

2015 
$

2014 
$

4,924,245

 4,730,756 

255,929

177,215

 207,888 

 164,848 

5,357,389

 5,103,492 

Balances and transaction between the Company and its subsidiaries, which are related parties of the Company, have been 
eliminated on consolidation and are not disclosed in this note. Details of transactions between the Group and other related 
parties during the financial year ended 30 June 2015 are disclosed below: 

• 

 Directors fees were paid to Cresent Capital Partners Pty Limited the manager of the parent entity’s majority shareholder CCP 
Bidco Pty Limited. 

The ultimate parent entity in the Group is ClearView Wealth Limited which is incorporated in Australia. 

125     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

35.   Related party transactions continued

Outstanding balances between the Group and its related parties

h
t
l
a
e
W
w
e
V
r
a
e
l
C

i

d
e
t
i

m
i
L

$

l
a
i
c
n
a
n
i
F
w
e
V
r
a
e
l
C

i

t
n
e
m
e
g
a
n
a
M

e
f
i
L
w
e
V
r
a
e
l
C

i

d
e
t
i

m
i
L
e
c
n
a
r
u
s
s
A

$

e
c
i
v
d
A

l
a
i
c
n
a
n
i
F

i

w
e
V
r
a
e
l
C

d
e
t
i

m
i
L
y
t
P

$

d
e
t
i

m
i
L

$

i

g
n
n
n
a
l
P
x
i
r
t
a
M

d
e
t
i

m
i
L
s
n
o
i
t
u
l
o
S

$

2015

i

n
m
d
A
w
e
V
r
a
e
l
C

i

y
t
P
s
e
c
i
v
r
e
S

d
e
t
i

m
i
L

$

e
f
i
L
w
e
V
r
a
e
l
C

i

y
t
P
s
e
e
n
m
o
N

i

d
e
t
i

m
i
L

$

l
a
t
o
T

$

ClearView Wealth Limited

                   -    (4,544,452)

(143,569)

(355,800)

(65,178) (4,634,875)

(8,891) (9,752,765)

ClearView Life Assurance Limited

4,544,452

-

133,977

429,256

ClearView Financial Management Limited

143,569

(133,977)

-

41,784

ClearView Financial Advice Pty Limited

355,800

(429,256)

(41,784)

Matrix Planning Solutions Limited

65,178

-

-

-

-

-

-

-

-

ClearView Admin Services Pty Limited

4,634,875 (5,430,633)

(234,018)

(594,859)

(312,103)

ClearView Life Nominees Pty Limited

8,891

-

543,666

-

-

5,430,633

- 10,538,318

234,018

(543,666)

(258,272)

594,859

312,103

-

-

-

-

479,619

377,281

- (1,936,738)

-

552,557

2014

$

$

$

$

$

$

$

9,752,765 (10,538,318)

258,272

(479,619)

(377,281) 1,936,738

(552,557)

-

$

ClearView Wealth Limited

 -    3,607,064

(204,676)

1,482,662

-

2,692,043

5,607

7,582,700

ClearView Life Assurance Limited

(3,607,064)

-

(142,272)

(439,841)

- (4,760,145)

- (8,949,322)

ClearView Financial Management Limited

204,676

142,272

-

(54,282)

- (1,703,004)

282,628 (1,127,710)

ClearView Financial Advice Pty Limited

(1,482,662)

439,841

54,282

Matrix Planning Solutions Limited

-

-

-

-

-

ClearView Admin Services Pty Limited

(2,692,043)

4,760,145

1,703,004

657,702

ClearView Life Nominees Pty Limited

(5,607)

-

(282,628)

-

-

-

-

-

(657,702)

- (1,646,241)

-

-

-

-

-

-

-

4,428,808

(288,235)

(7,582,700) 8,949,322 1,127,710 1,646,241

- (4,428,808)

288,235

-

(d) Transactions other than financial instrument transactions

No Director has entered into a material contract with the Company or the ClearView Group since the end of the previous 
financial year and there were no material contracts involving Directors’ interests existing at year end. Other transactions with 
directors, executives and their related parties are conducted on arm’s length terms and conditions, and are deemed trivial or 
domestic in nature. These transactions are in the nature of personal investment, life insurance policies and superannuation. 

ClearView Annual Report 2015     126

ClearView Wealth Limited 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Financial Statements
For the year ended 30 June 2015

Continued

36.   Financial instruments

(a) Management of Financial Instruments 

The financial assets of the Group (other than shareholder cash holdings) are managed by specialist investment managers who 
are required to invest the assets allocated in accordance with directions from the Board. BNP Paribas acts as master custodian 
on behalf of the Group and, as such, provides services including physical custody and safekeeping of assets, settlement of 
trades, collection of dividends and accounting for investment transactions. Daily operating bank accounts and shareholder 
cash are managed within the Group by the internal management and finance department. 

(b) Significant accounting policies 

Details of the significant accounting policies and methods adopted, including the criteria for recognition, the basis of 
measurement and the basis on which revenues and expenses are recognised, in respect of each class of financial asset and 
financial liability are disclosed in Note 3(x). 

(c) Capital risk management 

The Group maintains capital to protect customers, creditors and shareholders against unexpected losses to a level that is 
consistent with the Group’s risk appetite. The Group’s capital structure consists of ordinary equity comprising issued capital, 
retained earnings and reserves (as detailed in Notes 12 and 27). The capital structure remains unchanged from the previous 
financial period. 

(d) Fair value of financial instruments 

The fair values of financial assets and financial liabilities are determined in accordance with the fair value hierarchy. 

Fair Value Hierarchy 

The table below summarises financial instruments carried at fair value, by valuation method. The different levels have been 
defined as follows: 

• 

• 

 Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities; 

 Level 2: inputs other than quoted prices included within level 2 that are observable for the asset or liability, either directly  
(i.e. as prices) or indirectly (i.e. derived from prices); and 

• 

 Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs). 

Financial assets

2015

Equity Securities

Fixed Interest Securities

Unit Trusts

Total

2014

Equity Securities

Fixed Interest Securities

Unit Trusts

Total

127     ClearView Annual Report 2015

Level 1

Level 2

Level 3

$’000

$’000

$’000

Total

$’000

 222,891 

 -   

 -   

 661,977 

 565,383 

 -   

 788,274 

 661,977 

 233,817 

 -   

 -   

 641,410 

 461,542 

 -   

 695,359 

 641,410 

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 222,891 

 661,977 

 565,383 

 1,450,251 

 233,817 

 641,410 

 461,542 

 1,336,769 

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

36.   Financial instruments continued

Financial Liabilities

2015

Life investment policy liability

Total

2014

Life investment policy liability

Total

Level 1

Level 2

Level 3

$’000

$’000

$’000

Total

$’000

 1,160,627 

 1,160,627 

 1,122,364 

 1,122,364 

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 1,160,627 

 1,160,627 

 1,122,364 

 1,122,364 

(e) Categories of financial instruments 

The Company has investments in the following categories of financial assets and liabilities:

Financial assets

Investment in group companies

Cash and cash equivalents

Fixed interest deposits

Life insurance investment assets

Loans and receivables

Total

Financial liabilities

Net Policyholder liabilities

Payables

Borrowings

Current tax liabilities

Provisions

Total

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

 -   

 -   

 318,159 

257,892

 200,769 

183,299

107,035

88,759

1,450,251

1,336,769

34,447

8,115

 -   

1,111

25,179

 -   

15,516

11,876

9,884

16,353

1,773,571

1,620,703

370,605

300,535

1,001,753

991,214

24,774

45,500

4,548

5,375

25,069

-

4,622

3,588

1,081,950

1,024,493

 -   

357

-

4,548

 26 

4,931

 -   

349

-

4,622

19

4,990

(f) Financial risk management objectives

The primary asset risks borne by the Company relate to the 
financial assets of the Company and its operating subsidiaries 
excluding those in the non-guaranteed investment linked 
funds in ClearView Life’s statutory fund No.4 (referred to 
below as ClearView assets). The primary financial risks related 
to the financial assets in the non-guaranteed investment 
linked funds in ClearView Life’s statutory fund No.4 are borne 
by policyholders as the investment performance on those 
assets is passed through, in full, to the policyholders (referred 
to below as Policyholder assets). Nonetheless, the Company 

has a secondary exposure to the Policyholder assets and off-
balance sheet client funds, via the impact on the fees charged 
by the Company which vary with the level of Policyholder and 
client funds under management and under administration, as 
well as related reputational exposure. 

(g) Market risk 

Market risk is the risk that financial assets will be affected by 
changes in interest rates, foreign exchange rates and  
equity prices.   

ClearView Annual Report 2015     128

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

36.   Financial instruments continued

Interest rate risk   

(h) Credit risk

Interest rate risk arises on ClearView’s assets which are 
invested in fixed interest funds and cash. Interest rate risk is 
managed by the Company through: 

• 

• 

• 

 Maintaining the level of interest rate exposure within the 
tolerances set by the Board in the RMS; 

 Investing ClearView’s assets in accordance with the Board 
approved Investment Policy and Guidelines; and 

 By holding capital reserves in accordance with the 
Company’s ICAAP with respect to the residual interest rate 
risk exposure retained, in addition to the regulatory capital 
reserves held within ClearView Life in respect of interest 
rate risk. 

Equity price risk

Equity price risk is the risk that the fair value of investments 
in equities decreases or increases as a result of changes in 
market prices, whether those changes are caused by factors 
specific to the individual share price or factors affecting 
all equity instruments in the market. As at 30 June 2015, 
ClearView’s shareholder related assets were not exposed to 
equity price risk. 

In contrast to this, the Policyholder assets and other client 
funds under management and under administration, involve 
significant investment in equities. As noted above, the 
Policyholder asset risks are borne by the policyholders. The 
Company is exposed to secondary risks on its management 
and advice fees that are driven by the total funds under 
management and administration, as well as reputational risks 
from poor investment returns. 

The investment of the Policyholder assets and client moneys 
controlled by ClearView is undertaken in accordance with 
the Investment Policy and Guidelines approved by the Board, 
which inter alia stipulates the investment allocation mix, the 
portfolio’s risk characteristics, management response plans 
and the use of derivatives. 

To the extent required, capital reserve are held in accordance 
with the ICAAP with respect to the Company’s residual fee risk 
exposure. 

Credit risk refers to the risk that a counterparty will default 
on its contractual obligations resulting in financial loss to 
the Group. Credit risk exposures arising from investment 
activities are assessed by the Company’s internal investment 
management committee (the ClearView Investment 
Committee (CIC) appointed by the Board) prior to investing 
ClearView assets into any significant financial asset. The 
ongoing credit standing of material investments are 
monitored by the CIC, with the CIC charged to maintain 
the credit quality of ClearView assets within the Board’s 
investment guidelines. 

The large majority of debt assets invested in by the Company 
on behalf of policyholders and clients (including Policyholder 
assets) are managed under mandates with appointed 
funds managers. Those mandates include credit rating, 
diversification and maximum counterparty exposure rules 
and standards that are to be met. The funds managers 
adherence to those requirements are subject to ongoing 
monitoring by the funds managers, and are separately 
monitored by the Company’s custodian. Formal compliance 
reporting is monitored monthly by the CIC. 

Credit risk arising from other third party transactions, 
such as reinsurance recovery exposures and exposure to 
outsource service providers, are assessed prior to entering 
into financial transactions with those parties, are approved by 
the Board where material, and are monitored by appropriate 
mechanisms on an ongoing basis (for example, a quarterly 
monitoring and compliance reporting process in respect of 
the Company’s outsourced custodian). 

The Company does not expect any of its material 
counterparties to fail to meet their obligations and does not 
require collateral or other security to support these credit risk 
exposures. 

Specific capital reserves are held against credit risk under the 
regulatory capital requirements of ClearView Life (LAGIC) and 
credit risk is considered within the Company’s ICAAP. 

The Group does have significant credit risk exposure to 
counterparties but these counterparties have a high credit 
rating. The table below shows the maximum exposure to 
credit risk at the reporting date. It is the opinion of the Board 
that the carrying amounts of these financial assets represent 
the maximum credit risk exposure at the balance sheet date. 
The table reflects the credit risk exposure facing the Group.

129     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

36.   Financial instruments continued

Cash and cash equivalents and debt securities/fixed interest 
securities

Rating

AAA to AA-

A+ to A-

BBB+ to BBB-

BB+ and below

Unrated1

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

866,819

806,992

39,474

23,272

99,844

22,591

2,288

8,973

73,420

20,723

3,138

9,195

1,000,515

913,468

 -   

 1,005 

 -   

3,794

44,273

 -   

 -   

301

3,018

26,591

1. Unrated relate to term deposits invested in Australian Credit Union Institutions which are APRA Regulated ADIs.

Under the terms of the Company’s products (issued via 
ClearView Life and ClearView Financial Management) the 
payment of unit fund redemptions to policyholders and unit 
trust investors may be delayed, if necessary, until funds are 
available. To date no such delays have been imposed. 

The risks in respect of external (third party) funds are 
controlled via the Company’s Approved Product List, which 
restricts the external funds available for use by the Company’s 
advisers and planners to investment platform providers that 
are assessed to be reputable and financially sound. 

Credit risk associated with receivables is considered minimal. 
The main receivables balance is in relation to receivables from 
premiums receivable, accrued dividends, loans receivable, 
prepayments and outstanding settlements. Other receivables 
balances relate predominantly to management fees from 
external unit trusts. The concentration is spread across the 
various debtors with no single significant debtor. 

(i) Liquidity risk 

Liquidity risk is primarily the risk that the Company will 
encounter difficulty in meeting its obligations due to an 
inability to realise some or all of its assets in order to fund 
its cash flow needs, including the payment of amounts to 
its policyholders, members and clients. A secondary risk 
relates to the risk of the illiquidity of the external (including 
off balance sheet) funds its clients invest in, which may result 
in restricted fee flows to the Company and/or reputational 
damage via association. 

The primary risk is controlled through focusing the Company’s 
assets, as well as policyholder and member assets and the 
investment of client funds controlled by the Company, into 
assets which are highly marketable and readily convertible 
into cash. In addition, the Company maintains suitable cash 
holdings at call and an appropriate overdraft facility. 

The Company’s cash flow requirements are reviewed and 
forecast daily for a one week forward period. This assessment 
takes into account the timing of expected cash flows, the 
likelihood of significant benefit outflows over the short term 
and known significant one-off payments. 

ClearView Annual Report 2015     130

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

36.   Financial instruments continued

The following tables summarise the realisation profile of financial assets at the reporting date. There were no financial assets 
past due or impaired at the reporting date other than those provided for.

Consolidated

2015

Receivables

Outstanding life insurance premiums net of 
provision

Accrued dividends

Investment income and distribution income

Reinsurance receivable 1

Loans

Prepayments

Total

2014

Receivables

Outstanding life insurance premiums net of 
provision

Accrued dividends

Investment income and distribution income

Reinsurance receivable 1

Loans

Prepayments

Total

Less than  
3 months

3 to 6 
months

6 months 
to a year

1 year  
and over

Over  
5 years

$’000

$’000

$’000

$’000

$’000

4,246

1,358

1,883

886

19,313

668

1,835

 192 

517

 -   

 -   

721

262

171

30,189

1,863

Total

$’000

4,750

2,252

1,883

886

44

355

 -   

 -   

268

22

 -   

 -   

 -   

 -   

 -   

 -   

(6)

(4,702)

(17,559)

(2,233)

1,259

109

1,761

1,106

593

110

 166 

3,405

2,874

(2,713)

(17,283)

13,817

4,354

1,485

1,851

1,014

4,342

143

1,679

 -   

 -   

 -   

 -   

26

 -   

 -   

 -   

3

 -   

 -   

 -   

3,477

4,726

(16,417)

82

528

119

4

307

83

14,868

4,087

4,875

(16,024)

 -   

 -   

 -   

 -   

 -   

198

 -   

198

4,383

1,485

1,851

1,014

(3,872)

849

2,294

8,004

Company

2015

Trade receivables

Amounts from controlled/associated entities 

Total

2014

Trade receivables

Amounts from controlled/associated entities 

Total

Less than  
3 months

3 to 6 
months

6 months 
to a year

1 year  
and over

Over  
5 years

$’000

$’000

$’000

$’000

$’000

 14 

9,753

9,767

 2 

7,847

7,849

 15 

 -   

15

 2 

 -   

2

 28 

-

28

 3 

8,499

8,502

 74 

 -   

 74 

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

Total

$’000

131

9,753

9,884

7

16,346

16,353

1 

Reinsurance share of life insurance receivables are reflected in accordance with the likely settlement of the underlying claims to which they relate.

131     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

36.   Financial instruments continued

The following tables summarise the maturity profile of the Group and the Company’s financial liabilities all of which are non-
interest bearing. The tables have been drawn up based on the undiscounted cash flows of financial liabilities based on the 
earliest date on which the Company can be required to pay. The tables include both interest and principle cash flows.

2015

Payables

Current tax liabilities

Provisions

Reinsurance payable 1

Total

2014

Payables

Current tax liabilities

Provisions

Reinsurance payable 1

Total

2015

Payables

Current tax liabilities

Provisions

Total

2014

Payables

Current tax liabilities

Provisions

Total

Consolidated

Less than  
3 months

3 to 6 
months

6 months 
to a year

1 year  
and over

$’000

 18,346 

 -   

 111 

 5,142 

23,599

20,101

 -   

320

3,749

$’000

 119 

 4,548 

 76 

 -   

$’000

 558 

 -   

 4,014 

 -   

$’000

 528 

 -   

 813 

 -   

4,743

4,572

1,341

53

4,622

25

 -   

233

 -   

3,243

 -   

933

 -   

 -   

 -   

24,170

4,700

3,476

933

Over  
5 years

$’000

 83 

 -   

 361 

 -   

 444 

 -   

 -   

 -   

 -   

 -   

Less than  
3 months

3 to 6 
months

6 months 
to a year

1 year  
and over

Over  
5 years

$’000

357

 -   

-

 357 

 -   

 -   

 -   

 -   

$’000

$’000

$’000

$’000

-

4,548

26

4,574

349

4,622

19

4,990

-

 -   

-

 -   

 -   

 -   

 -   

 -   

-

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

Total

$’000

19,634

4,548

5,375

5,142

34,699

21,320

4,622

3,588

3,749

33,279

Company

Total

$’000

357

4,548

26

 4,931 

349

4,622

19

 4,990 

1 

Reinsurance payable represents reinsurance premium payable on reinsurance due in respect of life insurance premium.

ClearView Annual Report 2015     132

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

36.   Financial instruments continued

The following table gives information about how the fair values of these financial assets and financial liabilities are determined 
(in particular, the valuation techniques and inputs used, significant unobservable inputs and the relationship of unobservable 
inputs to fair value).

Fair value as at

2015 
$’000

2014 
$’000

Fair value 
hierarchy

Valuation techniques and key 
inputs

Equity Securities

 222,891 

 233,817 

 Level 1 

Fixed Interest Securities

 661,977

 641,411 

 Level 2 

Unit Trusts

Total

 565,383 

 461,544 

 Level 1 

 1,450,251 

 1,336,772 

(j) Financing Facilities

 Quoted bid prices in an 
active market 

The fair value of Fixed 
Interest Securities are 
based on a discounted 
cash flow model using a 
yield curve appropriate to 
the remaining maturity of 
the investment.

 Quoted bid prices in an 
active market 

Significant 
unobservable 
inputs

Relationship 
of unobserv-
able inputs 
to fair value

 n/a 

 n/a 

 n/a 

 n/a 

 n/a 

 n/a 

The Group has access to the following facilities: 

Bank Guarantees

– amount used

Overdraft and Credit

– amount used

– amount unused

Bank Revolving Facility

– amount used

– amount unused

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

 942 

1,084

-

 -   

2,000

2,250

 45,500   

4,500

 -   

-

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

The Company entered into a three year $50 million facility agreement with the Commonwealth Bank of Australia. As at 
the reporting date, the Company has drawn down $45.5 million on the facility, with $4.5 million of unused credit facilities 
available for immediate use. Interest on the loan accrues at BBSY plus a margin of 0.7% per annum, and is payable monthly. 
Furthermore, a line fee of 0.4% per annum is payable on the facility on a quarterly basis. The facility is secured by a number of 
cross guarantees, refer to Note 42 for details.

ClearView Life Assurance Limited has a $2 million overdraft facility with National Australia Bank at a benchmark interest rate 
of 10.76% p.a calculated daily. Any overdrawn balance in excess of the overdraft will incur an additional margin of 1.5% p.a 
above the benchmark interest rate. The bank overdraft is short-term in nature and was unutilised at 30 June 2014. There is an 
additional $0.25 million credit card facility with National Australia Bank in the name of ClearView Administration Services Pty 
Limited.  

133     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

36.   Financial instruments continued

Interest rate risk management  

The Group’s activities expose it to the financial risk of changes in interest rates. Floating rate instruments expose the Group to 
cash flow risk, whereas fixed interest rate instruments expose the Group to fair value interest rate risk. The Board monitors the 
Group’s exposures to interest rate risk. 

The tables below detail the Group’s exposure to interest rate risk at the balance sheet date by the earlier of contractual 
maturities or re-pricing. 

2015

Financial assets

Variable interest rate instruments:

Cash and cash equivalents

Fixed interest securities

Total

2014

Financial assets

Variable interest rate instruments:

Cash and cash equivalents

Fixed interest securities

Total

Consolidated

Company

Weighted 
average 
interest 
rate

Less than 6 
months

Weighted 
average 
interest 
rate

Less than 6 
months

%

$’000

%

$’000

1.74

3.11

3.33

3.55

71,433

107,035

178,468

64,959

88,759

153,718

1.35

3.40

2.50

3.43

34,447

8,115

42,562

1,111

25,179

26,290

Interest rate sensitivity analysis for floating rate financial instruments

The sensitivity analysis below have been determined based on the Group’s exposure to interest rates at the reporting date and 
the stipulated change taking place at the beginning of the financial year and held constant throughout the reporting period, 
in the case of instruments that have floating interest rates. A 0.5% (2014: 0.5%) increase or decrease is used when reporting 
interest risk internally to key management personal and represents management’s assessment of the reasonably possible 
change in interest rates. 

ClearView Annual Report 2015     134

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

36.   Financial instruments continued

The following table illustrates the effect for the Group from possible changes in market risk that are reasonably possible based 
on the risk the Group was exposed to at reporting date:    

Effect on  
operating profit 

Effect on  
securities

Effect on  
operating profit 

Effect on securities

Consolidated

Consolidated

Company

Company

2015 
$’000

 ±343

2014 
$’000

 ±379

2015 
$’000

 ±343

2014 
$’000

 ±379

2015 
$’000

 ±123

2014 
$’000

 ±43

2015 
$’000

 ±123

2014 
$’000

 ±43

±0.5% (2014: ±0.5%)

The method used to prepare the sensitivity analysis has not changed in the year. Based on the market exposure management 
believe that the interest rate variation above is considered appropriate in the current environment.

Fair value sensitivity analysis for fixed rate financial instruments

The Group does account for fixed rate financial assets and liabilities at fair value through profit and loss. Therefore a change in 
long term interest rates at reporting date would affect profit and loss. 

(k) Foreign currency risk management

Foreign currency risk is the risk that the market value of future cash flows of a financial instrument will fluctuate because of 
changes in foreign exchange rates. The Group undertakes certain investments denominated in foreign currencies, hence is 
exposed to the effects of exchange rate fluctuations. However, the foreign currency risk is borne by the policyholder and the 
shareholder has no direct exposure to foreign currency.  

USD

GBP

EUR

YEN

Forward foreign exchange contracts

The Group currently does not make use of forward foreign exchange contracts. 

Change 
in AUD 
relative 
to foreign 
currency

Effect on 
net assets/
INV return 
($) 
$’000

-18%

-12%

-1%

-2%

 -   

 -   

 -   

 -   

135     ClearView Annual Report 2015

ClearView Wealth Limited 
 
 
Notes to the Financial Statements
For the year ended 30 June 2015

Continued

37.  Disaggregated information by fund

Abbreviated income statement

2015

Life insurance premium revenue

Outwards reinsurance expense

Fee revenue

Investment revenue

Net fair gains/(losses) on financial assets at fair value

Net revenue and income

Claims expense

Reinsurance recoveries

Change in life insurance policy liabilities

Change in reinsurers' share of life insurance liabilities

Change in life investment policy liabilities

Other expenses

Profit for the year before income tax

Income tax expense

Net profit attributable to members of ClearView Life 
Assurance Limited

ClearView Life Assurance Limited (Company)

Shareholders 
Fund

Statutory 
Fund No.1

Statutory 
Fund No.2

Statutory 
Fund No.4

Total

$’000

$’000

$’000

$’000

$’000

Australian Non-Participating

 -   

 -   

 -   

 251 

 -   

251

 -   

 -   

 -   

 -   

 -   

 104,811 

(18,293)

 -   

 353 

(68)

 956 

 2,998 

 1,434 

 -   

89,516

(32,901)

15,010

40,822

(7,367)

85

2,760

(50)

 -   

129

 -   

 -   

 -   

 23,251 

 78,251 

 31,385 

132,887

 -   

 -   

 -   

 -   

 105,164 

(18,361)

 24,207 

 82,934 

 31,470 

225,414

(32,951)

15,010

40,951

(7,367)

 -   

(3,214)

(105,984)

(109,198)

 (112)   

(79,460)

139

(42)

25,620

(7,684)

(600)

(975)

1,559

(23,116)

(103,288)

3,787

(3,296)

28,571

(9,463)

97

17,936

584

491

19,108

ClearView Annual Report 2015     136

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

37.  Disaggregated information by fund continued

Abbreviated statement of financial position

2015

Investments in controlled entities

ClearView Life Assurance Limited (Company)

Shareholders 
Fund

Statutory 
Fund No.1

Statutory 
Fund No.2

Statutory 
Fund No.4

Total

$’000

 2,950 

$’000

$’000

$’000

$’000

 -   

 53,985 

 1,108,594 

 1,165,529 

Australian Non-Participating

Policy liabilities ceded under reinsurance

 -   

(2,487)

105,670

103,183

(156,747)

254

2,680

 -   

(2,233)

16,952

128,640

56,919

1,125,546

1,291,936

105

 -   

(156,642)

 -   

53,785

1,106,841

1,160,626

12,281

(10)

7,866

20,179

(144,466)

53,880

1,114,707

1,024,163

3,338

6,288

 -   

 -   

42

42

6,246

247,649

3,039

10,839

267,773

(6,476)

117,513

97

 -   

(7,000)

(13,379)

19,625

17,936

 -   

 -   

135,449

112,200

6,246

247,649

2,255

584

 -   

 -   

2,839

200

3,039

8,748

491

 -   

 -   

9,239

1,600

122,040

19,108

 -   

(7,000)

134,148

133,625

10,839

267,773

Other assets

Total assets

Gross policy liabilities – Life insurance contracts

Gross policy liabilities – Investment insurance 
contracts

Other liabilities

Total liabilities

Net assets

Shareholder’s retained profits

Opening retained profits

Operating profit

Capital transfer between funds

Dividend paid

Shareholder’s retained profits

Shareholder’s capital

Total equity

137     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

37.  Disaggregated information by fund continued

Abbreviated income statement

ClearView Life Assurance Limited (Company)

Shareholders 
Fund

Statutory 
Fund No.1

Statutory 
Fund No.2

Statutory 
Fund No.4

Total

Australian Non-Participating

2014

Life insurance premium revenue

Outwards reinsurance expense

Fee revenue

Investment revenue

Other revenue

Net fair gains/(losses) on financial assets at fair value

Net revenue and income

Claims expense

Reinsurance recoveries

Interest on loan

Change in life insurance policy liabilities

Change in life investment policy liabilities

Change in reinsurers' share of life insurance liabilities

Other expenses

Profit for the year before income tax

Income tax (expense)/benefit

Net profit attributable to members of ClearView Life 
Assurance Limited

$’000

 -   

 -   

 -   

$’000

 76,440 

(10,313)

 -   

 484 

 2,304 

 -   

 -   

68,431

(25,929)

11,680

-

34,234

 -   

 -   

484

 -   

 -   

(310)

 -   

 -   

 -   

 -   

174

(52)

122

$’000

$’000

 360 

(46)

 1,157 

 2,056 

(6)

(84)

 -   

 -   

 23,997 

 61,737 

(131)

 61,646 

3,437

147,249

-

-

-

(6)

 -   

 -   

 -   

 -   

$’000

76,800

(10,359)

25,154

66,581

(137)

61,562

219,601

(25,929)

11,680

(310)

34,228

-

(2,837)

(123,547)

(126,384)

(9,994)

(61,034)

17,388

(5,217)

12,171

-

 -   

(9,994)

(1,293)

(15,617)

(77,944)

(699)

910

211

8,085

(1,789)

6,296

24,948

(6,148)

18,800

ClearView Annual Report 2015     138

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

37.  Disaggregated information by fund continued

Abbreviated statement of financial position

ClearView Life Assurance Limited (Company)

Shareholders 
Fund

Statutory 
Fund No.1

Statutory 
Fund No.2

Statutory 
Fund No.4

Total

$’000

 1,450 

 -   

12,881

14,331

 -   

 -   

9,682

9,682

4,649

(6,598)

122

 -   

 -   

(6,476)

11,125

Australian Non-Participating

$’000

$’000

$’000

$’000

 -   

60,646

1,062,781

1,124,877

(3,991)

88,314

84,323

119

2,152

 -   

(3,872)

17,711

121,058

62,917

1,080,492

1,242,063

(127,328)

49

 -   

(127,279)

 -   

60,159

1,062,204

1,122,363

9,938

254

8,440

28,314

(117,390)

60,462

1,070,644

1,023,398

201,713

2,455

9,848

218,665

98,342

12,171

 7,000 

 -   

117,513

84,200

2,044

211

 -   

 -   

2,255

200

2,455

9,452

6,296

(7,000)

 -   

8,748

1,100

9,848

103,240

18,800

 -   

 -   

122,040

96,625

218,665

4,649

201,713

2014

Investments in controlled entities

Policy liabilities ceded under reinsurance

Other assets

Total assets

Gross policy liabilities – Life insurance contracts

Gross policy liabilities – Investment insurance 
contracts

Other liabilities

Total liabilities

Net assets

Shareholder’s retained profits

Opening retained profits

Operating profit

Capital transfer between funds

Dividend paid

Shareholder’s retained profits

Shareholder’s capital

Total equity

139     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
Notes to the Financial Statements
For the year ended 30 June 2015
For the year ended 30 June 2015

Continued
Continued

38.  Investment in controlled unit trusts

Name

Controlled unit trusts

International Fixed Interest Fund

Fund of Funds Australian Equity Fund

Bond Fund

Fund of Funds International Equity Fund

Property Fund

Money Market Fund

Infrastructure Fund

Emerging Markets Fund

CVW Platinum International Shares Fund

CVW Hyperion Australian Shares Fund

CVW Vanguard Listed International Infrastructure 
Fund

CVW Vanguard Emerging Markets Fund

CVW Plato Australian Shares Fund

CVW MFS International Shares Fund

39.  Leases

Not longer than 1 year

Longer than 1 year and not longer than 5 years

Longer than 5 years

Total

Lease committmens relate to:

Consolidated
2015

Consolidated
2014

Type

$’000

%

$’000

%

Debt

Equities

Debt

Equities

Property

Debt

Infrastructure

Equities

Equities

Equities

Infrastructure

Equities

Equities

Equities

27,454

113,451

322,339

104,388

46,381

239,571

114,709

106,922

8,734

5,924

4,752

4,852

47,819

15,283

95.23

59.26

68.47

93.10

83.14

80.77

69.11

71.56

97.99

83.95

96.36

96.69

78.70

63.88

30,287

171,983

308,253

106,918

48,009

244,259

109,970

103,748

-

-

-

-

-

-

1,162,579

1,123,427

95.65

75.48

82.25

92.50

89.46

88.84

84.15

80.37

-

-

-

-

-

-

Consolidated

2015 
$’000

2,367

3,045

18

5,412

2014 
$’000

1,897

2,650

 -   

4,547

Company

2014 
$’000

2015 
$’000

 -   

 -   

 -   

 -   

 -   

 -   

 -   

 -   

• 

• 

• 

 ClearView Group’s offices in various locations. Under these arrangements ClearView generally pays rent on a periodic basis 
at rates agreed at the inception of the lease.

 Tools of trade cars utilised by employees in the performance of their work responsibilities. The Group does not have an 
option to purchase the leased assets at expiry of the leases. 

 Printers and copiers utilised in the business. The Group does not have an option to purchase the leased assets at expiry of 
the leases. 

ClearView Annual Report 2015     140

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2014

Continued

39.  Leases continued

In respect of non-cancellable operating leases the following liabilities have been recognised: 

Make good provision (Note 23)

Current

Non-current

Total

Consolidated

2015 
$’000

2014 
$’000

2015 
$’000

Company

2014 
$’000

 100 

 333 

433

46

 270 

316

 -   

 -   

 -   

 -   

 -   

 -   

book of business in the coming financial year at a price that 
is not yet determined and that includes deferred uncertain 
components. It is possible that the market value or resale 
value of such a business purchased may be less than the cost 
to the Group. Due to the uncertainty of these circumstances 
arising no value can be reliably placed on the contingent 
liability. 

The Group has term deposits that back financial guarantees 
issued by National Australia Bank in favour of landlords for 
leased premises in relation to rental deposits of $105,852 
(2014: $303,329).

The Group has term deposits to back financial guarantees 
issued by Westpac Bank in favour of landlords for leased 
premises in relation to rental deposits of $941,615 (2014: 
$780,946)

The Company in the ordinary course of business has 
guaranteed the obligations of one of its subsidiaries in respect 
of its obligations for leasehold premises.

The Company has guaranteed the obligations of one of 
its subsidiaries in respect of employee entitlements of 
employees who were previously employed by MBF Holding Pty 
Limited (Bupa Australia).

Other than the above, the Directors are not aware of any 
other contingent liabilities in the Group at the year end.

40.  Contingent liabilities and contingent assets
There are outstanding claims and potential claims against 
the ClearView Group in the ordinary course of business. 
The ClearView group does not consider the outcome of any 
such claims known to exist at the date of this report, either 
individually or in aggregate is likely to have a material effect 
on its operations or financial position. The Directors are of 
the opinion that provisions are not required in respect of 
these matters, as it is not probable that a future sacrifice 
of economic benefits will be required or the amount is not 
capable of reliable measurement. 

Certain subsidiaries act as trustee for various trusts. In this 
capacity, the subsidiaries are liable for the debts of the trusts 
and are entitled to be indemnified out of the trust’s assets for 
all liabilities incurred on behalf of the trusts. 

In the ordinary course of business, certain ClearView 
subsidiaries enter into various types of investment contracts 
that can give rise to contingent liabilities. It is not expected 
that any significant liability will arise from these transactions 
as any losses or gains are offset by corresponding gains or 
losses on the underlying exposure. 

The Group has contractual agreements with a limited number 
of advisers to purchase the adviser’s business should the 
adviser want to sell their business and on the satisfaction of 
certain criteria. The terms and conditions provide that on the 
satisfaction of specific requirements, the adviser’s book of 
business will be purchased for a price based on the adviser’s 
recurring income stream from the Group. It is anticipated 
that one or more advisers may initiate the purchase of their 

141     ClearView Annual Report 2015

ClearView Wealth LimitedNotes to the Financial Statements
For the year ended 30 June 2015

Continued

41.  Capital commitments
The Group has committed to the following capital commitments subsequent to the year end. 

Technology projects

Your Insure 1

Total

Consolidated

2015 
$’000

 1,645 

1,589

3,234

2014 
$’000

 300 

 2,700 

 3,000 

Company

2014 
$’000

 -   

-

-

2015 
$’000

 -   

-

-

1 

 ClearView Wealth Limited will provide funding to Your Insure up to a maximum limit of $3.3 million on a draw down basis. As at the balnce date $1.7 million of 
the facility is still available to be drawn down subject to the achievement of set performance hurdles.

42.  Guarantees 
The facility entered into with the Commonwealth Bank of Australia is guaranteed jointly and severally by:

•  ClearView Wealth Limited 

•  ClearView Group Holdings Pty Limited 

ACN 106 248 248

ACN 107 325 388

•  ClearView Administration Services Pty Limited 

ACN 135 601 875

•  ClearView Financial Management Limited* 

•  Matrix Planning Solutions Limited* 

•  ClearView Financial Advice Pty Ltd*   

ACN 067 544 549

ACN 087 470 200

ACN 133 593 012

*These entities provide a limited guarantee. The recovery granted from the guarantee is limited to the extent that it does not 
result in the entities breaching their Australian Financial Services Licence conditions.

The guarantees are supported by collateral (in the form of the shares) of the entities.

43.  Subsequent events

Dividends

On 25 August 2015, the Group proposed a final dividend of $12.30 million representing 2.1 cents per share fully franked. The 
record date for determining entitlement to the dividend is 3 September 2015 and the dividend will be paid on 17 September 
2015. Since the dividend has not been declared at year end it has not been recognised as payable in these accounts. 

The Directors are not aware of any other matter or circumstance not otherwise dealt with in this report or the financial 
statements that has significantly, or may significantly; affect the operations of the Group, the results of those operations or the 
state of the affairs of the Group in future financial years. 

ClearView Annual Report 2015     142

ClearView Wealth Limited 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Declaration

The Directors declare that: 

(a)   In the Directors’ opinion, there are reasonable grounds to 
believe that the Company will be able to pay its debts as 
and when they become due and payable; 

(b)   In the Directors’ opinion, the attached financial 

statements and notes thereto are in accordance with 
the Corporations Act 2001, including the compliance 
with accounting standards and giving a true and fair 
view of the financial position and the performance of the 
Company and the consolidated entity; 

(c)   In the Directors’ opinion, the financial statements and 
notes thereto are in accordance with International 
Financial Reporting Standards issued by the International 
Accounting Standards Board as disclosed in Note 3; and 

(d)  The Directors have been given the declarations required 
by section 295A of the Corporations Act 2001. Signed 
in accordance with a resolution of the Directors made 
pursuant to section 295(5) of the Corporations Act 2001. 
On behalf of the Directors 

Dr Gary Weiss 

Chairman 

25 August 2015 

143     ClearView Annual Report 2015

ClearView Wealth LimitedIndependent Auditor’s Report

Deloitte Touche Tohmatsu 
ABN 74 490 121 060 

550 Bourke Street 
GPO Box 78 
Melbourne 3000 
Australia 

Tel:  +61 (0) 3 9671 7000 
Fax:  +61 (0) 3 9671 7001 
www.deloitte.com.au 

Independent Auditor’s Report 
to the members of ClearView Wealth Limited 

Report on the Financial Report  

We have  audited the accompanying financial report of  ClearView Wealth Limited, which comprises 
the consolidated statement of financial position as at 30 June 2015, the consolidated statement of profit 
or  loss  and  other  comprehensive  income,  the  consolidated  statement  of  cash  flows  and  the 
consolidated  statement  of  changes  in  equity  for  the  year  ended  on  that  date,  notes  comprising  a 
summary  of  significant  accounting  policies  and  other  explanatory  information,  and  the  directors’ 
declaration  of  the  consolidated  entity,  comprising  the  company  and  the  entities  it  controlled  at  the 
year’s end or from time to time during the financial year as set out on page 60 to 143.  

Directors’ Responsibility for the Financial Report 

The directors of the company are responsible for the preparation of a financial report that gives a true 
and fair view in accordance with Australian Accounting Standards and the Corporations Act 2001 and 
for such internal control as the directors determine is necessary to enable the preparation of a financial 
report that gives a true and fair view and is free from material misstatement, whether due to fraud or 
error.  In  Note  3,  the  directors  also  state,  in  accordance  with  Accounting  Standard  AASB  101 
Presentation of Financial Statements, that the financial statements comply with International Financial 
Reporting Standards. 

Auditor’s Responsibility 

Our responsibility is to express an opinion on the financial report based on our audit. We conducted 
our audit in accordance with Australian Auditing Standards. Those standards require that we comply 
with  relevant  ethical  requirements  relating  to  audit  engagements  and  plan  and  perform  the  audit  to 
obtain reasonable assurance whether the financial report is free from material misstatement.   

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures 
in  the  financial  report.  The  procedures  selected  depend  on  the  auditor’s  judgement,  including  the 
assessment of the risks of material misstatement of the financial report, whether due to fraud or error. 
In  making  those  risk  assessments,  the  auditor  considers  internal  control,  relevant  to  the  entity’s 
preparation of the financial report that gives a true and fair view, in order to design audit procedures 
that  are  appropriate  in  the  circumstances,  but  not  for  the  purpose  of  expressing  an  opinion  on  the 
effectiveness of the entity’s internal control. An audit also includes  evaluating the appropriateness of 
accounting policies used and the reasonableness of accounting estimates made by the directors, as well 
as evaluating the overall presentation of the financial report. 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for 
our audit opinion. 

Liability limited by a scheme approved under Professional Standards Legislation. 
Member of Deloitte Touche Tohmatsu Limited. 

ClearView Annual Report 2015     144

ClearView Wealth Limited 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Independent Auditor’s Report

Auditor’s Independence Declaration 

In conducting  our audit, we  have complied  with the independence requirements  of the  Corporations 
Act  2001.  We  confirm  that  the  independence  declaration  required  by  the  Corporations  Act  2001, 
which  has been given to the  directors of  ClearView  Wealth Limited,  would be  in the same terms if 
given to the directors as at the time of this auditor’s report.  

Opinion 

In our opinion: 

(a)  the  financial  report  of  ClearView  Wealth  Limited  is  in  accordance  with  the  Corporations  Act 

2001, including: 

(i)  giving a true and fair view of the company’s and consolidated entity’s financial position as at 

30 June 2015 and of their performance for the year ended on that date; and 

(ii)  complying with Australian Accounting Standards and the Corporations Regulations 2001; and 

(b)  the financial statements also comply with International Financial Reporting Standards as disclosed 

in Note 3. 

Report on the Remuneration Report 

We have audited the Remuneration Report included in pages  42 to 57 of the directors’ report for the 
year  ended  30  June  2015.  The  directors  of  the  company  are  responsible  for  the  preparation  and 
presentation  of  the  Remuneration  Report  in  accordance  with  section  300A  of  the  Corporations  Act 
2001.  Our  responsibility  is  to  express  an  opinion  on  the  Remuneration  Report,  based  on  our  audit 
conducted in accordance with Australian Auditing Standards. 

Opinion 

In  our  opinion  the  Remuneration  Report  of  ClearView  Wealth  Limited  for  the  year  ended  30  June 
2015, complies with section 300A of the Corporations Act 2001.  

DELOITTE TOUCHE TOHMATSU 

Peter A. Caldwell 
Partner 
Chartered Accountants 
Melbourne, 25 August 2015 

145     ClearView Annual Report 2015

ClearView Wealth Limited 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Shareholders’ Information
As at 6 August 2015

Substantial shareholders
As at the date of this Annual Report, the following entities have notified ClearView that they hold a substantial holding  
in shares.

No. of shares 
as per notice

% of issued 
capital

310,076,859

62,447,883

52.9%

10.7%

Rank

Name

1

2

1 

CCP Bidco Pty Ltd and Associates

Macquarie Investment Management Limited

 Crescent Capital Partners Management Pty Limited represent the interests of CCP Bidco Pty Limited (CCP Bidco) and Macquarie Investment Management 
Limited (MIML) as manager. MIML’s 10.7% is therefore included in the 52.9% holding of CCP Bidco in the table above.

Twenty largest shareholders (as at 6 August 2015)

Rank

Name

No. of shares 
as per notice

% of issued 
capital

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

CCP Bidco Pty Ltd

Macquarie Investment Management Limited 

Citicorp Nominees Pty Limited

CCP Trusco 4 Pty Limited 

Portfolio Services Pty Ltd

CCP Bidco Pty Limited 

CCP Trusco 5 Pty Limited

CCP Trusco 1 Pty Limited 

Pacific Custodians Pty Limited

Macquarie Investment Management Limited 

HSBC Custody Nominees (Australia) Limited

J P Morgan Nominees Australia Limited

CCP Trusco 3 Pty Limited 

BNP Paribas Noms Pty Ltd 

National Nominees Limited

Mr Simon Swanson

CCP Trusco 4 Pty Limited 

CCP Trusco 2 Pty Limited 

CCP Bidco Pty Limited 

Salamanca Group Trust (Switzerland) SA

92,294,252

47,580,009

33,525,225

30,972,903

25,450,635

24,011,127

21,955,128

20,224,844

15,432,642

14,867,874

14,824,553

13,718,621

11,557,052

10,495,016

10,011,121

10,000,000

9,678,460

9,630,878

7,503,034

7,500,000

15.76

8.12

5.72

5.29

4.34

4.10

3.75

3.45

2.63

2.54

2.53

2.34

1.97

1.79

1.71

1.71

1.65

1.64

1.28

1.28

ClearView Annual Report 2015     146

ClearView Wealth LimitedShareholders’ Information
As at 6 August 2015

Ordinary Share Capital
There are 585,768,954 fully paid ordinary shares held by 1,795 shareholders. All the shares carry one vote per share. 

Distribution of shareholders
The distribution of Shareholders as at 6 August 2015 is as follows:

Range

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

Total

Unmarketable parcels

Minimum $500.00 parcel at $0.80 per unit

Shares under voluntary escrow
There are no shares subject to voluntary escrow as at 30 June 2015.

Total 
holders

279

498

292

522

204

Units

94,481

1,483,340

2,227,847

15,761,273

566,202,013

1,795

585,768,954

% of issued 
capital

0.02

0.25

0.38

2.69

96.66

100.00

Minimum 
parcel size

535

Holders

189

Units

19,833

147     ClearView Annual Report 2015

ClearView Wealth LimitedThis page has been left blank intentionally.

ClearView Annual Report 2015     148

ClearView Wealth LimitedThis page has been left blank intentionally.

149     ClearView Annual Report 2015
149     ClearView Annual Report 2015

ClearView Wealth Limited

ClearView Wealth Limited

ClearView Annual Report 2015     150

ClearView Wealth LimitedAuditors
Deloitte Touche Tohmatsu

Stock Listing
ClearView Wealth Limited is listed on 
the Australian Securities Exchange (ASX) 
under the ASX code “CVW”.

Annual Corporate 
Governance Statement
The ClearView Annual Corporate 
Governance Statement may be viewed 
at www.clearview.com.au/page/
shareholders/corporate-governance

Directory

Directors
 Dr Gary Weiss (Chairman)

Andrew Sneddon

Bruce Edwards

David Brown 

Gary Burg

Jennifer Newmarch

Michael Alscher 

 Michael Lukin  
(Alternate to Mrs Newmarch)

Nathanial Thomson

Simon Swanson

Managing Director
Simon Swanson

Company Secretaries
Chris Robson

Athol Chiert

Appointed Actuary 
Ashutosh Bhalerao

Chief Actuary and  
Risk Officer
Greg Martin

Registered Office  
and Contact Details
Level 12, 20 Bond Street 
Sydney NSW 2000

GPO Box 4232 
Sydney NSW 2001

Telephone: +61 2 8095 1300 
Facsimile: +61 2 9233 1960 
Email: ir@clearview.com.au 
Website: www.clearview.com.au

Share Registry
For all enquiries relating to 
shareholdings, dividends and related 
matters, please contact the share 
registry:

Computershare Investor 
Services Pty Limited 
Level 3, 60 Carrington Street 
Sydney NSW 2000

GPO Box 2975 
Melbourne VIC 3001

Telephone: 

 1300 850 505 
+61 3 9415 4000

Facsimile:   

+61 3 9473 2500

www.computershare.com.au

149     ClearView Annual Report 2015

ClearView Wealth Limited

ClearView Wealth Limited

ClearView Annual Report 2015     150

ClearView Wealth Limited

ABN 83 106 248 248

www.clearview.com.au

ASX code CVW